dobutamine has been researched along with Heart Failure in 736 studies
*Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 189 (25.68) | 18.7374 |
| 1990's | 192 (26.09) | 18.2507 |
| 2000's | 207 (28.13) | 29.6817 |
| 2010's | 121 (16.44) | 24.3611 |
| 2020's | 27 (3.67) | 2.80 |
| Authors | Studies |
|---|---|
| Erhardt, PW | 1 |
| Bostwick, JS; Brigance, R; Finlay, HJ; Gargalovic, PS; Generaux, CN; Luk, CE; Meng, W; Onorato, JM; Pi, Z; Rossi, KA; Schumacher, WA; Wang, T; Wexler, RR | 1 |
| Ambinathan, JPN; Burns, KD; Cherney, DZI; Godoy, LC; Lytvyn, A; Lytvyn, Y; Osuntokun, O; Parker, JD; Testani, JM | 1 |
| Ochiai, ME; Pereira Barretto, AC; Silva, EVC; Vieira, KRN | 1 |
| Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Pruc, M; Rafique, Z; Szarpak, L; Szwed, P | 1 |
| Bandyopadhyay, D; Biswas, S; Briasoulis, A; Fonarow, GC; Goel, A; Gupta, R; Lanier, GM; Malik, AH; Naidu, SS | 1 |
| Bader, I; Bergin, P; Dagan, M; Easton, K; Hare, JL; Kaye, DM; Lankaputhra, M; Leet, A; Linton, A; McLean, C; Patel, HC; Taylor, A; Tee, SL; Yeung, T | 1 |
| Anand, V; Kane, GC; Lee, AT; McCully, RB; Pellikka, PA; Pislaru, C; Pislaru, SV; Scott, CG | 1 |
| Le Jemtel, T; Rajapreyar, I; Samson, R; Stencel, J | 1 |
| Acharya, P; Al-Masry, AA; Bajwa, S; Bakel, AV; Boda, I; Dalia, T; Goyal, A; Mastoris, I; Maurides, S; Noonan, G; Parimi, N; Sami, F; Sauer, A; Shah, Z; Tran, C | 1 |
| Eaton, RE; Haas, GJ; Kissling, KT; McLaughlin, EM; Pickworth, KK | 1 |
| Aydın, C; Kaplangoray, M | 1 |
| Alkadri, J; Hu, R; Jeffers, MS; McDonald, B; McIsaac, DI; Ross, J | 1 |
| Billia, F; Brahmbhatt, DH; Fung, NL; Luis Scolari, F; Luk, A; Mihajlovic, V; Otsuki, M; Overgaard, CB; Rodenas-Alesina, E; Wang, VN | 1 |
| Dong, N; Guo, Q; Lan, H; Li, C; Shi, J; Wang, G; Xiong, T; Zhang, J; Zheng, Q | 1 |
| Fujita, T; Fukushima, N; Fukushima, S; Hada, T; Kainuma, S; Kamiya, H; Kunioka, S; Mochizuki, H; Seguchi, O; Shimojima, M; Tadokoro, N; Tsukamoto, Y; Watanabe, T | 1 |
| AbouEzzeddine, OF; Behfar, A; Borlaug, BA; Chareonthaitawee, P; Fudim, M; Kemp, BJ; Mullan, BP; Pislaru, SV; Redfield, MM | 1 |
| How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| Cheng, J; Kelly, J; Lupi, K; Malloy, R | 1 |
| Araújo, I; Campos, L; Cunha, GJL; Fernandes, L; Ferraz, M; Fonseca, C; Gomes, RV; Morais, R; Rocha, BML | 1 |
| Gyoda, Y; Kawauchi, J; Oikawa, Y; Sakuma, E; Watanabe, J | 1 |
| Agoston, G; Amor, M; Arbucci, R; Barbieri, A; Beleslin, B; Bombardini, T; Borguezan Daros, C; Boshchenko, A; Boskovic, N; Bossone, E; Camarozano, AC; Carpeggiani, C; Celutkiene, J; Ciampi, Q; Citro, R; Colonna, P; Cortigiani, L; Costantino, FM; D'Alfonso, MG; D'Andrea, A; de Castro E Silva Pretto, JL; DE Nes, M; Dekleva, M; DI Salvo, G; Djordjevic-Dikic, A; Dodi, C; Ferrara, F; Gaibazzi, N; Gligorova, S; Gregori, D; Haberka, M; Kasprzak, JD; Kovacevic Preradovic, T; Lattanzi, F; Lowenstein, J; Merlo, PM; Monte, IP; Mori, F; Morrone, D; Nikolic, A; Ostojic, M; Paterni, M; Petrovic, M; Picano, E; Rabia, G; Re, F; Reisenhofer, B; Rigo, F; Rodrìguez-Zanella, H; Ryabova, T; Salamé, M; Salustri, A; Scali, MC; Severino, S; Simova, I; Szymczyk, E; Tesic, M; Torres, MA; Varga, A; Vargas Mieles, PE; Vladova, M; Wdowiak-Okrojek, K; Wejner-Mik, P; Wierzbowska-Drabik, K; Zagatina, A; Zhuravskaya, N | 1 |
| Bottio, T; Gerosa, G; Piperata, A | 1 |
| Jakovljevic, DG; MacGowan, GA; Mungulmare, K; Okwose, NC; Sengupta, SP | 1 |
| Ahn, C; Aronow, WS; Cooper, HA; Gass, AL; Gupta, CA; Khan, MH; Lanier, GM; Levine, A; Lloji, A; Mody, BP; Zaid, S | 1 |
| Cun, Y; Jianlong, W | 1 |
| Alvarez, J; Bettex, D; Bouchez, S; Fruhwald, S; Girardis, M; Grossini, E; Guarracino, F; Heringlake, M; Herpain, A; Pollesello, P; Toller, W; Tritapepe, L | 1 |
| Filipiak, KJ; Gasecka, A; Jaguszewski, MJ; Szarpak, L; Targonski, R | 1 |
| Dadfar, B; Doye, AA; Gwathmey, JK; Jaleel, R; Naushad, J; Parambathazhath, J; Siri-Angkul, N; Xie, LH | 1 |
| Biskupiak, J; Bress, AP; King, JB; Munger, MA; Sainski-Nguyen, A; Shah, RU | 1 |
| Balik, M; Mokotedi, CM | 1 |
| Carpeggiani, C; Ciampi, Q; Michelassi, C; Picano, E; Villari, B | 1 |
| Almeida, I; Caetano, F; Costa, M; Fernandes, A; Gonçalves, L; Madeira, M; Reis, L | 1 |
| Hirai, T; Joho, S; Kinugawa, K; Nakagaito, M; Nakamura, M; Ushijima, R | 1 |
| Ceyssens, W; Dupont, M; Jacobs, L; Luwel, E; Martens, P; Mullens, W; Potargent, P; Renaers, M; Van Aerde, H; Vercammen, J | 1 |
| Gerds, TA; Jakobsen, CJ; Karaliunaite, Z; Nielsen, DV; Skals, RK; Torp-Pedersen, C | 1 |
| Al Madfai, F; Ming, LC; Patel, RP; Peterson, GM; Valah, B; Wanandy, T; Zaidi, STR | 1 |
| Bischoff, E; Boehme, P; Dinh, W; Hoffmann, J; Hüser, J; Kolkhof, P; Mondritzki, T; Park, JW; Sandner, P; Truebel, H; Vogel, J; Walsh, S; White, J | 1 |
| Apostolopoulou, SC; Kakava, F; Rammos, S; Tsoutsinos, A; Vagenakis, GA | 1 |
| Adesiyun, T; Beard, D; Davis, RE; Hashimoto, T; Hendrick, JP; Hoxie, HR; Hsu, S; Kass, DA; Kim, GE; Lee, DI; Nakagawa, R; O'Brien, JJ; Tunin, RS; Wennogle, LP; Yao, W; Zhu, G | 1 |
| Anker, SD; Balligand, JL; Bauersachs, J; Brutsaert, D; Carrier, L; Chlopicki, S; Cleland, JG; de Boer, RA; de Keulenaer, G; Dietl, A; Eschenhagen, T; Fischmeister, R; Hamdani, N; Harjola, VP; Heinzel, FR; Heymans, S; Hilfiker-Kleiner, D; Holzmeister, J; Limongelli, G; Linke, WA; Lund, LH; Lyon, AR; Maack, C; Manstein, DJ; Masip, J; Mebazaa, A; Metra, M; Metzger, J; Mueller, C; Papp, Z; Pieske, B; Ponikowski, P; Ristić, A; Ruschitzka, F; Seferović, PM; Skouri, H; Tocchetti, CG; Yilmaz, MB; Zimmermann, WH | 1 |
| Bakkehaug, JP; How, OJ; Kildal, AB; Myrmel, T; Rødland, L; Rønning, L | 1 |
| Andersson, B; Bartfay, SE; Bergh, N; Bollano, E; Dahlberg, P; Gilljam, T; Hjalmarsson, C; Karason, K; Lannemyr, L; Ljungman, C; Ricksten, SE; Rundqvist, B | 1 |
| Bovenzi, F; Coltelli, M; Cortigiani, L; Picano, E; Ramirez, P | 1 |
| Aggeli, C; Couloheri, S; Dilaveris, P; Gatzoulis, K; Giannoulis, E; Kallikazaros, I; Katsaros, A; Koukos, M; Koutagiar, I; Lagoudakou, S; Margioula, E; Poulidakis, E; Sfendouraki, E; Sideris, S; Stefanadis, C; Tousoulis, D | 1 |
| Ishido, H; Iwamoto, Y; Kuwata, S; Masutani, S; Nishida, T; Saiki, H; Senzaki, H; Taketazu, M | 1 |
| Bellagamba, CCA; Bertoluci, C; Bombardini, T; Camarozano, AC; Ciampi, Q; De Nes, M; Junior, AIH; Picano, E; Quevedo, NM; Texeira, TF; Torres, MAR | 1 |
| B Bastos, M; Brugts, JJ; Bunge, JJH; Constantinescu, AA; Daemen, J; den Uil, CA; Engstrom, AE; Jewbali, LS; Lenzen, MJ; Manintveld, OC; Van Mieghem, NM; Wilschut, JM; Zijlstra, F | 1 |
| Caballero, LG; Clausell, N; Domingues, FB; Goldraich, LA; Hastenteufel, LCT; Neyeloff, JL; Silva, ERRD | 1 |
| Khemka, A; Sawada, SG | 1 |
| Izumi, C | 1 |
| Abe, Y; Arai, K; Ashihara, K; Hagiwara, N; Haze, K; Itoh, A; Naruko, T; Shoda, M; Takagi, A; Yagishita, D; Yagishita-Tagawa, Y; Yoshikawa, J | 1 |
| Barbosa, AC; Oliveira, MG; Passos, LC; Santos, EG | 1 |
| Apitz, C; Binder, W; Hofbeck, M; Kerst, G; Latus, H; Sieverding, L | 1 |
| Ayik, F; Balcioglu, O; Baysal, B; Engin, C; Erkul, S; Oguz, E; Ozbaran, M; Ozturk, P; Yagdi, T | 1 |
| Huang, LQ; Huang, X; Jiang, RL; Lei, S; Xia, GL; Zhi, YH; Zhu, MF | 1 |
| C Marboe, C; Mancini, D; Sugiyama Kato, T; Yoshizawa, S | 1 |
| Carll, AP; Cascio, WE; Costa, DL; Farraj, AK; Haykal-Coates, N; Hazari, MS; King, CJ; Krantz, QT; Perez, CM | 1 |
| Hata, N; Kobayashi, N; Okazaki, H; Shinada, T; Shirakabe, A; Tomita, K; Tsurumi, M; Yamamoto, Y; Yokoyama, S | 1 |
| Chłopicki, S; Drelicharz, L; Heinze-Paluchowska, S; Jabłońska, M; Skórka, T; Tyrankiewicz, U; Woźniak, M | 1 |
| McNally, EM | 1 |
| Garcia-Menendez, L; Gong, G; Karamanlidis, G; Kolwicz, SC; Lee, CF; Morgan, PG; Sedensky, MM; Suthammarak, W; Tian, R; Wang, W | 1 |
| Barrett, NA; Berry, WT; Hewson, RW; Langrish, CJ; McKenzie, CA | 1 |
| Bacaksiz, A; Erdogan, E; Ergelen, M; Erturk, M; Karakurt, H; Sonmez, O; Tasal, A; Turfan, M; Uyarel, H; Vatankulu, MA | 1 |
| Balk, AH; Caliskan, K; Constantinescu, AA; Jewbali, L; Manintveld, OC; van Domburg, R | 1 |
| Mitro, P; Murin, P; Simurda, M; Valocik, G | 1 |
| Gu, Y; Niu, HY; Pan, HY; Pan, M; Yu, XH; Zhu, JH | 1 |
| Baleine, J; Cambonie, G; de la Villéon, G; Durand, S; Jacquot, A; Milesi, C; Novais, AR; Roujeau, T | 1 |
| Barretto, AC; Brancalhão, EC; Cardoso, JN; Ochiai, ME; Oliveira, MT; Puig, RS; Vieira, KR | 1 |
| Akturk, IF; Birant, A; Erturk, M; Karakurt, H; Kurtar Mansıroglu, A; Oner, E; Somuncu, MU; Uzun, F; Yalcin, AA; Yildirim, A | 1 |
| Cavusoglu, Y; Mert, U; Morrad, B; Mutlu, F; Nadir, A; Ulus, T | 1 |
| Cepeda, JM; Conthe, P | 1 |
| Chivite, D; Corbella, X; Formiga, F | 1 |
| Mitro, P; Murín, P; Spurný, P; Valocik, G | 1 |
| Butterick, TA; Cabrera, JA; Duffy, CM; Holley, CT; Kelly, RF; Lindsey, ME; Long, EK; McFalls, EO; Ward, HB | 1 |
| Czer, LS; Lee, CC; Luthringer, DJ | 1 |
| Balestra, GM; Eerbeek, O; Mik, EG; Specht, PA; van der Laarse, WJ; Zuurbier, CJ | 1 |
| Abroug, F; Dachraoui, F; Fekih-Hassen, M; Ouanes Besbes, L; Ouanes, I; Souheil, E | 1 |
| Andersen, MJ; Borlaug, BA; Fetterly, K; Hwang, SJ; Kane, GC; Melenovsky, V; Olson, TP | 1 |
| Abdellatif, M; Falcão-Pires, I; Fontoura, D; Leite, S; Leite-Moreira, AF; Lourenço, AP; Oliveira-Pinto, J; Tavares-Silva, M | 1 |
| Arai, M; Horiguchi, J; Koitabashi, N; Kurabayashi, M; Ohyama, Y; Rokutanda, N; Tateno, R | 1 |
| Charles, CJ; Ellmers, LJ; Mark Richards, A; Rademaker, MT | 1 |
| Shan, YX; Wang, XC; Zhu, DM | 1 |
| Mittal, M; Radhakrishnan, M; UmamaheswaraRao, GS | 1 |
| Çavuşoğlu, Y; Demirtaş, S; Gencer, E; Güneş, H; Kalaycı, S; Korkmaz, Ş; Mert, UK; Mutlu, F; Özdemir, S; Şaşmaz, H; Yılmaz, MB | 1 |
| Ban, T; Chen, H; Chen, WR; Fan, Y; Li, BY; Qiao, QF; Sun, HL; Yan, ZY | 1 |
| Al-Hesayen, A; Cherney, DZ; Floras, JS; Gilbert, C; Mak, S; Parker, AB; Parker, JD | 1 |
| Bode, EF; Borland, SJ; Briston, SJ; Dibb, KM; Horn, MA; Kirkwood, GJ; Richards, MA; Trafford, AW | 1 |
| Acharya, D; Hashim, T; Loyaga-Rendon, RY; Morgan, CJ; Pamboukian, SV; Revilla-Martinez, M; Sanam, K; Tallaj, JA | 1 |
| Ertl, G; Pauschinger, M; von Scheidt, W | 1 |
| Harjola, VP; Kivikko, M; Nieminen, MS; Pollesello, P; Sarapohja, T; Tarvasmäki, T | 1 |
| Dupont Birkler, RI; Frederiksen, CA; Heiberg, J; Hyldebrandt, JA; Johannsen, M; Ravn, HB; Schmidt, MR; Støttrup, NB | 1 |
| Bauersachs, J; Bengel, FM; Bogeski, I; Erschow, S; Haghikia, A; Hagl, C; Hilfiker-Kleiner, D; Jauhiainen, M; Kappl, R; Knuuti, J; Kohlhaas, M; Maack, C; Müller, M; Nickel, AG; Pietzsch, S; Ricke-Hoch, M; Roivainen, A; Saar, JA; Saraste, A; Scherr, M; Sieve, I; Silvola, JM; Stapel, B; Thackeray, JT; Tudorache, I | 1 |
| Brugaletta, S; Comerci, G; Di Giannuario, G; Forni, F; Lombardo, A; Loperfido, F; Lotrionte, M; Marchese, N; Natali, R; Pisanello, C; Savino, M; Vigna, C | 1 |
| Anastasiou-Nana, M; Dimopoulos, S; Gerovasili, V; Kaldara, E; Kourtidou, S; Nanas, J; Nanas, S; Pierrakos, C; Roussos, C; Sarafoglou, S; Venetsanakos, J | 1 |
| Bacal, F; Bocchi, EA; Cardoso, LF; Ferreira, SM; Grativvol, PS; Mangini, S; Mocelin, AO; Seguro, LF; Silva, CP; Silveira, FS | 1 |
| Carlson, M; Jones, JA; Ma, YJ; Rajagopalan, V; Zucker, IH | 1 |
| Amour, J; Coriat, P; Ibanez-Esteve, C; Langeron, O; Nicolas-Robin, A; Riou, B | 1 |
| Akyuz, S; Alioglu, E; Bozkaya, YT; Duygu, H; Gunduz, R; Kirilmaz, B; Ozdogan, O; Payzin, S; Turk, U; Turkoglu, C | 1 |
| Bulsara, M; Chamberlain, J; Harding, R; Ho, KM | 1 |
| Bistola, V; Filippatos, G; Ikonomidis, I; Kremastinos, DT; Papadopoulos, C; Paraskevaidis, IA; Parissis, JT | 1 |
| Fischer, G; Stephani, U; van Baalen, A; von Spiczak, S | 1 |
| Blake, SL; Bloch, KD; Brownell, AL; Buys, ES; Derumeaux, G; Kaneki, M; Kuruppu, D; Picard, MH; Raher, MJ; Rieusset, J; Scherrer-Crosbie, M; Shimizu, N; Thibault, HB | 1 |
| Akilli, A; Akin, M; Duygu, H; Ergene, O; Erturk, U; Nalbantgil, S; Nazli, C; Ozerkan, F; Zoghi, M | 1 |
| Donati, A; Elisei, D; Falzetti, G; Pelaia, P; Principi, T | 1 |
| Mebazaa, A; Paraskevaidis, I; Parissis, JT; Rafouli-Stergiou, P | 1 |
| Cleland, JG; Cohen-Solal, A; Filippatos, GS; Huang, B; Mebazaa, A; Nieminen, MS; Padley, RJ; Salon, JE; Thakkar, R | 1 |
| Erdem, A; Karadas, F; Tandogan, I; Turgut, OO; Yalta, K; Yilmaz, A; Yilmaz, MB; Yontar, C | 2 |
| Bonios, M; Drakos, SG; Kaldara, E; Kanakakis, JV; Katsaros, F; Nanas, JN; Nanas, S; Pantsios, C | 1 |
| Blair, JE; Filippatos, GS; Gheorghiade, M; Harinstein, ME; Khan, H; Metra, M; Porchet, H; Sabbah, HN; Valentini, G; Vogel, M | 1 |
| Ciampi, Q; Citro, R; Piacenti, M; Picano, E; Pratali, L; Villari, B | 1 |
| Donlan, SM; Gheorghiade, M; Pang, PS; Quattromani, E | 1 |
| Chay Woodward, T; de Lissovoy, G; Fraeman, K; Salon, J; Sterz, R | 1 |
| Cai, D; Cohen-Solal, A; Huang, B; Logeart, D; Mebazaa, A; Nieminen, MS | 1 |
| Böhm, M; Link, A; Reil, JC; Selejan, S | 1 |
| Boyd, JH; Indrambarya, T; McConechy, M; Walley, KR; Wang, Y | 1 |
| Bodi, V; Chaustre, F; Chorro, FJ; Forteza, MJ; Husser, O; Llacer, A; Lopez-Lereu, MP; Mainar, L; Monmeneu, JV; Nunez, J; Rumiz, E; Sanchis, J; Trapero, I | 1 |
| Wu, KC | 1 |
| Braz, JC; Corbly, AK; Gill, RM; Jin, N; Jones, BD; Shen, W; Vlahos, CJ; Wu, Q | 1 |
| Chughtai, H; Dall'Armellina, E; Hamilton, CA; Hundley, WG; Kitzman, DW; Link, KM; Morgan, TM; Ntim, W; Walsh, TF | 1 |
| Blier, L; Champagne, J; Dubois, M; Dumesnil, JG; Garceau, P; Lancellotti, P; Magne, J; Molin, F; O'Hara, G; Philippon, F; Pierard, L; Sénéchal, M | 1 |
| Kiviniemi, V; Kurola, J; Leppikangas, H; Lindgren, L; Ruokonen, E; Rutanen, J | 1 |
| Chu, EC; Gorodeski, EZ; Hsich, E; Reese, JR; Shishehbor, MH; Starling, RC | 1 |
| Kato, M; Kitakaze, M; Sanada, S | 1 |
| Bilgehan, K; Duman, D; Palit, F; Sacide, A; Simsek, E | 1 |
| Cas, LD; Cotter, G; Gheorghiade, M; Metra, M; Sabbah, HN; Teerlink, JR; Zacà, V | 1 |
| Bertoletti, L; Humbert, M; Jaïs, X; Price, LC; Simonneau, G; Sitbon, O; Souza, R; Sztrymf, B | 1 |
| Bombardini, T; Ciampi, Q; Della Porta, M; Petruzziello, B; Picano, E; Pratali, L; Sicari, R; Villari, B | 1 |
| Lage, SG; Lagudis, S; Mansur, AJ; Medeiros, CC; Vieira, ML; Yamada, AT | 1 |
| Agresti, C; Baroncini, C; Caldi, F; Innocenti, F; Mannucci, E; Monami, M; Pini, R | 1 |
| Omerovic, E; Swedberg, K; Waagstein, F | 1 |
| Andersson, B; Bergh, CH; Dahlström, U; Forfang, K; Kivikko, M; Sarapohja, T; Ullman, B; Wikström, G | 1 |
| Barretto, AC; Cardoso, JN; Morgado, PC; Munhoz, RT; Ochiai, ME; Ramires, JA | 1 |
| Alexander, PM; Butt, WW; Penny, DJ; Ryerson, LM; Shann, FA; Shekerdemian, LS | 1 |
| Azam, S; Berthiaume, JM; Bray, MS; Chandler, MP; Chen, X; Hoit, BD; McElfresh, TA; Young, ME | 1 |
| Campia, U; Gheorghiade, M; Nodari, S | 1 |
| Bauer, R; Blain, A; Bushby, K; Greally, E; Laval, S; Lochmüller, H; MacGowan, GA; Straub, V | 1 |
| Wikström, BG | 1 |
| Ayub-Ferreira, SM; Bacal, F; Bocchi, EA; Mangini, S; Marcondes-Braga, FG | 1 |
| Barretto, AC; Brancalhão, EC; Cardoso, JN; Grativvol, KM; Grativvol, PS; Lima, MV; Morgado, PC; Munhoz, RT; Ochiai, ME; Scipioni, AR | 1 |
| Gjessing, PF; Hermansen, SE; How, OJ; Kildal, AB; Myrmel, T; Røsner, A; Stenberg, TA | 1 |
| Cui, L; Hao, YM; Jiang, DJ; Li, GP; Li, HM; Liu, J; Qi, GX; Wang, L; Wang, WZ; Wei, JP; Zhang, YD | 1 |
| Kawada, T; Sugimachi, M; Sunagawa, K; Uemura, K | 1 |
| Erdem, A; Tandogan, I; Yalta, K; Yilmaz, MB; Yontar, OC | 1 |
| Coons, JC; McGraw, M; Murali, S | 1 |
| Anastasiou-Nana, M; Bistola, V; Ikonomidis, I; Papadopoulos, C; Paraskevaidis, IA; Parissis, J; Stassinos, V | 1 |
| Ata, N; Birdane, A; Cavuşoğlu, Y; Demirüstü, C; Göktekin, Ö; Görenek, B; Tek, M; Ünalır, A | 1 |
| Böhm, M; Cai, D; Cohen Solal, A; Filippatos, GS; Huang, B; Kivikko, M; Link, A; Mebazaa, A; Nieminen, MS; Padley, RJ; Salem, R | 1 |
| Ashley, EA; Denault, AY; Deschamps, A; Haddad, F; Haddad, H; Vrtovec, B | 1 |
| Charoenpanichkit, C; Dall'Armellina, E; Hamilton, CA; Hundley, WG; Little, WC; Mandapaka, S; Morgan, TM | 1 |
| Chiribiri, A; Egnell, C; Fleck, E; Gebker, R; Hamdan, A; Jahnke, C; Kelle, S; Klein, C; Paetsch, I; Vierecke, J; Wellnhofer, E | 1 |
| Garot, J; O h-Ici, D | 1 |
| Cheng, XW; Funahashi, H; Hirashiki, A; Inden, Y; Izawa, H; Murohara, T; Nomura, M | 1 |
| Arai, AE; Schwitter, J | 1 |
| Bettari, L; Bugatti, S; Carubelli, V; Danesi, R; Dei Cas, L; Lazzarini, V; Lombardi, C; Metra, M; Monti, A; Villa, C | 1 |
| Ding, ZM; Hansen, G; Read, RW; Shi, ZZ; Van Sligtenhorst, I; Vogel, P | 1 |
| Altman, RK; Chen-Tournoux, AA; McCarty, D; Orencole, M; Park, MY; Picard, MH; Riedl, L; Singh, JP; Tournoux, FB | 1 |
| Ekholm, S; Germin, BI; Hu, R; Huang, Y; Kolar, B; Liu, X; Tian, W; Zhong, J | 1 |
| Brasolin, B; Bruno, N; Caira, C; D'Ambrosi, A; Fedele, F; Mancone, M | 1 |
| Montalto, M | 1 |
| Barbosa, AC; Passos, LC; Santos, EG | 1 |
| Burger, AJ; Josephson, ME; Mittleman, MA; Nearing, BD; Verrier, RL; Wellenius, GA | 1 |
| Delaney, A; McCaffrey, J; Tacon, CL | 1 |
| Aquaro, GD; Cospite, V; De Marchi, D; Emdin, M; Gallotta, M; L'Abbate, A; Lionetti, V; Lombardi, M; Lorenzoni, V; Molinaro, S; Passino, C; Pingitore, A | 1 |
| Jovicić, B; Kosutić, J; Nikolić, L; Prijić, S; Rakić, S; Stajević, M; Vukomanović, V | 1 |
| Akki, A; Caceres, V; Chacko, VP; Foster, DB; Gerstenblith, G; Gupta, A; Kirk, JA; Lai, S; Leppo, MK; Paolocci, N; Shi, S; Steenbergen, C; Su, J; Wang, Y; Weiss, RG | 1 |
| Borlu, F; Dal, MS; Oztekin, E; Paksoy, F; Tursun, I; Ulaş, T | 1 |
| Bonadei, I; Bugatti, S; Caretta, G; D'Aloia, A; Dei Cas, L; Vizzardi, E; Zanini, G | 1 |
| Nagdev, A; Sivitz, A | 1 |
| Fujiwara, H; Fukuhara, R; Miyamoto, T; Nishi, K; Saijo, S; Sato, Y; Takatsu, Y; Taniguchi, R; Toma, M | 1 |
| Alalawi, R; Alexopoulos, D; Davlouros, P; Jumper, C; Karabinis, A; Karakitsos, D; Papanikolaou, J; Wachtel, M | 1 |
| Besancon, A; de Haro, L; Glaizal, M; Hayek-Lanthois, M; Klouche, K; Schmitt, C; Tichadou, L | 1 |
| An, T; Huang, Y; Lü, R; Qing, EM; Qing, P; Wei, BQ; Zhang, J; Zhang, YH; Zhou, Q; Zou, CH | 1 |
| Bai, XJ; Huang, Y; Jiang, YN; Li, H; Liu, WX; Qing, EM; Qu, P; Sun, YX; Wei, BQ; Zhang, J; Zhang, L; Zhang, YH; Zhou, Q | 1 |
| Amir, O; Zafrir, B | 1 |
| Bonadei, I; Bugatti, S; Curnis, A; D'Aloia, A; Dei Cas, L; Del Magro, F; Rovetta, R; Vizzardi, E | 1 |
| Hirayama, A; Kato, M | 1 |
| Chaanine, AH; Chemaly, ER; Hajjar, RJ; Sakata, S | 1 |
| Cai, D; Cohen-Solal, A; Deye, N; Kivikko, M; Laribi, S; Laterre, PF; Mebazaa, A; Nikolaou, M; Parissis, J; Paugam-Burtz, C; Poder, P; Pohjanjousi, P; Seronde, MF; Yilmaz, MB | 1 |
| Chlopicki, S; Jablonska, M; Petkow-Dimitrow, P; Skorka, T; Tyrankiewicz, U | 1 |
| Apajasalo, M; D'Ambrosi, A; Fedele, F; Lucioni, C; Mazzi, S; Pollesello, P | 1 |
| Abe, T; Kobayashi, S; Misawa, H; Sakata, S; Tabayashi, N; Takaki, M; Takenaka, C; Taniguchi, S; Yoshikawa, Y | 1 |
| Blackburn, B; Chandler, MP; Morita, H; Roth, BA; Sabbah, HN; Stanley, WC; Suzuki, G; Wolff, A | 1 |
| Reek, S | 1 |
| Bristow, MR; D'Aloia, A; Dei Cas, L; Metra, M; Muneretto, C; Nodari, S; Robertson, AD | 1 |
| Himura, Y; Kashiki, M; Liang, CS; Stevens, SY | 1 |
| Corbly, AK; Gill, RM; Jones, BD; Shen, W; Steinberg, MI; Zhang, JP | 1 |
| Böhm, M | 1 |
| Akintürk, H; Benson, M; Bräu, M; Hempelmann, G; Junger, A; Kwapisz, MM; Müller, M; Schindler, E | 1 |
| Duboc, D | 1 |
| Burger, AJ; Cheng, ML; Dennish, G; Dinerman, J; Elkayam, U; Ghali, JK; Horton, DP; Koren, M; LeJemtel, T; Silver, M; Torre, G | 1 |
| Allanic, L; Da Conceiçao, M; Fassassi, M; Favier, JC; Pitti, R; Steiner, T | 1 |
| Asanoi, H; Inoue, H; Ishizaka, S; Joho, S; Kameyama, T | 1 |
| Cerný, J; Frélich, M; Groch, L; Hude, P; Krejcí, J; Meluzín, J; Panovský, R; Rambousková, L; Spinarová, L; Stetka, F; Toman, J | 1 |
| Apajasalo, M; Cleland, JG; Kobelt, G; Takala, A; Zethraeus, N | 1 |
| Gattis, WA; Gheorghiade, M; Jain, P; Klein, L; Massie, BM | 1 |
| Adams, KF; Gheorghiade, M; Mathur, VS | 1 |
| Adams, KF; Gattis, WA; Gheorghiade, M; Jaffe, AS; O'Connor, CM | 1 |
| Felker, GM; O'connor, CM | 1 |
| Aranda, JM; Cleeton, TS; Hill, JA; Leach, D; Lopez, LM; Monroe, VS; Pauly, DF; Schofield, RS; Walker, TC | 1 |
| Bax, JJ; Borghetti, A; De Sutter, J; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; van Domburg, RT; Vourvouri, EC | 1 |
| Edwards, N; Hankins, S; Hauff, H; Lang, CC; Mancini, DM; Maybaum, S | 1 |
| Gronda, E; Mangiavacchi, M | 1 |
| Chatterjee, K; De Marco, T | 1 |
| Aronson, D; Burger, AJ | 3 |
| Rich, MW; Shore, BL | 1 |
| Andersson, B; Bollano, E; Hjalmarson, A; Täng, MS; Waagstein, F | 1 |
| Chana, JS; Kocheril, AG; Moazemi, K; Willard, AM | 1 |
| Aronson, D; Burger, AJ; Burger, MR; Horton, DP | 1 |
| Aranda, JM; Hill, JA; Hsu, K; Pauly, DF; Schofield, R | 1 |
| Castelli, G; Dolara, A; Favilli, S; Mori, F; Olivotto, I; Zuppiroli, A | 1 |
| Stevenson, LW | 1 |
| Adamson, PB; Carminati, P; Gagnol, JP; Germany, R; Mattera, GG; Schwartz, PJ; Vanoli, E | 1 |
| Bender, C; Braun, K; Dittrich, S; Germanakis, I; Hentschel, R; Kececioglu, D | 1 |
| Carron, C; Gibbons, W; López-Candales, A; Schwartz, J; Simmons, P; Vora, T | 1 |
| Burger, AJ; Ciesla, G; de Lissovoy, G; Munger, M; Stier, DM | 1 |
| Boldt, J; Kirchner, J; Lehmann, A | 1 |
| Burger, AJ; Silver, MA | 1 |
| Mak, S; Newton, GE | 1 |
| Somers, VK; van de Borne, P; Velez-Roa, S | 1 |
| Campana, C; Constantin, C; Fontana, A; Ghio, S; Klersy, C; Raineri, C; Tavazzi, L | 1 |
| Appleton, C; DeMaria, A; Eichhorn, EJ; Frantz, R; Grayburn, PA; Greenberg, B; Krause-Steinrauf, H; Mayer, SA; Oh, J; Plehn, J; St John Sutton, M | 1 |
| Degaute, JP; Renard, M; van de Borne, P; Velez-Roa, S | 1 |
| Follath, F | 1 |
| Anifantakis, A; Athanassopoulos, G; Chatzigeorgiou, G; Cokkinos, DV; Iakovis, P; Karatasakis, G; Koutsogiannis, N; Manginas, A; Maounis, T; Papadakis, M; Spargias, KS | 1 |
| Adamopoulos, S; Karatzas, D; Kremastinos, DT; Paraskevaidis, IA; Tsiapras, D | 1 |
| Carron, C; López-Candales, AL; Schwartz, J | 1 |
| Doi, M; Kobayashi, S; Kohno, M; Matsuzaki, M; Oda, T; Ohkusa, T; Okuda, S; Tokuhisa, T; Yamamoto, T; Yano, M | 1 |
| Kaplinsky, EJ; Manito, N; Pujol, R | 1 |
| Airaksinen, KE; Bax, JJ; Engblom, E; Kalliokoski, R; Knuuti, J; Koistinen, J; Naum, A; Nekolla, SG; Stolen, KQ; Sundell, J; Ylitalo, A | 1 |
| Katz, SD; Lee, FA; Nystrom, K; Saldarriaga, C; Sedrakyan, A; Upadya, S; Verma, S | 1 |
| Habet, KJ | 1 |
| Anastasiou-Nana, MI; Kanakakis, J; Moon, T; Nanas, JN; Nanas, SN; Terrovitis, JV; Tsagalou, EP | 1 |
| Sharma, M; Teerlink, JR | 1 |
| Azar, R; Barsumau, J; Decaudin, B; Horrent, S; Odou, P; Vairon, MX; Wierre, L | 1 |
| Doverspike, A; Hentosz, T; Huerbin, R; Mathier, MA; Nikolaidis, LA; Shannon, RP; Shen, YT; Trumble, D | 1 |
| Buttrick, PM; Geenen, DL; Goldspink, PH; McKinney, RD; Montgomery, DE; Solaro, RJ; Urboniene, D; Walker, LA | 1 |
| Ahluwalia, MS; Butany, J; El Demellawy, D; Graba, J; Nair, V; Rao, V; Ross, H | 1 |
| Andrisin, TE; Aquilante, CL; Hamilton, KK; Humma, LM; Johnson, JA; Lewis, JF; Yarandi, HN | 1 |
| Bendall, JK; Damy, T; Heymes, C; Loyer, X; Marotte, F; Marty, I; Milliez, P; Monceau, V; Ratajczak, P; Robidel, E; Samuel, JL | 1 |
| Badagliacca, R; Fedele, F; Sciomer, S; Vizza, CD | 1 |
| Feinberg, MS; Freimark, D; Hochberg, N; Matezky, S; Shechter, M | 1 |
| Agrios, N; Anastasiou-Nana, MI; Christodoulou, K; Dalianis, A; Kanakakis, J; Nanas, JN; Papazoglou, PP; Terrovitis, JV; Tsagalou, EP; Tsolakis, E | 1 |
| Papalia, U; Puddu, PE; Schiariti, M; Usta, C | 1 |
| Barzilai, B; Gage, BF; Gleva, MJ; Katsiyiannis, WT; Lindsay, BD; Rogers, JG; Sanchez, JM; Waggoner, AD | 1 |
| Bove, T; Crivellari, M; Landoni, G; Zangrillo, A | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Ntalianis, A; Papazoglou, P; Terrovitis, JV; Tsagalou, EP; Tsolakis, E | 1 |
| Hausmann, H; Hennig, F; Hetzer, R; Lehmkuhl, HB; Potapov, EV; Sodian, R; Volk, HD; Wagner, FD | 1 |
| Sackner-Bernstein, JD | 1 |
| Andreadou, I; Androulakis, A; Avgeropoulou, C; Demopoulou, M; Kallikazaros, I; Markantonis-Kyroudis, S; Missovoulos, P | 1 |
| Dean, AS; Gaughan, JP; Libonati, JR; Margulies, KB; Nicholas, JJ; Rubin, S | 1 |
| Buttrick, PM; de Tombe, PP; Geenen, DL; Goldspink, PH; Montgomery, DE; Rundell, VL; Urboniene, D | 1 |
| Bloem, LJ; Gill, RM; Higgins, MA; Ingwall, JS; Jin, N; Ryan, TP; Shen, W; Spindler, M | 1 |
| Abraham, WT; Adams, KF; Berkowitz, RL; Cheng, ML; Costanzo, MR; Fonarow, GC; LeJemtel, TH; Wynne, J | 1 |
| Dec, GW | 1 |
| Mak, S; Newton, GE; Overgaard, CB | 1 |
| Barretto, AC; Canaviera, R; Follador, W; Martins, ML; Oliveira, MT; Scipioni, A; Tsuji, RL | 1 |
| Reingardiene, D | 1 |
| Cittadini, A; Condorelli, G; Di Gianni, A; Di Rella, F; Iaccarino, G; Monti, MG; Peschle, C; Saccà, L; Sorriento, D; Strömer, H; Trimarco, B; Tsichlis, PN | 1 |
| Bax, JJ; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, F; van Domburg, RT | 1 |
| Gortney, JS; Porter, KB | 1 |
| Burger, AJ | 1 |
| Adams, KF; Gattis Stough, W; Gheorghiade, M; Hasselblad, V; Jaffe, AS; O'Connor, CM | 1 |
| Bayram, M; De Luca, L; Gheorghiade, M; Massie, MB | 1 |
| Barraud, D; Mebazaa, A; Welschbillig, S | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kanakakis, J; Nanas, JN; Nanas, SN; Papazoglou, PD; Terrovitis, JV; Toumanidis, S; Tsagalou, EP; Tsolakis, EJ | 1 |
| Bax, JJ; Boersma, E; de Roos, A; Kaandorp, TA; Lamb, HJ; van der Wall, EE; Viergever, EP | 1 |
| Hidaka, I; Kamiya, A; Kawada, T; Shimizu, S; Shishido, T; Sugimachi, M; Sunagawa, K; Uemura, K; Yoshizawa, M | 1 |
| Ducharme, A; Guertin, MC; He, Y; Ibrahim, R; Lavoie, J; Racine, N; Rouleau, JL; Schiffrin, EL; Touyz, RM; White, M; Whittom, L; Yao, G | 1 |
| Gerhard, T; Hartzema, AG; Winterstein, AG; Zineh, I | 1 |
| Atar, D; Hodt, A; Steine, K | 1 |
| Brodde, OE; Bruck, H; Leineweber, K | 1 |
| Adamopoulos, S; Farmakis, D; Filippatos, GS; Gheorghiade, M; Iliodromitis, EK; Karatzas, D; Kremastinos, DT; Paraskevaidis, I; Parissis, JT; Tsiapras, D | 1 |
| Hennersdorf, M; Müller, K; Peters, A; Strauer, BE; Zeus, T | 1 |
| Arnold, LM; Carroll, NV; Crouch, MA; Oinonen, MJ | 1 |
| Bangalore, S; Chaudhry, FA; Hematpour, K | 1 |
| Brimioulle, S; Demester, JP; Fesler, P; Huez, S; Kerbaul, F; Naeije, R; Rondelet, B | 1 |
| Kurien, S; Miller, WL; Warfield, KT; Wood, CM | 1 |
| Deftereos, D; McKechnie, R; Norton, GR; Osadchii, OE; Woodiwiss, AJ | 1 |
| George, A; Hauptman, PJ; Hoover, R; Mikolajczak, P; Mohr, CJ; Schnitzler, MA; Swindle, J | 1 |
| Gotthardt, M; Granzier, H; Labeit, S; Molkentin, JD; Peng, J; Raddatz, K; Wu, Y | 1 |
| Akilli, A; Akin, M; Duygu, H; Ergene, O; Nalbantgil, S; Nazli, C; Ozerkan, F; Zoghi, M | 1 |
| Khoury, DS; Nagueh, SF; Thohan, V; Torre-Amione, G; Wang, J | 1 |
| Cavusoglu, Y | 1 |
| Barraud, D; Damy, T; Faivre, V; Gayat, E; Heymes, C; Mebazaa, A; Payen, D; Shah, AM; Welschbillig, S | 1 |
| Erdem, A; Karadas, F; Tandogan, I; Yilmaz, MB | 1 |
| Berg, AM; Mahle, WT; Snell, L | 1 |
| Cohen-Solal, A; Kivikko, M; Kleber, FX; Mebazaa, A; Nieminen, MS; Packer, M; Padley, RJ; Pocock, SJ; Põder, P; Thakkar, R | 1 |
| Aaronson, K; Frazier, OH; Mancini, D; Margulies, K; Maybaum, S; McRee, S; Miller, LW; Pagani, FD; Starling, RC; Torre-Amione, G; Xydas, S | 1 |
| Farmakis, D; Nieminen, M; Parissis, JT | 1 |
| Barr, M; Bourge, RC; Jessup, ML; Lilly-Hersley, J; Linde, P; Mancini, D; McCluskey, T; Mehra, MR; Radovancevic, B; Rayburn, B; Taylor, DO | 1 |
| Kagaya, Y | 1 |
| Iino, K; Ito, H | 1 |
| Kajimoto, K; Kawana, M; Watanabe, H | 1 |
| Bars, C; Dubois-Randé, JL; Elbaz, N; Guéret, P; Hamdaoui, B; Lellouche, N; Lim, P; Mitchell-Heggs, L; Roiron, C | 1 |
| Barold, SS; Cutro, R; Dewhurst, R; Herweg, B; Ilercil, A; Krishnan, S; Weston, M | 1 |
| Butler, J; Giamouzis, G; Giannakoulas, G | 1 |
| Hata, K; Hirata, K; Inoue, N; Masai, H; Matsumoto, D; Matsumoto, H; Otake, H; Ozawa, T; Shinke, T; Shite, J; Takaoka, H; Watanabe, S; Yokoyama, M; Yoshikawa, R | 1 |
| Akilli, A; Akin, M; Duygu, H; Ergene, O; Nalbantgil, S; Nazli, C; Ozerkan, F; Yildiz, A; Zoghi, M | 1 |
| Azevedo, CH; Bacal, F; Bocchi, EA; Carneiro, RM; Chizzola, PR; Ferreira, SM; Issa, VS; Mangini, S | 1 |
| Damman, K; Voors, AA | 1 |
| Bax, JJ; Bleeker, GB; Holman, ER; Schalij, MJ; Sieders, A; van der Wall, EE; Ypenburg, C | 1 |
| van der Wall, EE; Verwey, HF; Ypenburg, C | 1 |
| Brügemann, J; de Jonge-Weber, AT; Rienstra, M; van den Broek, SA; van Veldhuisen, DJ; Zijlstra, F | 1 |
| Bartunek, J; de Bruyne, B; Delrue, L; Goethals, M; Mullens, W; Vanderheyden, M; Verstreken, S; Wijns, W | 1 |
| Chu, AL; Chun, J; Elsherif, L; Huang, MS; Kaufman, SJ; Li, RY; Mekany, MA; Ross, RS; Shai, SY; Yang, Y | 1 |
| Komamura, K; Matsuo, H; Sasaki, T | 1 |
| Alamgir, MF; Chattopadhyay, S; Clark, AL; Cleland, JG; Fraser, AG; Nikitin, NP | 1 |
| Haritakis, CN; Nyktari, EG; Parthenakis, FI; Patrianakos, AP; Vardas, PE; Zacharis, EA | 1 |
| Dalampiras, P; Kelepeshis, G; Sitafidis, G; Skoularigis, J; Triposkiadis, F | 1 |
| Al-Hesayen, A; Parker, JD | 1 |
| Du, J; Feng, HZ; Gobara, N; Hossain, MM; Huang, XP; Jean-Charles, PY; Jin, JP; Li, Y; Liu, J; Zhang, C | 1 |
| Agha, SA; Butler, J; Georgiopoulou, V; Giamouzis, G; Giannakoulas, G; Kalogeropoulos, A; Karvounis, H; Tsarpalis, K | 1 |
| Celik, T; Iyisoy, A; Kardesoglu, E; Yuksel, UC | 1 |
| Roberts, R | 2 |
| Carlier, J; Cremers, S; D'Orio, V; el Allaf, D | 1 |
| Sharpe, DN | 1 |
| Baumann, G; Permanetter, B; Wirtzfeld, A | 1 |
| Klein, G; Schnelle, K; Wirtzfeld, A | 1 |
| Shevchenko, VA | 1 |
| Storstein, L; Taylor, SH | 1 |
| Bodem, G; Ochs, HR | 1 |
| Goldberg, LI; Rajfer, SI | 2 |
| Brandt, D; Klein, W | 1 |
| Artman, M; Graham, TP; Parrish, MD | 1 |
| Doherty, JU; Hood, WB; Lee, VW; Liang, CS; Sherman, LG; Wellington, K | 1 |
| Grom, E; Hauf, GF | 1 |
| Cohn, JN | 2 |
| Awan, NA; Beattie, JM; Evenson, MK; Mason, DT; Needham, KE | 1 |
| Bernard, R; Jacobs, P; Renard, M; Vainsel, H | 1 |
| Benjamin, GC | 1 |
| Pachinger, O | 1 |
| Brandt, D; Klein, W; Pristautz, H | 1 |
| Bernard, R; Englert, M; Jacobs, P; Melot, C; Renard, M | 1 |
| Hashimoto, K; Mori, T; Yabuuchi, Y; Yamashita, S | 1 |
| Ye, JM | 1 |
| Leier, CV; Unverferth, DV | 1 |
| Chodera, A; Chodera-Otuszewska, R; Pieczyńska, A | 1 |
| Bernard, R; Renard, M | 1 |
| Hermiller, JB; Leier, CV; Leithe, ME; Magorien, RD; Unverferth, DV | 1 |
| Jüngst, BK; Schranz, D; Stopfkuchen, H | 1 |
| Ferraro, N; Martin, JL; Wilson, JR | 1 |
| Cohn, JN; Levine, TB; Petein, M | 1 |
| Bendersky, R; Chatterjee, K; Parmley, WW | 1 |
| Boucher, R; David, A; Fortin, L; Gagnon, RM; Gilbert, S; Lemire, J; Morrisette, M; Present, S | 1 |
| Applefeld, MM; Grove, WR; Linberg, SE; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ | 1 |
| Brown, GP; Leier, CV; Magorien, RD; Unverferth, DV | 1 |
| Hutton, I; Rae, AP; Tweddel, AC | 1 |
| Kadota, K; Kambara, H; Kawai, C; Kawashita, K; Saimyoji, H | 1 |
| Bödigheimer, K; Delius, W; Ischinger, T; Nowak, FG | 1 |
| Forman, R; Frishman, WH; LeJemtel, TH; Maskin, CS; Sonnenblick, EH | 1 |
| Altschuld, R; Kolibash, AJ; Leier, CV; Lewis, RP; Magorien, RD; Unverferth, DV | 1 |
| Gürtler-Krawczyńska, E; Pałko, T; Pietrzyk, E | 1 |
| Smith-Collins, A | 1 |
| Gunnar, RM | 1 |
| Ikram, H; Maslowski, AH; Nicholls, MG | 1 |
| Andrews, V; Janicki, JS; Weber, KT | 1 |
| Huss, P; Leier, CV; Lewis, RP; Unverferth, DV | 1 |
| Bleifeld, W; Hanrath, P; Kupper, W; Waller, D | 1 |
| Clemens, R; Emmrich, P; Jüngst, BK; Schranz, D; Stopfkuchen, H | 1 |
| Chierchia, S; Crea, F; Distante, A; L'Abbate, A; Maseri, A; Moscarelli, E; Parodi, O; Pesola, A | 1 |
| Bauer, R; Klein, G; Sauer, E; Sebening, H; Wirtzfeld, A | 1 |
| Dirschinger, J; Rudolph, W | 1 |
| Bortz, R; DiBianco, R; Fletcher, RD; Katz, RJ; Myerburg, RJ; Pozen, RG | 1 |
| Frishman, WH; Klein, NA; LeJemtel, TH; Siskind, SJ; Sonnenblick, EH | 1 |
| Doenecke, P; Schmengler, K | 1 |
| Awan, NA; DeMaria, AN; Evenson, MK; Hermanovich, J; Joye, JA; Mason, DT; Needham, K | 1 |
| Bendersky, R; Brundage, BH; Chatterjee, K; Parmley, WW; Ports, TA | 1 |
| Kopman, EA | 1 |
| Bodem, G; Spannbrucker, N; Vogel, F | 1 |
| Alepuz Ferrer, R; Montero Benzo, R; Vicente Sánchez, JL | 1 |
| Segal, BL | 1 |
| Leier, CV; Magorien, RD; Unverferth, DV | 1 |
| Blanford, M; Kates, RE; Leier, CV; Unverferth, DA | 1 |
| Goldstein, RA; Passamani, ER; Roberts, R | 1 |
| Baba, N; Croskery, R; Dick, MR; Kolibash, AJ; Leier, CV; Magorien, RD; Meacham, JA; Svirbely, JR; Unverferth, DV | 1 |
| Leier, CV | 2 |
| Awan, NA; Evenson, MK; Mason, DT; Needham, KE | 1 |
| Mercadante, S; Simonetti, MT | 1 |
| Adamopoulos, S; Bernardi, L; Coats, AJ; Piepoli, M; Sleight, P | 1 |
| Berkland, D | 1 |
| Giesen, G; Kersting, F; Kupp, M | 1 |
| Marks, R | 1 |
| Sherman, A | 1 |
| Berger, R; Frey, B; Hülsmann, M; Ioannides, C; Pacher, R; Stanek, B; Wutte, M | 1 |
| Beanlands, RS; Schwaiger, M | 1 |
| Buser, PT; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, SY | 1 |
| Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Iwase, M; Nagata, K; Sobue, T; Yokota, M | 1 |
| Adamopoulos, S; Bernardi, L; Coats, A; Davies, M; Forfar, C; Piepoli, M; Pissimissis, E; Qiang, F; Sleight, P | 1 |
| Barbarash, R; Beckham, V; Coulter, L; Davila-Roman, VG; Kurz, H; Morello, PJ; Rich, MW; Sperry, J; Spinner, L; Woods, WL | 1 |
| Norris, RM | 1 |
| Martin, C; Papazian, L; Perrin, G | 1 |
| Lie, KI; van Zwieten, PA | 1 |
| Gorrie, M; Nicholls, A | 1 |
| Domínguez de Rozas, JM; Guindo Soldevila, J; Martínez Vílchez, R; Rodríguez Font, E | 1 |
| da Silva, MA | 1 |
| Arnal, JF; Bourdarias, JP; Chikli, F; Delorme, G; Dubourg, O; Dumas, C; Jondeau, G; Kamoun, L | 1 |
| Berger, R; Globits, S; Heinz, G; Kreiner, G; Pacher, R; Presch, I; Radosztics, S; Rödler, S; Weber, H; Wutte, M | 1 |
| Fedel, FJ; Kataoka, T; Keteyian, SJ; Levine, AB; Levine, TB; Marks, CR | 1 |
| Hasenfuss, G; Holubarsch, C; Just, H; Pieske, B | 1 |
| Ohizumi, Y | 1 |
| Armstrong, PW; Grima, EA; Howard, RJ; Moe, GW; Seth, R | 1 |
| Bonijoly, S; Favre, E; Marcon, JL | 1 |
| Gheorghiade, M; Sy, J; Vitarelli, A | 1 |
| Bashchinskiĭ, SE; Osipov, MA; Volkov, GV | 1 |
| Alam, M; Goldstein, S; Kono, T; Rosman, H; Sabbah, HN; Shimoyama, H | 1 |
| Bersin, RM; Chatterjee, K; de Marco, T; Henderson, GN; Khorrami, P; Klinski, C; Kwasman, M; Lau, D; Tanaka, K; Wolfe, C | 1 |
| Scrima, DA | 1 |
| Faggiano, P; Ghizzoni, G; Lombardi, C; Rusconi, C; Sorgato, A; Spedini, C | 1 |
| Chang, WC; Chen, JH; Cheng, JT; Kwan, CM; Lin, LJ; Teng, JK; Tsai, LM | 1 |
| Agostini, A; Angelucci, E; Cesaroni, P; Lucarelli, G; Mariotti, E; Sgarbi, E | 1 |
| Bain, RJ; Davies, MK; Lawson, N; Qiang, FX; Townend, JN; Virk, SJ | 1 |
| Gheorghiade, M; Goldstein, S; Kono, T; Levine, TB; Sabbah, HN | 1 |
| Berton, C; Boujdaria, R; Graini, L; Richard, C; Teboul, JL | 1 |
| Cannon, MA; Povlow, MJ | 1 |
| Annane, D; Auzepy, P; Bellissant, E; Giudicelli, JF; Richard, C; Teboul, JL; Thuillez, C | 1 |
| van der Giessen, WJ; van Woerkens, LJ; Verdouw, PD | 1 |
| Szatmari, A; Terlouw, JF; Umans-Eckenhausen, MA; van den Anker, JN | 1 |
| Jolobe, OM | 1 |
| Caldicott, LD; Channer, KS; Hawley, K; Heppell, R; Woodmansey, PA | 1 |
| Coddens, J; Delooft, T; Vandenbroucke, G | 1 |
| Doi, Y; Hori, M; Kamada, T; Kondo, H; Mano, T; Masuyama, T; Nagano, R; Naito, J; Yamamoto, K | 1 |
| Izumi, T; Kodama, M; Koyama, S; Shibata, A | 1 |
| Christmann, G; Fleischer, F; Haussmann, R; Lange, R; Martin, E | 1 |
| Hess, ML; Shipley, JB | 1 |
| Manetti, A; Pipitone, S | 1 |
| Ishihara, H; Kanda, H; Kato, R; Nagata, K; Sobue, T; Yokota, M | 1 |
| Berder, V; Cherrier, F; Danchin, N; Feldmann, L; Juillière, Y; Perrin, O | 1 |
| Barbe, F; Crozatier, B; Hittinger, L; Laplace, M; Su, JB | 1 |
| Goldberg, D; Goldstein, S; Lesch, M; Levine, AB; Levine, TB; Narins, B | 1 |
| Berger, R; Hülsmann, M; Pacher, R; Siegel, A; Stanek, B; Wutte, M | 1 |
| Adamopoulos, S; Bemardi, L; Coats, AJ; Piepoli, M; Ponikowski, P; Radaelli, A; Sleight, P | 1 |
| Clark, WA; Denes, P; Fernandez, RN; Heaney, L; Marius-Nunez, AL; Ranganini, A; Silber, E | 1 |
| Berk, MR; DeMaria, AN; DeWood, MA; Karlsberg, RP; Lasher, KP | 1 |
| Hogan, PM; Novotny, MJ | 1 |
| Colucci, WS; Landzberg, JS; Newton, GE; Parker, AB; Parker, JD | 1 |
| Counihan, PJ; Gorcsan, J; Kormos, RL; Mandarino, WA; Murali, S | 1 |
| Campa, PP; Dawodu, AA; De Biase, L; Gentile, C; Lilla Della Monica, PL; Monti, F; Puddu, PE; Schiariti, M; Vaccaro, M | 1 |
| Bedogni, F; Bottero, M; Centofante, P; Cera, A; Fortunato, A; La Vecchia, L; Ometto, R | 1 |
| Assmann, G; Breithardt, G; Brisse, B; Deng, MC; Erren, M; Lütgen, A; Scheld, HH; Schmitz, W; Zimmermann, P | 1 |
| Hanzawa, K; Kamiyama, Y; Murayama, K; Shiraishi, M; Warabi, K | 1 |
| Berger, R; Daneschvar, H; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Pacher, R; Rödler, S; Siegel, A; Stanek, B | 1 |
| Bareiss, P; Roul, G | 1 |
| Erdmann, E | 1 |
| Benoit, T; Gillain, D; Limet, R; Piérard, L; Rigo, P; Van Damme, H | 1 |
| Kapoor, C; Mehra, MR; Smart, FW; Stapleton, DD; Ventura, HO; Zimmerman, D | 1 |
| Benhalima, B; Chauvel, C; Cohen, A; Desert, I; Guyon, P; Valty, J | 1 |
| Harjai, KJ; Lapeyre, YM; Mehra, MR; Murgo, JP; Smart, FW; Stapleton, DD; Ventura, HO | 1 |
| Heyman, S; Ozdemir, S; Zucker, I | 1 |
| Kaan, AF; Keogh, AM; Macdonald, PS; McCosker, CJ; Sindone, AP | 1 |
| Bauce, B; Boffa, GM; Cacciavillani, L; Cannas, S; Grassi, G; Livi, U; Maddalena, F; Marzari, A | 1 |
| Abraham, WT; Bristow, MR; Ferguson, DA; Lindenfeld, J; Lowes, BD; Scheffel, CA; White, M; Wolfel, EE | 1 |
| Capomolla, S; Cobelli, F; Febo, O; Maestri, R; Opasich, C; Pozzoli, M; Riccardi, G; Salvucci, F; Sisti, M; Tavazzi, L | 1 |
| Drew, BJ; Ide, B | 1 |
| Dernellis, JM; Toutouzas, PK; Vyssoulis, GP; Zacharoulis, AA | 1 |
| Matsuzaki, M; Nakamura, Y; Ohkusa, T; Ryoke, T; Tanaka, N | 1 |
| Appleby, S; Johnson, RG; Kivilghn, SD; Krause, SM; Lynch, JJ; Prahalada, S; Shen, YT; Siegl, PK; Woltmann, RF | 1 |
| Fujii, H; Ishizu, T; Kousogabe, Y; Kurasaka, N; Otani, S; Tanaka, T; Tokioka, H | 1 |
| Asano, M; Maehara, J; Momose, K; Saitoh, C; Saitoh, M; Sato, S; Taguchi, K; Tanaka, H; Usuda, S | 1 |
| Belardinelli, R; Georgiou, D; Purcaro, A | 1 |
| Agliata, S; Bosimini, E; Cavagnino, A; Corrà, U; Giannuzzi, P; Sacco, A; Schweiger, K | 1 |
| Maisel, A; Nuñez, S | 1 |
| McCloskey, WW | 1 |
| Bonser, RS; Camici, PG; Lorenzoni, R; Ordoubadi, F; Pagano, D; Townend, JN | 1 |
| Chen, CK; Chen, CP; Chen, YT; Ho, HY; Hsueh, CW; Huang, DS; Huang, JL; Lee, WL; Ting, CT | 1 |
| Berton, C; Lenique, F; Mercat, A; Richard, C; Teboul, JL | 1 |
| Bental, T; Elis, A; Kimchi, O; Lishner, M; Ravid, M | 1 |
| Anzai, T; Gao, M; Hammond, HK; Lai, NC | 1 |
| Baumann, G; Iven, H; Kieback, AG; Stolzenburg, K | 1 |
| Anthopoulos, L; Filippatos, G; Kappos, K; Kranidis, A | 1 |
| Ambrosino, N; D'Aloia, A; Faggiano, P; Giordano, A; Gualeni, A; Pagani, M | 1 |
| Cocozza, M; De Vecchis, R; Imperatore, F; Nocerino, L; Pucciarelli, G; Setaro, A; Torre, G | 1 |
| Bermúdez-Cañete, R; Díez-Balda, JI; Domínguez, F; Gómez, R; Martínez, A; Ramos, A; Vellibre, D | 1 |
| Crilley, JG; Dark, JH; Hall, JA | 1 |
| Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C | 1 |
| Finocchi, G; Ometto, R; Vecchia, L; Vincenzi, M | 1 |
| Junger, E; Liziczai, I; Nagy, L; Tarján, J | 1 |
| Delehanty, J; Liang, CS; Odorisi, ML | 1 |
| Berger, R; Bojic, A; Frey, B; Grimm, M; Hülsmann, M; Laufer, G; Locker, G; Pacher, R; Rödler, S; Stanek, B; Sturm, B | 1 |
| Dukić, M; Gradinac, S; Hercog, D; Jovanović, I; Jovović, L; Kokai, G; Simeunović, S; Stajević, M | 1 |
| Mutnick, AH; Souney, PF | 1 |
| Boldt, J; Faust, K; Lang, J; Lehmann, A; Thaler, E; Werling, C | 1 |
| Kaul, S; Lahiri, A; Senior, R | 1 |
| Liu, L; Zhao, SP | 1 |
| Adams, KF; Califf, RM; Gattis, WA; Gheorghiade, M; Grossman, SH; McKenna, WJ; McNulty, SE; O'Connor, CM; Swedberg, K; Uretsky, BF; Zannad, F | 1 |
| Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Poldermans, D; Rambaldi, R; Roelandt, JR | 1 |
| Silver, MA | 1 |
| Latini, R; Maggioni, AP; Mauri, F; Nicolis, E; Oliva, F; Politi, A; Staszewsky, L | 1 |
| Fujiwara, A; Hirota, Y; Kawamura, K; Kono, T; Morita, H; Nishina, T | 1 |
| Frey, B; Hartter, E; Kos, T; Kubecova, L; Pacher, R; Spinar, J; Stanek, B; Vitovec, J; Wimmer, A; Yilmaz, N | 1 |
| Drazner, MH; Solomon, MA; Thompson, B; Yancy, CW | 1 |
| Cherng, WJ; Hung, MJ; Wang, CH | 1 |
| Blankenship, JS | 1 |
| Karas, SM; Kefalas, CG; Mentzikof, DG; Parissis, JT; Venetsanou, KF; Ziras, NG | 1 |
| Bristow, MR; Lindenfeld, J; Lowes, BD | 1 |
| Bonser, RS; Camici, PG; Pagano, D; Parums, DV; Townend, JN | 1 |
| Mingrone, R; Opasich, C; Russo, A; Tavazzi, L; Zambelli, M | 1 |
| Bristow, MR; Lowes, BD; Simon, MA; Tsvetkova, TO | 1 |
| Borzak, S; Goldstein, S; Mishima, T; Sabbah, HN; Steinberg, MI; Tanimura, M | 1 |
| Delle-Karth, G; Haumer, M; Heinz, G; Koller-Strametz, J; Koreny, M; Siostrzonek, P | 1 |
| Hata, K; Kawai, H; Kijima, Y; Murata, T; Okubo, H; Shinke, T; Takaoka, H; Takeuchi, M; Yokoyama, M | 1 |
| Armstrong, WF; Avelar, E; Grossman, PM; Nicklas, JM; Oral, H; Sachdev, V; Sherman, HL | 1 |
| Duncan, KF; Newberry, JW; Rauch, ED; Stammers, AH; Willett, LD | 1 |
| Lagioia, R; Napoli, V; Passantino, A; Ricci, A; Rizzon, P; Scrutinio, D | 1 |
| Das, MK; Mahoney, DW; McCully, RB; Oh, JK; Pellikka, PA; Roger, VL; Seward, JB | 1 |
| Bojic, A; Frey, B; Hartter, E; Locker, G; Pacher, R; Stanek, B; Woloszczuk, W | 1 |
| Diehl, JL; Faisy, C; Guerot, E; Labrousse, J; Rezgui, N | 1 |
| Cianfrone, N; De Rito, V; Fanelli, R; Fusilli, S; Lombardo, A; Loperfido, F; Natali, R; Russo, A; Siena, GP; Vigna, C | 1 |
| Bommer, WJ; Dhond, MR; Donnell, K; Nguyen, T; Whitley, TB | 1 |
| Moen, EK; Young, JB | 1 |
| Agricola, E; Alfieri, O; La Canna, G | 1 |
| Atsumi, H; Endoh, M; Nakada, S; Sakurai, K; Sugawara, H; Tomoike, H | 1 |
| Dienesch, C; Haase, A; Leupold, A; Neubauer, S; Rommel, E; Ruff, J; Wiesmann, F | 1 |
| Kahn, JH; Starling, MR; Supiano, MA | 1 |
| Elliott, WG; Levine, AB; Levine, TB; Narins, B; Stomel, RJ | 1 |
| Alexopoulos, GP; Anastasiou-Nana, MI; Kontoyannis, DA; Moulopoulos, SD; Nanas, JN; Stamatelopoulos, SF; Tsagalou, EP | 1 |
| Cadariu, AR; Carolan, S; Longo, MD; Ramahi, TM; Rohlfs, K; Slade, M; Vallejo, E; Wackers, FJ | 1 |
| Burnett, JC; Hahn, EL; Hart, CY; Meyer, DM; Redfield, MM | 1 |
| Aronson, D; Burger, AJ; Elkayam, U; Ghali, J; Haught, H; Horton, DP; Neibaur, MT | 1 |
| De la Peña-Almaguer, E; Desai, MY; Mannting, F | 1 |
| Durand, JB; Kobrin, I; Nagueh, S; Pratt, C; Torre-Amione, G; Vooletich, MT | 1 |
| Bache, RJ; Godinot, C; Gong, G; Ishibashi, Y; Liu, J; Murakami, Y; Ochiai, K; Prody, C; Wang, C; Zhang, J | 1 |
| Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF | 1 |
| Capomolla, S; Caporotondi, A; Cobelli, F; Febo, O; Gnemmi, M; Guazzotti, G; La Rovere, MT; Maestri, R; Mortara, A; Opasich, C; Pinna, GD; Vona, M | 1 |
| Borghetti, V; Ceconi, C; Coletti, G; La Canna, G; Lorusso, R; Minzioni, G; Parrinello, G; Totaro, P | 1 |
| Frantz, S; Kelly, RA; Paulus, WJ | 1 |
| Albert, N; Haji, SA; Kelly, L; Knack, DL; Starling, RC; Yamani, MH; Young, JB | 1 |
| Bristow, MR; Eichhorn, EJ; Gilbert, EM; Lowes, BD; Tsvetkova, T | 1 |
| Van Besouw, J | 1 |
| Elkayam, U; Ghali, JK; Horton, DP; Silver, MA | 1 |
| Al-Hesayen, A; Azevedo, ER; Newton, GE; Parker, JD | 1 |
| Gorski, LA | 1 |
| Diakakis, GF; Filippou, OK; Kanakaraki, MK; Kanoupakis, EM; Parthenakis, FI; Skalidis, EI; Vardas, PE | 1 |
| Anagnostopoulos, P; Chaudhry, PA; Emala, CW; Gupta, RC; Kass, DA; Mishima, T; Paolocci, N; Saavedra, WF; Sabbah, HN; Suzuki, G; Tunin, RS | 1 |
| Kübler, W; Mäurer, W; Tillmanns, H | 1 |
| Bredakis, J; Gunner, RM; Loeb, HS | 1 |
| Bolen, JL; Harrison, DC; Stoner, JD | 1 |
| Frishman, WH; LeJemtel, TH; Sonnenblick, EH | 1 |
| Kates, RE; Leier, CV; Unverferth, DV | 1 |
| Armstrong, PW | 1 |
| Bolte, HD; Cyran, J | 2 |
| Lundman, T; Rehnqvist, N | 1 |
| Codecà, L; De Lorenzi, E; Pradella, A | 1 |
| Bush, CA; Heban, PT; Huss, P; Leier, CV; Lewis, RP | 1 |
| Cohn, JN; Franciosa, JA | 1 |
| Jackson, PG; Jennings, K; Jewitt, D | 1 |
| Bleifeld, W; Hanrath, P; Kupper, W; Mathey, D | 1 |
| Kates, RE; Leier, CV | 1 |
| Davidson, J; Delius, W; Himmler, C; Klein, G; Volger, E; Wirtzfeld, A | 1 |
| Ambrosioni, E; Branzi, A; Capitanucci, P; Magnani, B; Picchio, F | 1 |
| Ali, N; Andy, JJ; Curry, CL; Mehrotra, PP | 1 |
| Bush, CA; Leier, CV; Webel, J | 1 |
| Bardet, J; Boschat, J; Bourdarias, JP; Ferreira, A; Rigaud, M; Rocha, P | 1 |
| Cohn, JN; Franciosa, JA; Mikulic, E | 1 |
| Delius, W; Mathes, P; Sebening, H; Wirtzfeld, A | 1 |
| Delius, W; Sebening, H; Wirtzfeld, A | 1 |
| Anderson, FL; Bristow, MR; Hanson, G; Hershberger, RE; Kralios, AC; Port, JD; Reid, BB | 1 |
| Bier, S; Burkhoff, D; de Tombe, PP; Gerstenblith, G; Harasawa, Y; Hunter, WC; Kass, DA; Wolff, MR | 1 |
| Quaale, S | 1 |
| Amano, M; Kanamori, T; Kinoshita, M; Shichiri, G; Takahashi, M | 1 |
| Qi, WH | 1 |
| Adnot, S; Benvenuti, C; Bourguignon, MH; Castaigne, A; Dubois-Randé, JL; Loisance, D; Merlet, P; Syrota, A; Valette, H | 1 |
| Reynolds, GW; Richmond, A; Silke, B; Taylor, SH; Verma, SP | 1 |
| Benvenuti, C; Bohuon, C; Carville, C; Castaigne, A; Comoy, E; Dubois-Randé, JL; Hittinger, L; Macquin-Mavier, I; Merlet, P | 1 |
| Elis, A; Lishner, M; Ravid, M | 1 |
| Sleight, P | 1 |
| Cleland, JG; Frost, G; Good, J; Oakley, CM | 1 |
| Bleifeld, W; Erlemeier, HH; Kupper, W | 2 |
| Asanoi, H; Ishizaka, S; Sasayama, S | 2 |
| Bossan, P; Drici, M; Ferrari, E; Gibelin, P; Morand, P | 1 |
| Bubik, JS; Robison-Strane, SR | 1 |
| Asanoi, H; Ishizaka, S; Kameyama, T; Sasayama, S | 2 |
| Honda, H; Hoshi, N; Kikuchi, J; Koiwa, Y; Takagi, T; Takishima, T | 1 |
| Annane, D; Bellissant, E; Depret, J; Richard, C; Teboul, JL; Thuillez, C | 1 |
| Brown, G; Douglas, I; Herkes, R; O'Leary, M | 1 |
| Araghi, A; Dietrich, KA; Dooley, F; Landau, SW; Mene, M; Sacher, HL; Sacher, ML | 1 |
| Pickworth, KK | 1 |
| Gerdesmeyer, L; Herrmann, G; Meissner, A; Simon, R | 1 |
| Bittl, JA; Colucci, WS; Landzberg, JS; Mirsky, I; Parker, JD | 1 |
| Baumann, G; Gerzer, R; Stangl, K; Weil, J | 1 |
| Frey, MJ; Lanoce, V; Liang, BT; Manning, DR; Marzo, KP; Molinoff, PB; Wilson, JR | 1 |
| Hilleman, DE; Mohiuddin, SM | 1 |
| Hua, J; Uretsky, BF | 1 |
| Fan, TM; Frantz, RP; Guthinger, L; Liang, CS; Sakamoto, S; Suematsu, M; Sullebarger, JT | 1 |
| Asanoi, H; Fujita, M; Miyagi, Y; Nakajima, H; Sasayama, S | 1 |
| Budzinski, D; Goldberg, AD; Jafri, SM; Levine, TB; Pilla, A; Reddy, BR | 1 |
| Debets, JJ; Schoemaker, RG; Smits, JF; Struyker-Boudier, HA | 1 |
| Costa, R; De Marino, V; Marino, A | 1 |
| Keller, N; Larsen, J; Sykulski, R | 1 |
| Boldt, J; Hempelmann, G | 1 |
| Zeplin, HE | 1 |
| Peters, P; Saborowski, F; Schneider, M | 1 |
| Brichant, C; Cauwe, F; De Coster, P; Gonzalez, M; Installe, E; Lessire, H | 1 |
| Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G | 1 |
| Paccagnella, A; Simini, G; Valfré, C | 1 |
| Gofman, AM; Ol'binskaia, LI; Poptsov, VN | 1 |
| Guy, S; Silke, B | 1 |
| Adamopoulos, S; Coats, AJ | 1 |
| Binkley, PF; Hammer, DF; Leier, CV; Starling, RC | 1 |
| Camous, JP; Drici, M; Gibelin, P; Lapalus, P; Morand, P; Sbirrazzuoli, V | 1 |
| Arter, WJ; Field, MJ; Kiyingi, A; Lawrence, JR; Pawsey, CC; Yiannikas, J | 1 |
| Bristow, MR; Gilbert, EM; Ginsburg, R; Hershberger, RE; Larrabee, P; Mealey, P; Murray, J; Port, JD; Volkman, K | 1 |
| Fournier, P; Fraysse, JB; Grosgogeat, Y; Komajda, M; Landault, C; Lechat, P; Richaud, M | 1 |
| Baumann, G; Felix, SB; Filcek, SA | 1 |
| Lewis, RP | 1 |
| van Zwieten, PA | 1 |
| Buttrick, P; Geenen, D; Lahorra, M; Malhotra, A; Perla, C; Scheuer, J | 1 |
| Littler, WA; Murray, RG; Tan, LB | 2 |
| Hilger, HH; Höpp, HW; Klocke, RK; Kux, A; Mager, G; Volkmann, A | 1 |
| Baumann, G; Cremer, G; Joder-Ohlenbusch, AM; Ningel, K; Vieweg, J | 1 |
| Schoemaker, RG; Smits, JF | 1 |
| Benvenuti, C; Cachera, JP; Castaigne, A; Deleuze, P; Dubois-Randé, JL; Duval-Moulin, AM; Lellouche, D; Loisance, D; Merlet, P; Saal, JP | 1 |
| Annane, D; Bellissant, E; Richard, C; Teboul, JL; Thuillez, C | 1 |
| Bounhoure, JP; Edouard, P; Fauvel, JM; Fourcade, J; Galinier, M; Massabuau, P; Puel, J; Rochiccioli, JP | 1 |
| Besse, P; Coste, P; Durrieu, C; Le Goff, G; Rochoux, G | 1 |
| Allal, J; Barraine, R; Bouton, S; Couetil, JP; Dreyfus, G; Farge, D; Ourbak, P; Pornin, M; Prevost, D; Sarkis, A | 1 |
| Liu, ZQ; Ma, AQ; Yang, DY; Zhang, L | 1 |
| Gunnar, RM; Stecy, P | 1 |
| Applefeld, MM; Sohl, LL | 1 |
| Marcus, RH; Mitha, A; Patel, J; Raw, K; Sareli, P | 1 |
| Herrmann, V; Merkle, EJ; Miller, LW | 1 |
| Follath, F; Ha, HR; Ritz, R; Schmidlin, O; Weiss, P | 1 |
| Imburgia, M; Rich, MW | 1 |
| Campbell, CA; Held, AC; Johnson, V; Lavine, SJ | 1 |
| Chance, B; Ferraro, N; Mancini, DM; Schwartz, M; Seestedt, R; Wilson, JR | 1 |
| De Backer, D; Kahn, RJ; Roman, A; Vincent, JL | 1 |
| Demedts, M; Van den Brande, P; Van Mieghem, W | 1 |
| Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH | 1 |
| Bayliss, J; Poole-Wilson, P; Thomas, L | 1 |
| Hood, WB; Imai, N; Kawashima, S; Liang, CS; Stone, CK; Thomas, A | 1 |
| Baumann, G; Ningel, K; Permanetter, B | 2 |
| Gilfrich, HJ; Römer, A; Witzke-Gross, J | 1 |
| Gans, SJ; Zwaveling, JH | 1 |
| Katz, S; Keren, G; LeJemtel, TH; Sonnenblick, EH; Strom, J | 1 |
| Kahn, RJ; Madhoun, P; Primo, G; Vincent, JL | 1 |
| Carey, RA; Jacob, L | 1 |
| Drexler, H; Just, H; Meinertz, T | 1 |
| Aïtkaciali, F; Cupa, M; Fosse, JP; Fournier, JL; Hoang, P; Pourriat, JL | 1 |
| Buser, PT; Camacho, SA; Higgins, CB; Jasmin, G; Parmley, WW; Wikman-Coffelt, J; Wu, ST | 1 |
| Bhatt-Mehta, V; Nahata, MC | 1 |
| Bain, RJ; Littler, WA; Tan, LB | 1 |
| Dieckelmann, A; Haan, J; Haupts, M; Kaliwoda, A; Rembs, E; Zumtobel, V | 1 |
| Keren, G; Laniado, S; Lejemtel, TH; Sonnenblick, EH | 1 |
| Banerjee, SP; Fan, TH; Kawashima, S; Liang, CS | 1 |
| Colucci, WS; Denniss, AR; Gauthier, DF; Leatherman, GF; Ludmer, PL; Marsh, JD; Quigg, RJ | 1 |
| Matoba, M | 1 |
| Fukuzaki, H; Nakanishi, M; Yokota, Y | 1 |
| Acar, J; Le Potier, J; Michel, PL; Sergent, J; Vahanian, A | 1 |
| Braunwald, E; Colucci, WS; Wright, RF | 1 |
| Kopia, GA; Ruffolo, RR | 1 |
| Andersson, KE | 1 |
| Ruffolo, RR; Shebuski, RJ; Smith, JM | 1 |
| Dhainaut, JF | 1 |
| Colucci, WS | 2 |
| Sonoki, H; Sugimoto, T; Tomaru, T; Uchida, Y | 1 |
| Cohn, JN; Goldenberg, IF; Levine, TB; Olivari, MT | 1 |
| Reddy, PS; Uretsky, BF; Valdes, AM | 1 |
| Hakki, A; Iskandrian, AS; Likoff, MJ; Ulrich, S | 1 |
| Generalovich, T; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 1 |
| Jain, MC; Janicki, JS; Weber, KT | 1 |
| Uretsky, BF | 1 |
| Collard, P; Gonzalez, M; Installé, E; Jacquemart, JL; Pourbaix, S; Roulette, F; Tremouroux, J | 1 |
| LeJemtel, TH; Mancini, DM; Sonnenblick, EH | 1 |
| Kleinschmidt, R; Spannbrucker, N; Vogel, F | 1 |
| Applefeld, MM; Roffman, DS | 1 |
| Ruggie, N | 1 |
| Bristow, MR; Fowler, MB; Hopkins, GL; Laser, JA; Minobe, W | 1 |
| Halon, DA; Hardoff, R; Lewis, BS; Merdler, A; Rodeanu, ME; Saggie, Y | 1 |
| Autenrieth, G | 1 |
| Amin, DK; Brandon, G; Hulse, S; Shah, PK; Shellock, FG; Spangenberg, R; Swan, HJ | 1 |
| Keren, G; LeJemtel, TH; Mancini, D; Sonnenblick, EH | 1 |
| Crawford, MV; Schactman, M | 1 |
| Marshall, LE; Thomas, RL; Watson, D | 1 |
| Kolesar, JA; Lawless, CE; Reddy, PS; Uretsky, BF; Valdes, AM; Verbalis, JG | 1 |
| Ruffolo, RR | 1 |
| Hattori, R; Kawai, C; Sakaguchi, K; Susawa, T; Takatsu, Y; Yui, N; Yui, Y | 1 |
| Drexler, H; Faude, F; Freudenberg, N; Just, H; Winterer, H; Wollschläger, H | 1 |
| Anand, IS; Gurden, J; Harris, P; Poole-Wilson, PA; Wanless, RB | 1 |
| Casanegra, P; Chamorro, G; Corbalán, R; Illanes, G; Jalil, J; Martínez, A | 1 |
| Jaski, BE; Peters, C | 1 |
| Kindler, M; Kramer, W; Kremer, P; Schlepper, M; Thormann, J | 1 |
| Martínez Martínez, A; Salvati, A; Suárez, LD | 1 |
| Baim, DS; Lanoue, AS; Monrad, ES; Smith, HS | 1 |
| Braunwald, E; Colucci, WS; Fifer, MA; Jaski, BE; Wright, RF | 1 |
| Riemenschneider, TA; Tiefenbrunn, LJ | 1 |
| Mauro, LS; Mauro, VF | 1 |
| Huth, R; Jüngst, BK; Schranz, D; Stopfkuchen, H | 1 |
| Benotti, JR; Biddle, TL; Creager, MA; Faxon, DP; Firth, BG; Fitzpatrick, PG; Kershner, RP; Konstam, MA; Krebs, C; Walton, L | 1 |
| Agmon, J; Davidson, E; Hellman, C; Lewin, RF; Sclarovsky, S; Strasberg, B; Zafrir, N | 1 |
| Bache, RJ; Cohn, JN; Heppner, B; Petein, M; Pierpont, GL | 1 |
| Iwasaki, T; Komasa, N; Mihata, S; Mori, S; Nishian, K; Tateishi, J; Yasutomi, N | 1 |
| Applefeld, MM; Grove, WR; Newman, KA; Reed, WP; Roffman, DS; Sutton, FJ; Talesnick, BS | 1 |
| Margolis, J; Puram, B; Puram, V | 1 |
| Hagège, HH | 1 |
| Colucci, WS; Gauthier, DF; Leatherman, GF; Ludmer, PL | 1 |
| Baerman, JM; de Buitleir, M; DiCarlo, LA; Krol, RB; Morady, F; Schork, MA; Schurig, L; Sereika, SM | 1 |
| Cornyn, J; Loge, D; Massie, BM; Podolin, RA; Topic, N | 1 |
| Eichhorn, EJ; Konstam, MA; Martin, TT; Roberts, DJ; Salem, DN; Stransky, NB; Weiland, DS | 1 |
| Aiba, S; Nakazawa, M; Ohta, H; Okuda, H; Takahashi, Y; Takao, A | 1 |
| Bleifeld, W; Erlemeier, HH; Hamm, CW; Kupper, W | 1 |
| Gage, J; LeJemtel, TH; Lucido, D; Rutman, H | 1 |
| Hayakawa, H; Katoh, T; Koh, M; Munakata, K; Nejima, J; Seino, Y; Shimai, S; Takada, K; Takano, T; Tanaka, K | 1 |
| Bates, ER; Dilworth, LR; Hodgson, JM; Kline, EM; Krell, MJ; Laufer, N; Pitt, B; Vogel, RA | 1 |
| Seino, Y; Takano, T; Tanaka, K | 1 |
| Geraets, DR | 1 |
| Applefeld, MM; Hassan, E; Roffman, DS | 1 |
| McGuirk, SM; Muir, WW | 1 |
| Domenech, R; Goich, J; Thumala, A | 1 |
| Beck, OA | 1 |
| Ferraro, N; Fink, LI; Wilson, JR | 1 |
| Applefeld, MM | 1 |
| David, S; Zaks, JM | 1 |
| Elert, O; Pomer, S; Sarai, K; Satter, P | 1 |
| Greenberg, M; Grose, R; LeJemtel, TH; Strain, J | 1 |
| Berger, M; McSherry, CK | 1 |
| Alpert, JS; Benotti, JR; McCue, JE | 1 |
| Janicki, JS; Maskin, CS; Weber, KT | 1 |
| Fukuzaki, H; Hayakawa, M; Inoh, T; Kubo, M; Kumaki, T; Maehashi, N; Seo, T; Takarada, A; Toh, S; Yokota, Y | 1 |
105 review(s) available for dobutamine and Heart Failure
| Article | Year |
|---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone | 2022 |
Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Randomized Controlled Trials as Topic; Retrospective Studies; Shock, Cardiogenic | 2023 |
Comprehensive and Safe Decongestion in Acutely Decompensated Heart Failure.
Topics: Cardiac Output, Low; Diuretics; Dobutamine; Heart Failure; Humans; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Water-Electrolyte Imbalance | 2022 |
Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
Topics: Cardiac Surgical Procedures; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone | 2023 |
[The Role of Pharmacists in Home Medical Care of Patients with Heart Failure].
Topics: Catecholamines; Chronic Disease; Dobutamine; Furosemide; Heart Failure; Home Care Services; Humans; Injections; Patient Care Team; Pharmacists; Professional Role | 2020 |
An update on levosimendan in acute cardiac care: applications and recommendations for optimal efficacy and safety.
Topics: Adrenergic beta-Antagonists; Cardiac Surgical Procedures; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Hemodynamics; Humans; Shock, Cardiogenic; Simendan | 2021 |
Efficacy and safety of levosimendan and dobutamine in heart failure: A systematic review and meta-analysis.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Treatment Outcome | 2021 |
Calcium and Heart Failure: How Did We Get Here and Where Are We Going?
Topics: Adenosine Triphosphatases; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Antagonists; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Calcium; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Sarcoplasmic Reticulum | 2021 |
Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis.
Topics: Aged; Aged, 80 and over; Cardiac Resynchronization Therapy; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Odds Ratio; Predictive Value of Tests; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2017 |
Dobutamine echocardiography for assessment of viability in the current era.
Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Echocardiography, Stress; Heart Failure; Humans; Myocardial Contraction; Myocardial Ischemia; Prognosis; Tissue Survival; Ventricular Dysfunction, Left | 2019 |
Is there evidence favoring the use of beta-blockers and dobutamine in acute heart failure?
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans | 2013 |
Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Comorbidity; Critical Illness; Dobutamine; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Hypotension; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Simendan; Survival Rate; Treatment Outcome | 2013 |
[Possibilities of clinical echocardiography in patients with heart failure: some examples from clinical practice].
Topics: Acute Coronary Syndrome; Acute Disease; Aged; Arrhythmias, Cardiac; Counterpulsation; Diagnostic Errors; Dobutamine; Dyspnea; Echocardiography; Gastroenteritis; Heart Failure; Humans; Male; Middle Aged; Myocarditis; Norepinephrine; Point-of-Care Systems; Pulmonary Embolism; Radiography; Respiration, Artificial; Shock, Cardiogenic; Stroke Volume; Systole | 2014 |
[Organ-protection therapy. A new therapeutic approach for acute heart failure?].
Topics: Acute Disease; Amides; Benzazepines; Cardio-Renal Syndrome; Dobutamine; Fumarates; Heart Failure; Humans; Hydrazones; Inflammation; Kaplan-Meier Estimate; Multicenter Studies as Topic; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Recombinant Proteins; Relaxin; Simendan; Therapies, Investigational; Tolvaptan | 2014 |
Scorpion-related cardiomyopathy: Clinical characteristics, pathophysiology, and treatment.
Topics: Animals; Cardiomyopathies; Cardiotonic Agents; Combined Modality Therapy; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Oxygen Inhalation Therapy; Pulmonary Edema; Respiration, Artificial; Scorpion Stings; Scorpion Venoms; Scorpions; Time Factors; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2015 |
Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis.
Topics: Acute Disease; Cardiotonic Agents; Cohort Studies; Dobutamine; Heart Failure; Hospital Mortality; Humans; Natriuretic Peptide, Brain; Patient Readmission; Survival Analysis | 2015 |
Long-term intravenous inotropes in low-output terminal heart failure?
Topics: Administration, Intravenous; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Drug Administration Schedule; Heart Failure; Heart Transplantation; Humans; Hydrazones; Milrinone; Odds Ratio; Practice Guidelines as Topic; Pyridazines; Risk Factors; Simendan; Time Factors; Treatment Outcome; Waiting Lists | 2016 |
Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
Topics: Acute Disease; Animals; Cardiotonic Agents; Dobutamine; Etiocholanolone; Heart Failure; Hemodynamics; Humans; Pulmonary Wedge Pressure; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sodium-Potassium-Exchanging ATPase | 2009 |
Therapy for acute heart failure syndromes.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Milrinone; Mineralocorticoid Receptor Antagonists; Morphine; Nitroprusside; Practice Guidelines as Topic; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Severity of Illness Index; Survival Analysis; Syndrome; Treatment Outcome | 2009 |
Agents with inotropic properties for the management of acute heart failure syndromes. Traditional agents and beyond.
Topics: Acute Disease; Cardiotonic Agents; Digoxin; Dobutamine; Etiocholanolone; Exercise Test; Heart Failure; Hemodynamics; Hospitals, Group Practice; Humans; Hydrazones; Prognosis; Pyrazines; Pyridazines; Quinolines; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Treatment Outcome; Urea; Vasodilator Agents | 2009 |
Pharmacotherapy for acute heart failure syndromes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Heart Failure; Humans; Milrinone; Morphine; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Practice Guidelines as Topic; Vasodilator Agents | 2011 |
The concept of ventricular reserve in heart failure and pulmonary hypertension: an old metric that brings us one step closer in our quest for prediction.
Topics: Coronary Artery Disease; Dobutamine; Exercise Test; Health Status Indicators; Heart Failure; Heart Valve Diseases; Humans; Hypertension, Pulmonary; Myocardial Contraction; Prognosis; Stroke Volume; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2011 |
Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance.
Topics: Cardiotonic Agents; Chronic Disease; Contrast Media; Coronary Artery Disease; Death, Sudden, Cardiac; Diagnosis, Differential; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Infarction; Myocardial Ischemia; Patient Safety; Prognosis | 2011 |
Dobutamine for patients with severe heart failure: a systematic review and meta-analysis of randomised controlled trials.
Topics: Adult; Cardiotonic Agents; Databases, Bibliographic; Dobutamine; Heart Failure; Humans; Mortality; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Outcome | 2012 |
Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives.
Topics: Acute Disease; Adrenergic beta-Antagonists; Cardiotonic Agents; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Heart Failure; Hospitalization; Humans; Hydrazones; Phosphodiesterase Inhibitors; Practice Guidelines as Topic; Pyridazines; Simendan | 2012 |
[Combination therapy; dobutamine and milrinone].
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Milrinone; Myocardial Ischemia; Phosphodiesterase 3 Inhibitors | 2011 |
[Are cardiac glycosides still needed in the treatment of cardiac insufficiency?].
Topics: Cardiac Glycosides; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Heart Failure; Humans; Multicenter Studies as Topic; Odds Ratio; Risk; Severity of Illness Index; Treatment Failure; Treatment Outcome | 2002 |
[Cardiac insufficiency of ischemic origin].
Topics: Cardiotonic Agents; Dobutamine; Echocardiography; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Thallium Radioisotopes; Tomography, Emission-Computed | 2002 |
Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
Topics: Aged; Diuretics; Dobutamine; Enalaprilat; Female; Heart Failure; Hemodynamics; Hospitalization; Humans; Hydrazones; Injections, Intravenous; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroprusside; Pulmonary Wedge Pressure; Pyridazines; Renal Agents; Simendan; Vasodilator Agents | 2003 |
B-type natriuretic peptide: from bench to bedside.
Topics: Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Cardiotonic Agents; Diuretics; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Randomized Controlled Trials as Topic; Receptors, Atrial Natriuretic Factor; Vasodilator Agents | 2003 |
[Inotropic agents in advanced and refractory heart failure].
Topics: Cardiotonic Agents; Dobutamine; Dopamine; Drug Administration Schedule; Heart Failure; Humans; Hydrazones; Phosphodiesterase Inhibitors; Pyridazines; Simendan; Treatment Failure; Treatment Outcome | 2003 |
Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
Topics: Adrenergic beta-Antagonists; Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Ethics, Clinical; Heart Failure; Humans; Milrinone; Myocardial Infarction; Nitroprusside; Quality of Life; Sympathomimetics; Vasodilator Agents | 2003 |
Intravenous vasodilator therapy in congestive heart failure.
Topics: Dobutamine; Endothelin Receptor Antagonists; Heart Failure; Humans; Injections, Intravenous; Nitroglycerin; Phosphodiesterase Inhibitors; Thrombocytopenia; Vasodilator Agents | 2003 |
Economic implications of nesiritide versus dobutamine in the treatment of patients with acutely decompensated congestive heart failure.
Topics: Acute Disease; Age Distribution; Aged; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Hospital Costs; Humans; Life Expectancy; Male; Middle Aged; Models, Econometric; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Admission; Predictive Value of Tests; Sex Distribution; Survival Analysis; Treatment Outcome; United States; Value of Life | 2003 |
The role of Ca++-sensitizers for the treatment of heart failure.
Topics: Calcium; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Myocardial Ischemia; Pyridazines; Simendan | 2003 |
[Inotropic therapy in heart failure: general aspects and clinical results].
Topics: Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Heart Failure; Humans; Milrinone; Treatment Outcome | 2004 |
A rational approach for the treatment of acute heart failure: current strategies and future options.
Topics: Acute Disease; Adenosine; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Drug Therapy; Endothelins; Forecasting; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Vasopressins | 2004 |
[Echocardiography in aortic stenosis: new insights into challenging scenarios].
Topics: Aged; Aortic Valve Stenosis; Cardiotonic Agents; Clinical Trials as Topic; Death, Sudden, Cardiac; Diagnosis, Differential; Disease Progression; Dobutamine; Echocardiography; Heart Failure; Heart Valve Prosthesis Implantation; Hemodynamics; Humans; Myocardial Contraction; Prognosis; Risk Factors; Severity of Illness Index; Time Factors; Ventricular Dysfunction, Left | 2004 |
Management of diuretic-refractory, volume-overloaded patients with acutely decompensated heart failure.
Topics: Cardiotonic Agents; Diuretics; Dobutamine; Edema; Heart Failure; Hemofiltration; Humans; Patient Care Management; Renal Dialysis; Treatment Outcome; Vasodilator Agents | 2005 |
[The novelty in the treatment of heart failure].
Topics: Adolescent; Adrenergic beta-Agonists; Adult; Aged; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Infant; Infant, Newborn; Infusions, Intravenous; Injections, Intravenous; Middle Aged; Multicenter Studies as Topic; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan; Vasodilator Agents | 2005 |
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Syndrome | 2005 |
Randomized clinical trials with levosimendan.
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Syndrome | 2005 |
[Medical and ventilatory treatment of acute heart failure].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Continuous Positive Airway Pressure; Diuretics; Dobutamine; Furosemide; Heart Failure; Humans; Hydrazones; Isosorbide Dinitrate; Natriuretic Agents; Natriuretic Peptide, Brain; Nitric Oxide Donors; Oxygen Inhalation Therapy; Practice Guidelines as Topic; Pyridazines; Simendan; Vasodilator Agents | 2006 |
Cardiac adrenoceptors: physiological and pathophysiological relevance.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dose-Response Relationship, Drug; GTP-Binding Proteins; Heart; Heart Failure; Heart Rate; Myocardium; Physical Conditioning, Animal; Polymorphism, Genetic; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Terbutaline | 2006 |
Dobutamine stress echocardiography: does it predict response to beta-blockers in patients with heart failure?
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Dobutamine; Echocardiography, Stress; Heart Failure; Humans; Predictive Value of Tests | 2006 |
The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
Topics: Aged; Biological Availability; Calcium Channels; Cardiotonic Agents; Dobutamine; Half-Life; Heart Failure; Hospitalization; Humans; Hydrazones; Prognosis; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Tissue Distribution; Treatment Outcome | 2007 |
Classical inotropes and new cardiac enhancers.
Topics: Algorithms; Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Hydrazones; Milrinone; Practice Guidelines as Topic; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Treatment Outcome | 2007 |
[Catecholamines--characteristics, mechanisms of action, pharmacokinetics, indications, contraindications, clinical trials, and side effects].
Topics: Acute Disease; Cardiotonic Agents; Catecholamines; Clinical Trials as Topic; Contraindications; Dobutamine; Dopamine; Heart Failure; Humans; Norepinephrine | 2007 |
[Catecholamines use in patients with heart failure].
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Norepinephrine | 2007 |
[Combination therapy with PDE III inhibitor for heart failure].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Chronic Disease; Clinical Trials as Topic; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Hydrazones; Milrinone; Phosphodiesterase Inhibitors; Pyridazines; Simendan | 2007 |
The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
Topics: Acute Disease; Blood Pressure; Cardiac Complexes, Premature; Cardiotonic Agents; Chronic Disease; Digoxin; Diuretics; Dobutamine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Myocardial Infarction | 1984 |
Newer inotropic agents.
Topics: Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Ethanolamines; Heart Failure; Humans; Practolol; Prenalterol; Receptors, Adrenergic, beta | 1984 |
[Treatment of heart failure in ischemic heart disease with beta-adrenostimulators and peripheral vasodilators].
Topics: Adrenergic beta-Agonists; Captopril; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Isoproterenol; Isosorbide Dinitrate; Nitroprusside; Nonachlazine; Phentolamine; Practolol; Prazosin; Prenalterol; Vasodilator Agents | 1983 |
[Catecholamines in the therapy of chronic cardiac insufficiency].
Topics: Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Metaproterenol; Myocardial Contraction; Norepinephrine; Practolol; Prenalterol; Receptors, Adrenergic, alpha; Vasoconstriction; Vasodilation | 1982 |
Congestive heart failure in childhood and adolescence: recognition and management.
Topics: Adolescent; Captopril; Cardiomyopathies; Child; Digoxin; Dobutamine; Dopamine; Echocardiography; Electrocardiography; Endocarditis, Bacterial; Furosemide; Heart; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Hydralazine; Isoproterenol; Nitroprusside; Physical Examination; Radionuclide Imaging; Rheumatic Heart Disease | 1983 |
[Currently used positive inotropic substances].
Topics: Cardiotonic Agents; Chemical Phenomena; Chemistry; Coronary Disease; Dobutamine; Dopamine; Epinephrine; Heart Failure; Hemodynamics; Humans; Isoproterenol; Norepinephrine | 1984 |
Assessment of vasodilatation in man.
Topics: Arterioles; Blood Pressure; Dobutamine; Heart Failure; Humans; Microcirculation; Nitroprusside; Pressoreceptors; Regional Blood Flow; Vascular Resistance; Vasodilation | 1984 |
Dobutamine in heart failure.
Topics: Catecholamines; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Oxygen Consumption | 1982 |
Vasodilator therapy of congestive heart failure.
Topics: Aortic Valve Insufficiency; Captopril; Dobutamine; Heart Failure; Humans; Hydralazine; Isosorbide Dinitrate; Minoxidil; Mitral Valve Insufficiency; Nitroglycerin; Nitroprusside; Phentolamine; Physical Exertion; Piperazines; Prazosin; Quinazolines; Time Factors; Vasodilator Agents | 1980 |
The role of vasodilating agents in the treatment of chronic heart failure.
Topics: Cardiac Output; Chronic Disease; Dobutamine; Heart Failure; Humans; Muscle Contraction; Nitroprusside; Phentolamine; Prazosin; Pulmonary Edema; Vascular Resistance; Vasodilator Agents | 1980 |
Creative solutions: home dobutamine infusions.
Topics: Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Patient Care Planning | 1995 |
Critical care management of the heart failure patient in the home.
Topics: Aged; Critical Care; Dobutamine; Heart Failure; Home Care Services; Humans; Male | 1995 |
[Dopexamine: a new dopaminergic agonist].
Topics: Adrenergic Agonists; Animals; Dobutamine; Dogs; Dopamine; Glomerular Filtration Rate; Heart; Heart Conduction System; Heart Failure; Hemodynamics; Humans; Natriuresis; Rats; Receptors, Dopamine; Shock, Septic; Splanchnic Circulation | 1993 |
[Neurohormonal compensation processes in chronic heart failure: the effect of drugs].
Topics: Adrenergic beta-Agonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Deoxyepinephrine; Diuretics; Dobutamine; Heart Failure; Humans; Receptors, Cell Surface; Renin-Angiotensin System; Sympathetic Nervous System | 1994 |
[Tendency of development on novel type of cardiotonic drugs].
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adrenergic beta-Agonists; Amrinone; Animals; Calcium; Catechols; Dobutamine; Dopamine; Fatty Alcohols; Heart Failure; Humans; Pyridazines; Troponin | 1993 |
[Intermittent infusions of dobutamine in the treatment of chronic cardiac failure in the terminal stage].
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged | 1993 |
Nicardipine in heart failure: distinguishing its acute beneficial from its chronic effects.
Topics: Acute Disease; Calcium Channel Blockers; Chronic Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Nicardipine; Renin-Angiotensin System; Time Factors | 1993 |
[Application of non-glycoside inotropic agents in newborn infants].
Topics: Cardiotonic Agents; Dobutamine; Dopamine; Heart Failure; Humans; Infant, Newborn; Infant, Newborn, Diseases; Isoproterenol; Myocardial Contraction; Oxygen; Oxygen Consumption | 1993 |
Inotropic therapy for the failing myocardium.
Topics: Adrenergic beta-Agonists; Cardiac Output; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Vasodilator Agents; Ventricular Dysfunction, Left | 1995 |
[Terminal heart failure; therapeutic strategies. Drug therapy in cases of absence of possibility of heart transplantation: dobutamine therapy, aspects of compassion?].
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Dobutamine; Heart Failure; Hemofiltration; Humans; Infusions, Intravenous; Phosphodiesterase Inhibitors; Quality of Life; Terminal Care; Vasodilator Agents | 1996 |
Reversed ventilation-perfusion mismatch involving a pediatric patient in congestive heart failure.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Lung; Male; Milrinone; Pulmonary Circulation; Pulmonary Ventilation; Pyridones; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Ventilation-Perfusion Ratio | 1997 |
Use of intravenous inotropic therapy in the home.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Heart Failure; Home Infusion Therapy; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1998 |
Intravenous inotropic agents in the intensive therapy unit: do they really make a difference?
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Critical Care; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Intensive Care Units; Phosphodiesterase Inhibitors | 2000 |
Outpatient parenteral inotropic therapy for advanced heart failure.
Topics: Adrenergic beta-Agonists; Aged; Ambulatory Care; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Prognosis; Severity of Illness Index; Survival Rate; Treatment Outcome | 2000 |
[Evaluation of hibernating myocardium in patients with heart insufficiency].
Topics: Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Heart Function Tests; Humans; Myocardial Contraction; Myocardial Revascularization; Myocardial Stunning; Prognosis; Tomography, Emission-Computed; Ultrasonography, Doppler; Ventricular Dysfunction, Left | 2000 |
Cardiovascular phenotype characterization in mice by high resolution magnetic resonance imaging.
Topics: Adrenergic beta-Agonists; Animals; Cardiovascular Physiological Phenomena; Cardiovascular System; Disease Models, Animal; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Phenotype; Ventricular Function, Left | 2000 |
[Anesthesia for heart transplantation].
Topics: Anesthesia, General; Animals; Cardiovascular Agents; Combined Modality Therapy; Dobutamine; Forecasting; Heart Failure; Heart Transplantation; Heart-Assist Devices; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Preanesthetic Medication; Preoperative Care; Swine; Tissue and Organ Procurement; Transplantation, Heterologous; Transplantation, Homologous | 2001 |
Dobutamine: a new synthetic cardioactive sympathetic amine.
Topics: Animals; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Humans; Myocardial Contraction; Myocardial Infarction; Sympathomimetics | 1979 |
Exercise and the heart.
Topics: Blood Pressure; Dobutamine; Exercise Therapy; Heart Diseases; Heart Failure; Humans; Hypertension; Myocardial Infarction; Risk | 1992 |
[Treatment of chronic heart insufficiency with dobutamine. Value and limitations].
Topics: Chronic Disease; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous | 1992 |
Outpatient dobutamine therapy: the rhyme and the riddle.
Topics: Ambulatory Care; Arrhythmias, Cardiac; Cardiomyopathies; Dobutamine; Drug Tolerance; Heart Failure; Hemodynamics; Humans; Oxygen Consumption | 1992 |
Long-term dobutamine therapy for refractory congestive heart failure.
Topics: Dobutamine; Heart Failure; Humans | 1992 |
Changing strategies in the management of chronic congestive heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Phosphodiesterase Inhibitors; Receptors, Adrenergic, beta | 1991 |
[Physiological bases and therapeutic uses of inodilator drugs].
Topics: Amrinone; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Sympathomimetics; Vasodilator Agents | 1991 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
Pharmacology of modalities of treatment.
Topics: Adrenergic beta-Antagonists; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Vasodilator Agents | 1990 |
[Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Myocardial Contraction; Vasodilation | 1990 |
Is intermittent dobutamine infusion useful in the treatment of patients with refractory congestive heart failure?
Topics: Dobutamine; Drug Administration Schedule; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous | 1990 |
The role of novel inotropic agents in the treatment of heart failure.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors | 1986 |
The role of dopaminergic agents and the dopamine receptor in treatment for CHF.
Topics: Benzazepines; Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Fenoldopam; Heart Failure; Humans; Levodopa; Receptors, Dopamine | 1989 |
Dopexamine in congestive heart failure: how do the pharmacological activities translate into the clinical situation?
Topics: Adrenergic Agonists; Animals; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Nitroprusside | 1989 |
Dopamine and dobutamine in pediatric therapy.
Topics: Child; Child, Preschool; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Shock | 1989 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 1.
Topics: Adenylyl Cyclases; Adrenergic alpha-Agonists; Calcium; Cardiotonic Agents; Cyclic AMP; Dobutamine; Dopamine; Drug Tolerance; Glucagon; Heart Failure; Histamine; Humans; Levodopa; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Receptors, Adrenergic; Receptors, Adrenergic, beta; Stimulation, Chemical; Sympathomimetics; Theophylline; Xanthines | 1986 |
Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Guinea Pigs; Heart Failure; Heart Rate; Heart Ventricles; Humans; Isoproterenol; Metoprolol; Myocardial Contraction; Norepinephrine; Propranolol; Rats; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Cell Surface; Receptors, Glucagon; Receptors, Histamine H2 | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
Positive inotropic therapy for short-term support and long-term management of patients with congestive heart failure: hemodynamic effects and clinical efficacy of MDL 17,043.
Topics: Administration, Oral; Animals; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Dogs; Enoximone; Heart Failure; Heart Rate; Hemodynamics; Hormones; Humans; Imidazoles; Injections, Intravenous; Kinetics; Lactates; Myocardial Contraction; Time Factors; Vasodilation | 1986 |
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation | 1985 |
Digitalis and other positive catecholamine-like inotropic agents in the management of congestive heart failure.
Topics: Adult; Aged; Arrhythmias, Cardiac; Cardiac Glycosides; Cardiotonic Agents; Digitalis Glycosides; Digoxin; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Middle Aged; Myocardial Contraction; Random Allocation; Risk; Sodium-Potassium-Exchanging ATPase; Stroke Volume | 1986 |
Congestive heart failure.
Topics: Aminopyridines; Amrinone; Angiotensin-Converting Enzyme Inhibitors; Cardiac Glycosides; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Milrinone; Nitrates; Nitroprusside; Prazosin; Pyridones; Sympathomimetics; Vasodilator Agents | 1986 |
Review of intermittent dobutamine infusions for congestive cardiomyopathy.
Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Outpatients | 1987 |
The pharmacology of dobutamine.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction | 1987 |
Persistent pulmonary hypertension of the newborn.
Topics: Animals; Cardiomyopathies; Catheterization; Diagnosis, Differential; Disease Models, Animal; Dobutamine; Echocardiography; Heart Failure; Humans; Hyperventilation; Infant, Newborn; Muscle Development; Muscle, Smooth, Vascular; Persistent Fetal Circulation Syndrome; Positive-Pressure Respiration; Pulmonary Circulation; Tolazoline | 1986 |
Use of intermittent dobutamine infusion in congestive heart failure.
Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous | 1986 |
[Pump failure syndrome].
Topics: Cardiac Output; Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroprusside | 1985 |
137 trial(s) available for dobutamine and Heart Failure
| Article | Year |
|---|---|
The use of peripherally inserted central catheter reduced the incidence of phlebitis in heart failure patients: A randomized trial.
Topics: Catheterization, Central Venous; Catheterization, Peripheral; Catheters, Indwelling; Central Venous Catheters; Dobutamine; Heart Failure; Humans; Incidence; Middle Aged; Phlebitis; Retrospective Studies | 2023 |
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double-Blind Controlled Trial.
Topics: Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamic Monitoring; Hemodynamics; Humans; Male; Middle Aged; p-Aminohippuric Acid; Renal Circulation; Renal Insufficiency; Renal Plasma Flow; Simendan | 2018 |
Primary intra-aortic balloon support versus inotropes for decompensated heart failure and low output: a randomised trial.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart-Assist Devices; Hemodynamics; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Treatment Outcome | 2019 |
Comparative effects of recombinant human brain natriuretic peptide and dobutamine on acute decompensated heart failure patients with different blood BNP levels.
Topics: Acute Disease; Administration, Intravenous; Aged; Aged, 80 and over; Blood Pressure; Cardiotonic Agents; China; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Recombinant Proteins; Recovery of Function; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2014 |
Short-term add-on therapy with angiotensin receptor blocker for end-stage inotrope-dependent heart failure patients: B-type natriuretic peptide reduction in a randomized clinical trial.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiac Output, Low; Dobutamine; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Time Factors; Treatment Outcome | 2014 |
Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
Topics: Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Pyridazines; Recovery of Function; Simendan; Stroke Volume; Systole; Time Factors; Treatment Outcome; Turkey; Ventricular Dysfunction, Left; Ventricular Function, Left | 2015 |
Ivabradine treatment prevents dobutamine-induced increase in heart rate in patients with acute decompensated heart failure.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Benzazepines; Cardiotonic Agents; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged | 2015 |
Global myocardial contractile reserve assessed by high-dose dobutamine stress echocardiography predicts response to the cardiac resynchronization therapy.
Topics: Cardiac Resynchronization Therapy; Dobutamine; Echocardiography, Stress; Exercise Test; Female; Fractional Flow Reserve, Myocardial; Heart Failure; Humans; Male; Middle Aged; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2015 |
Enhanced pulmonary vasodilator reserve and abnormal right ventricular: pulmonary artery coupling in heart failure with preserved ejection fraction.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Aged, 80 and over; Arterial Pressure; Diagnostic Techniques, Cardiovascular; Dobutamine; Female; Heart Failure; Humans; Hypertension, Pulmonary; Infusions, Parenteral; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Pulmonary Artery; Stroke Volume; Vasodilation; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right | 2015 |
Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
Topics: Adolescent; Adult; Aged; Biomarkers; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Serum Albumin; Serum Albumin, Human; Simendan; Treatment Outcome; Turkey; Young Adult | 2015 |
Effect of baseline characteristics on mortality in the SURVIVE trial on the effect of levosimendan vs dobutamine in acute heart failure: Sub-analysis of the Finnish patients.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Dobutamine; Drug Therapy, Combination; Female; Finland; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Proportional Hazards Models; Pyridazines; Retrospective Studies; Simendan; Survival Analysis; Treatment Outcome | 2016 |
Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Propanolamines; Pyridazines; Simendan; Time Factors; Treatment Outcome | 2008 |
Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
Topics: Aged; Atrial Function, Left; Blood Pressure; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Pyridazines; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Pressure | 2008 |
Behavior of B-type natriuretic peptide during mechanical ventilation and spontaneous breathing after extubation.
Topics: Adult; Aged; Biomarkers; Cell Size; Critical Illness; Dobutamine; Dyspnea; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Myocytes, Cardiac; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Respiration, Artificial; Sensitivity and Specificity; Ventilator Weaning; Ventricular Dysfunction, Left; Water-Electrolyte Balance | 2009 |
Levosimendan vs. dobutamine: outcomes for acute heart failure patients on beta-blockers in SURVIVE.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Cause of Death; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Survival Rate; Treatment Outcome | 2009 |
Comparative effects of levosimendan and dobutamine on right ventricular function in patients with biventricular heart failure.
Topics: Aged; Cardiotonic Agents; Diastole; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Stroke Volume; Systole; Treatment Outcome; Ventricular Dysfunction, Right; Ventricular Function, Right | 2009 |
The costs of treating acute heart failure: an economic analysis of the SURVIVE trial.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Female; Health Expenditures; Heart Failure; Humans; Hydrazones; Length of Stay; Male; Middle Aged; Patient Admission; Pyridazines; Simendan | 2008 |
Usefulness and limitation of dobutamine stress echocardiography to predict acute response to cardiac resynchronization therapy.
Topics: Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2010 |
Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
Topics: Adult; Aged; Aged, 80 and over; Atrial Function, Left; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Single-Blind Method; Treatment Outcome; Young Adult | 2009 |
The effect of dobutamine without and with L-arginine on arterial compliance in heart failure patients.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Brachial Artery; Dobutamine; Drug Therapy, Combination; Elastic Modulus; Elasticity Imaging Techniques; Female; Heart Failure; Humans; Male; Middle Aged; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2009 |
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Analysis of Variance; Antihypertensive Agents; Cardiotonic Agents; Confidence Intervals; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Myocardial Perfusion Imaging; Natriuretic Peptide, Brain; Odds Ratio; Perfusion; Pulmonary Wedge Pressure; Pyridazines; Simendan; Vasodilator Agents | 2010 |
[Is it necessary to suspend betablockers in decompensated heart failure with low output?].
Topics: Adrenergic beta-Antagonists; Cardiac Output, Low; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Prospective Studies; Withholding Treatment | 2010 |
[Efficacy and safety of intravenous levosimendan compared with dobutamine in decompensated heart failure].
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Injections, Intravenous; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome | 2010 |
Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Dobutamine; Female; Heart Conduction System; Heart Failure; Humans; Hydrazones; Male; Muscle Contraction; Pyridazines; Simendan; Statistics, Nonparametric | 2010 |
[Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
Topics: Acute Disease; Aged; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Parenteral; Male; Middle Aged; Pyridazines; Risk Factors; Simendan; Tachycardia, Ventricular; Ventricular Premature Complexes | 2010 |
Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial.
Topics: Acute Disease; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiotonic Agents; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; International Cooperation; Kaplan-Meier Estimate; Male; Middle Aged; Patient Discharge; Proportional Hazards Models; Pyridazines; Reference Values; Risk Assessment; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome | 2011 |
Crescendo in depolarization and repolarization heterogeneity heralds development of ventricular tachycardia in hospitalized patients with decompensated heart failure.
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Prognosis; Prospective Studies; Tachycardia, Ventricular | 2012 |
[The effect of levosimendan and dobutamine treatment on QT dispersion in patients with decompensated heart failure: a prospective study].
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Prospective Studies; Pyridazines; Simendan; Treatment Outcome | 2012 |
Acute effect of sildenafil on central hemodynamics in mechanically ventilated patients with WHO group III pulmonary hypertension and right ventricular failure necessitating administration of dobutamine.
Topics: Adrenergic beta-1 Receptor Agonists; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Piperazines; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Purines; Respiration, Artificial; Sildenafil Citrate; Sulfones; Time Factors; Treatment Outcome; Ventricular Dysfunction, Right | 2013 |
[Hemodynamic and efficacies of domestic levosimendan versus dobutamine in patients with acute decompensated heart failure].
Topics: Adolescent; Adult; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Young Adult | 2012 |
[Comparison on efficacy and safety between domestic levosimendan versus dobutamine for patients with acute decompensated heart failure].
Topics: Aged; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome | 2012 |
Effect of short-term infusive dobutamine therapy on thyroid hormone profile and hemodynamic parameters in patients with acute worsening heart failure and low-triiodothyronine syndrome.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Euthyroid Sick Syndromes; Heart Failure; Hemodynamics; Humans; Thyroid Hormones; Time Factors; Triiodothyronine | 2012 |
Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Dobutamine; Drug Interactions; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Metoprolol; Middle Aged; Propanolamines; Radionuclide Angiography; Severity of Illness Index; Time Factors; Treatment Outcome | 2002 |
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
Topics: Aged; Cardiotonic Agents; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Tachycardia, Ventricular | 2002 |
Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Topics: Aged; Cardiac Output, Low; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Double-Blind Method; Europe; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Life Expectancy; Male; Middle Aged; Patient Admission; Pyridazines; Randomized Controlled Trials as Topic; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Simendan; Survival Analysis; Treatment Outcome | 2003 |
Rationale and design of the pilot randomized study of nesiritide versus dobutamine in heart failure (PRESERVD-HF).
Topics: Cardiotonic Agents; Disease Progression; Dobutamine; Double-Blind Method; Endpoint Determination; Heart Failure; Hospitalization; Humans; Multicenter Studies as Topic; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Pilot Projects; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2003 |
Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Costs; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Prospective Studies; Statistics as Topic | 2003 |
Neurohumoral activation and ventricular arrhythmias in patients with decompensated congestive heart failure: role of endothelin.
Topics: Arrhythmias, Cardiac; Cardiotonic Agents; Cytokines; Dobutamine; Electrocardiography, Ambulatory; Endothelin-1; Female; Heart Failure; Humans; Male; Middle Aged; Multivariate Analysis; Natriuretic Agents; Natriuretic Peptide, Brain; Neurotransmitter Agents; Ventricular Premature Complexes | 2003 |
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure.
Topics: Adrenergic beta-Antagonists; Carbazoles; Cardiotonic Agents; Carvedilol; Chronic Disease; Cross-Over Studies; Dobutamine; Dopamine; Echocardiography, Stress; Heart Failure; Humans; Metoprolol; Middle Aged; Propanolamines; Single-Blind Method; Treatment Outcome | 2003 |
Comparison of the effects of dobutamine and nesiritide (B-type natriuretic peptide) on ventricular ectopy in acutely decompensated ischemic versus nonischemic cardiomyopathy.
Topics: Aged; Arrhythmias, Cardiac; Cardiomyopathies; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Prospective Studies; Treatment Outcome; Ventricular Premature Complexes | 2003 |
Therapeutic implications of contractile reserve elicited by dobutamine echocardiography in symptomatic, low-gradient aortic stenosis.
Topics: Adult; Aged; Aged, 80 and over; Aortic Valve Stenosis; Dobutamine; Echocardiography, Stress; Feasibility Studies; Female; Heart Failure; Humans; Male; Middle Aged; Mortality; Myocardial Contraction; Survival Analysis; Ventricular Dysfunction, Left | 2003 |
Symptomatic improvement in patients treated with intermittent infusion of inotropes: a double-blind placebo controled pilot study.
Topics: Aged; Cardiotonic Agents; Cross-Over Studies; Dobutamine; Double-Blind Method; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pilot Projects; Quality of Life; Time Factors | 2002 |
Dobutamine potentiates the peripheral chemoreflex in patients with congestive heart failure.
Topics: Adult; Aged; Chemoreceptor Cells; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Hypoxia; Male; Middle Aged; Pulmonary Ventilation | 2003 |
Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Chronic Disease; Dobutamine; Echocardiography; Enoximone; Exercise Test; Female; Heart Failure; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Peripheral sympathetic control during dobutamine infusion: effects of aging and heart failure.
Topics: Adrenergic beta-Agonists; Age Factors; Blood Pressure; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pressoreceptors; Sympathetic Nervous System; Vasodilation | 2003 |
Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Topics: Adrenergic beta-Agonists; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Europe; Heart Failure; Heart Rate; Humans; Hydrazones; Infusions, Intravenous; Morbidity; Myocardial Contraction; Pulmonary Wedge Pressure; Pyridazines; Risk Factors; Severity of Illness Index; Shock, Cardiogenic; Simendan; Stroke Volume; Survival Analysis; Time; Treatment Outcome; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Cardiomyopathy, Dilated; Cardiotonic Agents; Case-Control Studies; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Prospective Studies; Risk Factors | 2004 |
Need for hospice and palliative care services in patients with end-stage heart failure treated with intermittent infusion of inotropes.
Topics: Aged; Ambulatory Care; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Hospice Care; Humans; Infusions, Intravenous; Male; Milrinone; Needs Assessment; New York; Palliative Care; Patient Acceptance of Health Care; Quality of Life; Terminally Ill | 2004 |
Long-term intermittent dobutamine infusion, combined with oral amiodarone for end-stage heart failure: a randomized double-blind study.
Topics: Administration, Oral; Amiodarone; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Therapy, Combination; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Survival Rate; Vasodilator Agents | 2004 |
Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Hospitalization; Humans; Male; Middle Aged; Natriuretic Agents; Natriuretic Peptide, Brain; Sympathomimetics | 2004 |
Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure.
Topics: Adrenergic beta-Agonists; Adult; Aged; Brachial Artery; Dobutamine; Drug Therapy, Combination; Endothelium, Vascular; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Prospective Studies; Ultrasonography; Vasodilation; Vasodilator Agents | 2004 |
Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Diuretics; Dobutamine; Drug Therapy, Combination; Female; Furosemide; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Pyridazines; Simendan | 2004 |
Dobutamine effects on spontaneous variability of ventricular arrhythmias in patients with severe chronic heart failure: the Italian Multicenter Study.
Topics: Aged; Chronic Disease; Confidence Intervals; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Probability; Prospective Studies; Reference Values; Risk Assessment; Severity of Illness Index; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome | 2004 |
The Ca2+-sensitizer levosimendan improves oxidative damage, BNP and pro-inflammatory cytokine levels in patients with advanced decompensated heart failure in comparison to dobutamine.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Malondialdehyde; Middle Aged; Natriuretic Peptide, Brain; Oxidative Stress; Pyridazines; Simendan; Time Factors; Tumor Necrosis Factor-alpha | 2005 |
Effect of vitamin C and L-NMMA on the inotropic response to dobutamine in patients with heart failure.
Topics: Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Dobutamine; Drug Combinations; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Reverse left ventricular remodeling by intermittent dobutamine infusions and amiodarone in end-stage heart failure due to idiopathic dilated cardiomyopathy.
Topics: Administration, Oral; Adult; Aged; Amiodarone; Cardiomyopathy, Dilated; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Stroke Volume; Ventricular Remodeling | 2006 |
Increased systemic inflammation and oxidative stress in patients with worsening congestive heart failure: improvement after short-term inotropic support.
Topics: Biomarkers; C-Reactive Protein; Cardiotonic Agents; Case-Control Studies; Cell Adhesion Molecules; Chemokine CCL2; Colorimetry; Cytokines; Dinoprost; Disease Progression; Dobutamine; E-Selectin; Enzyme-Linked Immunosorbent Assay; Exercise Test; Female; Heart Failure; Humans; Inflammation; Interleukin-18; Interleukin-6; Male; Middle Aged; Milrinone; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Tyrosine | 2006 |
Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.
Topics: Cardiotonic Agents; Cost-Benefit Analysis; Decision Trees; Dobutamine; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Models, Economic; Models, Statistical; Monte Carlo Method; Natriuretic Agents; Natriuretic Peptide, Brain | 2006 |
Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
Topics: Aged; Apoptosis; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography; Fas Ligand Protein; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Interleukin-6; Male; Membrane Glycoproteins; Natriuretic Peptide, Brain; Peptide Fragments; Prognosis; Pulmonary Wedge Pressure; Pyridazines; Simendan; Stroke Volume; Treatment Outcome; Tumor Necrosis Factor-alpha; Tumor Necrosis Factors | 2006 |
Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Myocardial Ischemia; Prospective Studies; Pyridazines; Simendan; Single-Blind Method | 2008 |
Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aminoglycosides; Animals; Cardiac Catheterization; Cardiotonic Agents; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Enediynes; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mitral Valve; Models, Cardiovascular; Predictive Value of Tests; Propanolamines; Pulmonary Wedge Pressure; Ventricular Function, Left; Ventricular Pressure | 2007 |
Improvement in Doppler alternans in patients with severe heart failure: Levosimendan versus dobutamin.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Ventricular Function, Left | 2008 |
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Analysis | 2007 |
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
Topics: Cardiovascular Agents; Combined Modality Therapy; Cytokines; Dobutamine; Exercise Test; Exercise Tolerance; Female; Fibrosis; Heart Failure; Heart Function Tests; Heart Transplantation; Heart-Assist Devices; Humans; Hypertrophy; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Prospective Studies; Single-Blind Method; Stroke Volume; Treatment Outcome; Ultrasonography | 2007 |
Rationale, design, and methods for the Transplant-Eligible MAnagement of Congestive Heart Failure (TMAC) trial: a multicenter clinical outcomes trial using nesiritide for TMAC.
Topics: Cardiotonic Agents; Dobutamine; Double-Blind Method; Echocardiography; Eligibility Determination; Heart Failure; Heart Transplantation; Humans; Infusions, Intravenous; Natriuretic Agents; Natriuretic Peptide, Brain; Patient Selection; Preoperative Care; Research Design; Sample Size; Severity of Illness Index; Survival Rate; Treatment Outcome | 2007 |
Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure.
Topics: Adult; Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Conduction System; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Pyridazines; Simendan; Treatment Outcome; Ventricular Function, Right | 2008 |
Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Male; Middle Aged; Pyridazines; Simendan; Urination | 2007 |
Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Topics: Biomarkers; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Female; Furosemide; Heart Failure; Humans; Hypokalemia; Hyponatremia; Male; Middle Aged; Potassium; Renal Insufficiency; Saline Solution, Hypertonic; Severity of Illness Index; Sodium; Time Factors; Treatment Outcome; Urea | 2007 |
Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Oxygen Consumption; Physical Exertion | 1984 |
Drug-induced conditioning in congestive heart failure.
Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Catecholamines; Dobutamine; Drug Administration Schedule; Female; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Physical Exertion; Random Allocation; Time Factors | 1982 |
Sympathetic stimulations by exercise-stress testing and by dobutamine infusion induce similar changes in heart rate variability in patients with chronic heart failure.
Topics: Aged; Blood Pressure; Chronic Disease; Cross-Over Studies; Dobutamine; Exercise; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Sympathetic Nervous System | 1995 |
Preliminary evidence for the mechanism underlying the development of tolerance to prazosin in congestive heart failure: the alpha-agonistic properties of dobutamine unmasked by prazosin treatment.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prazosin; Up-Regulation; Vasodilator Agents | 1993 |
Sudden death and staged therapy for hemodynamic stabilization in patients enrolled in a heart transplantation program.
Topics: Alprostadil; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Digoxin; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Life Tables; Male; Middle Aged; Proportional Hazards Models; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome | 1995 |
Changes in myocardial oxygen consumption and efficiency with heart failure therapy measured by 11C acetate PET.
Topics: Acetates; Animals; Carbon Radioisotopes; Cardiomyopathy, Dilated; Dobutamine; Heart Failure; Humans; Myocardium; Nitroprusside; Oxygen Consumption; Tomography, Emission-Computed | 1995 |
Differential effects of dobutamine and a phosphodiesterase inhibitor on early diastolic filling in patients with congestive heart failure.
Topics: Administration, Oral; Blood Flow Velocity; Cardiac Catheterization; Coronary Circulation; Diastole; Dobutamine; Echocardiography, Doppler, Pulsed; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Isoquinolines; Male; Middle Aged; Phosphodiesterase Inhibitors; Tetrahydroisoquinolines; Ventricular Function, Left | 1995 |
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
Topics: Aged; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Heart Rate; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, beta; Up-Regulation; Vascular Resistance | 1995 |
A randomized comparison of intravenous amrinone versus dobutamine in older patients with decompensated congestive heart failure.
Topics: Aged; Aged, 80 and over; Amrinone; Analysis of Variance; Dobutamine; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Prospective Studies; Treatment Outcome; Ventricular Function, Left | 1995 |
[The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Topics: Adult; Aged; Analysis of Variance; Dobutamine; Dopamine; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Nitroprusside; Phosphodiesterase Inhibitors; Pyridones | 1994 |
Oral enoximone as a substitute for intravenous catecholamine support in end-stage congestive heart failure.
Topics: Administration, Oral; Aged; Cardiac Output, Low; Dobutamine; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged | 1994 |
Beneficial hemodynamic effects of prostaglandin E1 infusion in catecholamine-dependent heart failure: results of a prospective, randomized, controlled study.
Topics: Alprostadil; Analysis of Variance; Chronic Disease; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Single-Blind Method; Time Factors | 1994 |
[An outpatient study by stress echocardiography with dobutamine of myocardial function in patients with congestive heart failure (the first trial in Russia of the use of the dobutamine-echocardiography test)].
Topics: Adult; Aged; Ambulatory Care; Dobutamine; Echocardiography, Doppler; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Moscow; Myocardial Contraction | 1993 |
Intravenous enoximone or dobutamine for severe heart failure after acute myocardial infarction: a randomized double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Double-Blind Method; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left | 1993 |
Effects of dobutamine and/or nitroprusside on the pulmonary circulation in patients with pulmonary hypertension secondary to end-stage heart failure.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output, Low; Dobutamine; Drug Combinations; Electrocardiography; Heart Failure; Heart Rate; Heart Transplantation; Humans; Hypertension, Pulmonary; Middle Aged; Nitroprusside; Pulmonary Artery; Pulmonary Circulation; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Ventricular Function, Right | 1993 |
A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
Topics: Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Middle Aged; Oxygen Consumption; Prospective Studies; Quinolones; Vascular Resistance; Vasodilator Agents; Ventricular Function, Left | 1996 |
Beneficial cumulative role of both nitroglycerin and dobutamine on right ventricular systolic function in congestive heart failure patients awaiting heart transplantation.
Topics: Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Nitroglycerin; Premedication; Prognosis; Prospective Studies; Stroke Volume; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right | 1995 |
Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Topics: Acute Disease; Aged; Cardiotonic Agents; Dobutamine; Echocardiography; Electrocardiography, Ambulatory; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Myocardial Infarction; Pyridones; Treatment Outcome | 1996 |
Interleukin-6 correlates with hemodynamic impairment during dobutamine administration in chronic heart failure.
Topics: Adult; Chronic Disease; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Interleukin-6; Male; Middle Aged; Pilot Projects; Prognosis; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume; Vascular Resistance | 1996 |
Safety and clinical utility of long-term intravenous milrinone in advanced heart failure.
Topics: Adult; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Hypotension; Injections, Intravenous; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Prospective Studies; Pyridones; Survival Rate; Tachycardia, Supraventricular; Tachycardia, Ventricular; Thrombocytopenia; Treatment Outcome | 1997 |
Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: prognostic implication.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Exercise Test; Exercise Therapy; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Stunning; Oxygen Consumption; Predictive Value of Tests; Prognosis; Ultrasonography; Ventricular Dysfunction, Left | 1998 |
Dopamine and dobutamine have different effects on heart rate variability in patients with congestive heart failure.
Topics: Aged; Aged, 80 and over; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Sympathomimetics | 1998 |
Intermittent dobutamine treatment in patients with chronic refractory congestive heart failure: a randomized, double-blind, placebo-controlled study.
Topics: Adrenergic beta-Agonists; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Double-Blind Method; Drug Administration Schedule; Female; Heart Failure; Humans; Injections, Intravenous; Male; Myocardial Ischemia; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1998 |
Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.
Topics: Adult; Aged; Antihypertensive Agents; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Nitroprusside; Oxygen Consumption; Phosphodiesterase Inhibitors; Piperazines; Pyridones | 1998 |
Bridging to heart transplantation: prostaglandin E1 versus prostacyclin versus dobutamine.
Topics: Alprostadil; Ambulatory Care; Antihypertensive Agents; Cardiac Output; Cardiac Output, Low; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Epoprostenol; Female; Heart Failure; Heart Transplantation; Hospitalization; Humans; Infusions, Intravenous; Lung; Male; Middle Aged; Pilot Projects; Prospective Studies; Pulmonary Wedge Pressure; Risk Factors; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 1999 |
The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Tumor Necrosis Factor-alpha | 1999 |
Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Risk; Severity of Illness Index; Survival Analysis; Treatment Outcome | 1999 |
Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial.
Topics: Adult; Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Treatment Outcome | 1999 |
Effects of prostaglandin E1, dobutamine and placebo on hemodynamic, renal and neurohumoral variables in patients with advanced heart failure.
Topics: Alprostadil; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Endothelins; Female; Glomerular Filtration Rate; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Prospective Studies; Renal Circulation; Vasodilator Agents | 1999 |
Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
Topics: Aged; Cardiotonic Agents; Catecholamines; Critical Illness; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Prospective Studies | 2000 |
Nitric oxide spares myocardial oxygen consumption through attenuation of contractile response to beta-adrenergic stimulation in patients with idiopathic dilated cardiomyopathy.
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Volume; Cardiomyopathy, Dilated; Diastole; Dobutamine; Energy Metabolism; Enzyme Inhibitors; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Nitric Oxide; omega-N-Methylarginine; Oxygen Consumption; Pulmonary Wedge Pressure; Systole | 2000 |
Prognostic value of hemodynamic vs big endothelin measurements during long-term IV therapy in advanced heart failure patients.
Topics: Adult; Aged; Alprostadil; Ambulatory Care; Cardiotonic Agents; Dobutamine; Endothelin-1; Endothelins; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Long-Term Care; Male; Middle Aged; Prognosis; Prospective Studies; Protein Precursors; Survival Rate; Vascular Resistance; Vasodilator Agents | 2000 |
Effect of diabetes mellitus on heart rate variability in patients with congestive heart failure.
Topics: Atrial Natriuretic Factor; Cardiotonic Agents; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Signal Processing, Computer-Assisted | 2001 |
Long-term intermittent dobutamine infusion combined with oral amiodarone improves the survival of patients with severe congestive heart failure.
Topics: Administration, Oral; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Creatinine; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pulmonary Wedge Pressure; Sodium; Stroke Volume; Survival Rate | 2001 |
Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy.
Topics: Aged; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Double-Blind Method; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Natriuretic Peptide, Brain; Statistics, Nonparametric; Tachycardia, Ventricular; Treatment Outcome | 2001 |
A pilot safety trial of prolonged (48 h) infusion of the dual endothelin-receptor antagonist tezosentan in patients with advanced heart failure.
Topics: Acute Disease; Aged; Dobutamine; Double-Blind Method; Drug Tolerance; Echocardiography, Doppler; Endothelin Receptor Antagonists; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Pyridines; Safety; Tetrazoles | 2001 |
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Atrial Natriuretic Factor; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Natriuretic Peptide, Brain; Patient Readmission; Prospective Studies; Survival Rate; Time Factors; Treatment Outcome | 2002 |
Superiority of dobutamine over dopamine for augmentation of cardiac output in patients with chronic low output cardiac failure.
Topics: Aged; Blood Gas Analysis; Blood Pressure; Cardiac Output; Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Drug Evaluation; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Pulmonary Circulation; Vascular Resistance | 1977 |
Comparison of dobutamine and dopamine in treatment of severe heart failure.
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Drug Evaluation; Heart Failure; Hemodynamics; Humans | 1977 |
[Combined infusion of nitroprusside and dobutamine in the treatment of severe congestive heart failure (author's transl)].
Topics: Adult; Catecholamines; Coronary Disease; Dobutamine; Drug Synergism; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Nitroprusside | 1979 |
[Dopamine and dobutamine in the treatment of severe cardiac failure (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Oxygen Consumption; Pulmonary Circulation; Pulmonary Edema; Stroke Volume | 1978 |
Modulation of inotropic therapy by venodilation in acute heart failure: a randomised comparison of four inotropic agents, alone and combined with isosorbide dinitrate.
Topics: Adult; Aged; Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Male; Middle Aged; Prenalterol; Prospective Studies; Single-Blind Method; Vasodilation | 1992 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Aged; Chronic Disease; Diuresis; Dobutamine; Dopamine; Drug Interactions; Drug Therapy, Combination; Furosemide; Heart Failure; Humans; Kidney; Male; Middle Aged; Single-Blind Method | 1992 |
Intermittent infusion of dobutamine in the therapy of severe congestive heart failure--long-term effects and lack of tolerance.
Topics: Adult; Aged; Blood Pressure; Body Weight; Dobutamine; Drug Tolerance; Exercise Test; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen; Physical Exertion; Random Allocation | 1992 |
Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
Topics: Adult; Aged; Blood Pressure; Bucladesine; Cardiac Output; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vascular Resistance | 1990 |
[Hemodynamic effects of enoximone--comparative studies of heart surgery patients].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Drug Therapy, Combination; Enoximone; Epinephrine; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusion Pumps; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications | 1991 |
[The effect of enoximone and catecholamines on renal function after open heart surgery].
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Coronary Artery Bypass; Coronary Disease; Diuresis; Dobutamine; Enoximone; Heart Failure; Heart Valve Diseases; Heart Valve Prosthesis; Humans; Imidazoles; Kidney Function Tests; Middle Aged; Myocardial Contraction; Phosphodiesterase Inhibitors; Postoperative Complications; Prospective Studies; Vascular Resistance | 1991 |
[The hemodynamic profile of amrinone and enoximone in patients with severe heart failure].
Topics: Aged; Amrinone; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Phosphodiesterase Inhibitors | 1991 |
Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Topics: Adult; Aged; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pulmonary Wedge Pressure; Pyridones; Receptors, Adrenergic, beta; Stroke Volume; Time Factors | 1991 |
Metolazone in treatment of severe refractory congestive cardiac failure.
Topics: Aged; Aged, 80 and over; Body Weight; Clinical Trials as Topic; Diuresis; Diuretics; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Male; Metolazone; Middle Aged; Prognosis | 1990 |
[Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Topics: Adrenergic beta-Agonists; Adult; Blood Pressure; Cardiac Output; Clinical Protocols; Dobutamine; Down-Regulation; Echocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Norepinephrine; Propanolamines; Random Allocation; Sympathetic Nervous System; Xamoterol | 1990 |
Comparison of the haemodynamic effects of dopexamine and dobutamine in patients with severe congestive heart failure.
Topics: Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Vasodilator Agents | 1991 |
Piroximone, dobutamine and nitroprusside: comparative effects on haemodynamics in patients with congestive heart failure.
Topics: Adult; Aged; Analysis of Variance; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Random Allocation | 1991 |
[Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output].
Topics: Adult; Aged; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged | 1990 |
[Enoximone, vasodilator and/or inotropic agent in congestive cardiac insufficiency? Hemodynamic and ventriculographic study of 20 cases].
Topics: Adult; Aged; Angiography, Digital Subtraction; Cardiomyopathy, Dilated; Cardiotonic Agents; Cineangiography; Dobutamine; Enoximone; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Vasodilation | 1990 |
[Enoximone in the hemodynamic evaluation before heart transplantation. A new test].
Topics: Adult; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1990 |
Comparison of intravenous amrinone and dobutamine in congestive heart failure due to idiopathic dilated cardiomyopathy.
Topics: Adult; Amrinone; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Water-Electrolyte Balance | 1990 |
Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Nitroprusside; Pulmonary Circulation; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance; Vasodilator Agents | 1989 |
Clinical efficacy of pimobendan (UD-CG 115 BS) in patients with chronic congestive heart failure.
Topics: Adult; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Cardiotonic Agents; Chronic Disease; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Contraction; Nitroprusside; Pulmonary Artery; Pulmonary Wedge Pressure; Pyridazines; Receptors, Adrenergic, beta; Stroke Volume; Time Factors; Vascular Resistance | 1989 |
Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Topics: Aged; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Enoximone; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside | 1987 |
[Combination of dopamine and dobutamine in the differential therapy of acute and chronic myocardial failure].
Topics: Catecholamines; Clinical Trials as Topic; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Renal Circulation; Shock, Cardiogenic; Vascular Resistance; Vasodilation | 1985 |
Hemodynamic effect of oral TA-064 after dobutamine in congestive heart failure.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Cardiac Output, Low; Cardiotonic Agents; Chronic Disease; Clinical Trials as Topic; Dobutamine; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors | 1987 |
[Clinical effects of the infusion of dobutamine and amrinone in patients with refractory cardiac insufficiency].
Topics: Aged; Aged, 80 and over; Amrinone; Body Weight; Clinical Trials as Topic; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged | 1987 |
An analytical method to separate inotropic and vasodilatory drug effects in patients with heart failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Dobutamine; Felodipine; Female; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Male; Middle Aged; Nitrendipine; Vasodilator Agents | 1987 |
Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Topics: Clinical Trials as Topic; Dobutamine; Ferricyanides; Heart Failure; Hemodynamics; Humans; Milrinone; Myocardial Contraction; Nitroprusside; Oxygen Consumption; Pyridones | 1986 |
Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Topics: Aged; Blood Pressure; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardial Contraction; Nitroprusside; Norepinephrine; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilation | 1986 |
Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Topics: Cardiomyopathy, Dilated; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Milrinone; Pyridones | 1987 |
Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones; Systole | 1987 |
496 other study(ies) available for dobutamine and Heart Failure
| Article | Year |
|---|---|
Identification of a Hydroxypyrimidinone Compound (
Topics: Animals; Apelin Receptors; Dogs; Drug Discovery; Heart Failure; Humans; Pyrimidinones; Rats; Structure-Activity Relationship | 2021 |
Renal Hemodynamics and Renin-Angiotensin-Aldosterone System Profiles in Patients With Heart Failure.
Topics: Aldosterone; Biomarkers; Dobutamine; Heart Failure; Hemodynamics; Humans; Nitroprusside; Renin; Renin-Angiotensin System | 2022 |
Incidence and Predictors of Eosinophilic Myocardial Hypersensitivity in Patients Receiving Home Dobutamine.
Topics: Adult; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Incidence; Male; Middle Aged; Milrinone; Myocardium | 2022 |
Prognostic Role of Cardiac Power in a Large Cohort of Patients with Normal Ejection Fraction Referred for Dobutamine Stress Echocardiography.
Topics: Aged; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Prognosis; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2022 |
Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
Topics: Adrenergic beta-Antagonists; Adult; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies | 2022 |
Rehospitalization of Patients with Advanced Heart Failure Receiving Continuous, Palliative Dobutamine or Milrinone.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Retrospective Studies; Stroke Volume; Ventricular Function, Left | 2022 |
[Comparative assessment of the effects of dobutamine and levosimendan on right ventricular ejection fraction in patients with biventricular heart failure].
Topics: Cardiovascular Agents; Cross-Sectional Studies; Dobutamine; Heart Failure; Humans; Prospective Studies; Simendan; Stroke Volume; Ventricular Function, Left; Ventricular Function, Right | 2023 |
Improved mortality and haemodynamics with milrinone in cardiogenic shock due to acute decompensated heart failure.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Retrospective Studies; Shock, Cardiogenic | 2023 |
Preoperative Levosimendan Administration in Heart Transplant Patients with Severe Hepatic and Renal Impairment: A Retrospective Study.
Topics: Dobutamine; Dopamine; Heart Failure; Heart Transplantation; Humans; Renal Insufficiency; Retrospective Studies; Simendan | 2023 |
Successful echocardiography-guided medical management of severe early post-implant right ventricular failure in a patient with left ventricular assist device support: a case report.
Topics: Adolescent; Dobutamine; Echocardiography; Female; Heart Failure; Heart-Assist Devices; Humans; Milrinone; Retrospective Studies | 2023 |
Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Case-Control Studies; Coronary Circulation; Dobutamine; Echocardiography, Stress; Energy Metabolism; Female; Heart Failure; Humans; Male; Microcirculation; Middle Aged; Myocardium; Oxygen Consumption; Positron-Emission Tomography; Prospective Studies; Stroke Volume; Ventricular Function, Left | 2019 |
Combined Therapy With Dobutamine and Omecamtiv Mecarbil in Pigs With Ischemic Acute Heart Failure Is Attributed to the Effect of Dobutamine.
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Energy Metabolism; Heart Failure; Male; Myocardial Contraction; Myocardial Ischemia; Oxygen Consumption; Sus scrofa; Urea; Ventricular Function, Left | 2020 |
Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
Topics: Aged; Cardiotonic Agents; Cause of Death; Disease Progression; Dobutamine; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Milrinone; Recovery of Function; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Left | 2020 |
Levosimendan with other inotropes or vasopressors: Should you combine them?
Topics: Acute Disease; Aged; Aged, 80 and over; Arterial Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Hospital Mortality; Humans; Hypotension; Length of Stay; Male; Middle Aged; Norepinephrine; Simendan; Tachycardia, Supraventricular; Treatment Outcome; Vasoconstrictor Agents | 2020 |
Feasibility and value of two-dimensional volumetric stress echocardiography.
Topics: Aged; Dobutamine; Echocardiography; Echocardiography, Stress; Feasibility Studies; Heart Failure; Humans; Male; Middle Aged | 2022 |
COVID-19 infection in left ventricular assist device patients.
Topics: Aged; Cardiotonic Agents; COVID-19; Dobutamine; Furosemide; Heart Failure; Heart-Assist Devices; Humans; Male; Middle Aged; Simendan; Ventricular Dysfunction, Right | 2020 |
Comparison of cardiac output estimates by echocardiography and bioreactance at rest and peak dobutamine stress test in heart failure patients with preserved ejection fraction.
Topics: Cardiac Output; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Stroke Volume; Ventricular Function, Left | 2020 |
Survival With Continuous Outpatient Intravenous Inotrope Therapy in the Modern Era.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Milrinone; Outpatients; Retrospective Studies | 2020 |
Application of dopamine combined with dobutamine in children with pneumonia and heart failure.
Topics: Adrenergic beta-1 Receptor Agonists; Age Factors; Cardiotonic Agents; Case-Control Studies; Child, Preschool; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Female; Heart Failure; Humans; Infant; Length of Stay; Male; Pneumonia; Recovery of Function; Time Factors; Treatment Outcome | 2020 |
Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Milrinone; Mortality; Retrospective Studies | 2017 |
Is the mechanism of re-expansion pulmonary oedema in a heart-lung interaction?
Topics: Aged; Blood Pressure; Cardiotonic Agents; Dobutamine; Drainage; Echocardiography; Heart; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Lung; Male; Mitral Valve Insufficiency; Pleural Effusion; Pulmonary Edema; Respiratory Insufficiency; Stroke Volume; Ventricular Function, Left | 2017 |
Inotropes and cardiorenal syndrome in acute heart failure - A retrospective comparative analysis.
Topics: Acute Disease; Aged; Cardio-Renal Syndrome; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Incidence; Male; Middle Aged; Pyridazines; Retrospective Studies; Simendan | 2017 |
Successful Withdrawal from Dobutamine by Canagliflozin in a Diabetic Patient with Stage D Heart Failure.
Topics: Aged; Canagliflozin; Cardiotonic Agents; Diabetes Complications; Dobutamine; Female; Heart Failure; Humans; Hypoglycemic Agents | 2017 |
Effects of intravenous home dobutamine in palliative end-stage heart failure on quality of life, heart failure hospitalization, and cost expenditure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Male; Palliative Care; Quality of Life; Retrospective Studies; Stroke Volume; Treatment Outcome | 2018 |
Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
Topics: Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cardiotonic Agents; Cohort Studies; Denmark; Dobutamine; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Milrinone; Prospective Studies; Retrospective Studies | 2018 |
Stability of dobutamine in continuous ambulatory delivery devices.
Topics: Dobutamine; Drug Delivery Systems; Drug Packaging; Drug Stability; Heart Failure; Humans; Infusion Pumps; Temperature | 2018 |
Remote Left Ventricular Hemodynamic Monitoring Using a Novel Intracardiac Sensor.
Topics: Animals; Cardiac Catheterization; Cardiac Pacing, Artificial; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Equipment Design; Heart Failure; Hemodynamics; Male; Miniaturization; Predictive Value of Tests; Remote Sensing Technology; Reproducibility of Results; Time Factors; Transducers, Pressure; Vasopressins; Ventricular Function, Left | 2018 |
Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
Topics: Adolescent; Adult; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Humans; Infant; Infusions, Intravenous; Male; Milrinone; Retrospective Studies; Simendan; Survival Rate; Treatment Outcome; Young Adult | 2018 |
Acute Enhancement of Cardiac Function by Phosphodiesterase Type 1 Inhibition.
Topics: Animals; Calcium; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Dobutamine; Dogs; Heart Failure; Heart Rate; Hemodynamics; Heterocyclic Compounds, 4 or More Rings; Humans; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Rabbits; Receptors, Adrenergic, beta-2; Signal Transduction | 2018 |
Treatments targeting inotropy.
Topics: Acute Disease; Animals; Antioxidants; Calcium; Cardiotonic Agents; Case-Control Studies; Catecholamines; Clinical Trials as Topic; Diastole; Dobutamine; Dogs; Energy Metabolism; Excitation Contraction Coupling; Heart Failure; Humans; Mitochondria; Models, Animal; Myocardial Contraction; Nitrogen Oxides; Oxidation-Reduction; Phosphodiesterase Inhibitors; Placebos; Receptors, Adrenergic; Sarcomeres; Shock, Cardiogenic; Simendan; Swine; Systole; Urea | 2019 |
Opposite diastolic effects of omecamtiv mecarbil versus dobutamine and ivabradine co-treatment in pigs with acute ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Cardiovascular Agents; Diastole; Dobutamine; Drug Therapy, Combination; Heart Failure; Ivabradine; Male; Myocardial Ischemia; Swine; Treatment Outcome; Urea | 2018 |
Drop-off in positivity rate of stress echocardiography based on regional wall motion abnormalities over the last three decades.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echocardiography, Stress; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Reproducibility of Results; Retrospective Studies; Time Factors; Vasodilator Agents; Ventricular Function, Left | 2019 |
Echocardiography for prediction of 6-month and late response to cardiac resynchronization therapy: implementation of stress echocardiography and comparative assessment along with widely used dyssynchrony indices.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Cardiac Resynchronization Therapy; Dobutamine; Echocardiography, Doppler, Color; Echocardiography, Stress; Female; Heart Failure; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Recovery of Function; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Function, Right | 2019 |
Fenestration in the Fontan circulation as a strategy for chronic cardioprotection.
Topics: Adrenergic beta-1 Receptor Agonists; Child; Child, Preschool; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Fontan Procedure; Heart Defects, Congenital; Heart Failure; Heart Rate; Hemodynamics; Humans; Hyperemia; Male; Myocardial Contraction | 2019 |
The value of a simplified approach to end-systolic volume measurement for assessment of left ventricular contractile reserve during stress-echocardiography.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Coronary Artery Disease; Dipyridamole; Dobutamine; Echocardiography, Stress; Feasibility Studies; Female; Heart Failure; Humans; Italy; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Reproducibility of Results; Stroke Volume; Systole; Vasodilator Agents; Ventricular Function, Left | 2019 |
Continuous Intravenous Inotropes in Ward Units: Expanding Therapy Outside Intensive Care using a Safety-Oriented Protocol.
Topics: Adult; Aged; Cardiotonic Agents; Clinical Protocols; Critical Care; Dobutamine; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Milrinone; Patient Discharge; Retrospective Studies; Treatment Outcome | 2019 |
Ventricular dyssynchrony; it is a dynamic phenomenon.
Topics: Cardiac Resynchronization Therapy; Clinical Trials as Topic; Dobutamine; Echocardiography; Exercise Test; Heart Failure; Humans; Prognosis; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Low-dose dobutamine induces left ventricular mechanical dyssynchrony in patients with dilated cardiomyopathy and a narrow QRS: a study using real-time three-dimensional echocardiography.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Three-Dimensional; Electrocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Ventricular Dysfunction, Left | 2013 |
Right ventricular-pulmonary arterial coupling in patients after repair of tetralogy of Fallot.
Topics: Adolescent; Cardiac Catheterization; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Compliance; Dobutamine; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Myocardial Contraction; Predictive Value of Tests; Pulmonary Artery; Tetralogy of Fallot; Treatment Outcome; Vascular Stiffness; Ventricular Dysfunction, Right; Ventricular Function, Right; Young Adult | 2013 |
Left ventricular assist device implantation in heart failure patients with a left ventricular thrombus.
Topics: Dobutamine; Dopamine; Heart Failure; Heart-Assist Devices; Humans; Thrombosis; Ventricular Dysfunction, Left | 2013 |
Characteristics of patients with advanced heart failure having eosinophilic infiltration of the myocardium in the recent era.
Topics: Biopsy; Dobutamine; Eosinophils; Heart Failure; Heart Transplantation; Humans; Milrinone; Myocarditis; Myocardium; Prognosis; Retrospective Studies; Survival Analysis; Survival Rate | 2013 |
An autonomic link between inhaled diesel exhaust and impaired cardiac performance: insight from treadmill and dobutamine challenges in heart failure-prone rats.
Topics: Animals; Dobutamine; Electrocardiography; Heart Failure; Male; Rats; Rats, Inbred SHR; Vehicle Emissions; Walking | 2013 |
Usefulness of a surface cooling device (Arctic Sun®) for therapeutic hypothermia following cardiac arrest.
Topics: Aged; Body Temperature; Cardiotonic Agents; Dobutamine; Female; Heart Arrest; Heart Failure; Humans; Hypothermia, Induced; Infusions, Intravenous; Male; Middle Aged | 2014 |
The effect of the renin-angiotensin-aldosterone system inhibition on myocardial function in early and late phases of dilated cardiomyopathy in Tgaq*44 mice.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Canrenone; Cardiovascular Agents; Dobutamine; Heart Failure; Mice; Mice, Transgenic; Models, Animal; Perindopril; Renin-Angiotensin System | 2013 |
Can we do better than dobutamine?
Topics: Arrhythmias, Cardiac; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Discovery; Heart Failure; Humans; Myocardial Contraction; Risk Factors; Treatment Outcome | 2013 |
Mitochondrial complex I deficiency increases protein acetylation and accelerates heart failure.
Topics: Acetylation; Animals; Cardiotonic Agents; Dobutamine; Electron Transport Complex I; Female; Heart Failure; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitochondrial Diseases; Myocardium; NAD; Oxidative Stress; Pregnancy; Reactive Oxygen Species; Sirtuin 3 | 2013 |
Levosimendan: a retrospective single-center case series.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Hospital Mortality; Humans; Hydrazones; Intensive Care Units; Male; Milrinone; Norepinephrine; Pyridazines; Retrospective Studies; Simendan; Sympathomimetics; Treatment Outcome | 2013 |
Utility of the neutrophil to lymphocyte ratio for predicting in-hospital mortality after levosimendan infusion in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Disease Progression; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hydrazones; Infusions, Intravenous; Leukocyte Count; Lymphocyte Count; Male; Middle Aged; Neutrophils; Predictive Value of Tests; Pyridazines; Retrospective Studies; Simendan | 2014 |
Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Topics: Adrenergic beta-Antagonists; Adult; Bisoprolol; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Echocardiography; Enoximone; Female; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Prognosis; Propanolamines; Retrospective Studies; Survival Rate; Ventilator Weaning | 2014 |
Regional myocardial contractile reserve assessed by strain echocardiography and the response to cardiac resynchronization therapy.
Topics: Cardiac Resynchronization Therapy; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Heart Ventricles; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Prospective Studies; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2014 |
[Takotsubo cardiomyopathy in an adolescent girl].
Topics: Adolescent; Cerebellum; Dobutamine; Echocardiography; Female; Heart Failure; Heart Failure, Systolic; Hematoma; Humans; Intracranial Arteriovenous Malformations; Prognosis; Rupture, Spontaneous; Takotsubo Cardiomyopathy | 2014 |
Expression of uncoupling protein-2 remains increased within hibernating myocardium despite successful coronary artery bypass grafting at 4 wk post-revascularization.
Topics: Animals; Cardiac Imaging Techniques; Cardiotonic Agents; Cell Respiration; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Heart Failure; Ion Channels; Mitochondria; Mitochondrial Proteins; Myocardial Stunning; Oxidative Stress; Swine; Tomography, X-Ray Computed; Uncoupling Protein 2 | 2015 |
Dobutamine-induced fever and isolated eosinophilic myocarditis in a 66-year-old male awaiting heart transplantation: a case report.
Topics: Aged; Cardiotonic Agents; Dobutamine; Eosinophilia; Fever; Heart Failure; Heart Transplantation; Humans; Male; Myocarditis; Waiting Lists | 2014 |
Increased in vivo mitochondrial oxygenation with right ventricular failure induced by pulmonary arterial hypertension: mitochondrial inhibition as driver of cardiac failure?
Topics: Administration, Inhalation; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Disease Progression; Dobutamine; Energy Metabolism; Heart Failure; Hexokinase; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; L-Lactate Dehydrogenase; Male; Mitochondria, Heart; Monocrotaline; Oxygen; Oxygen Consumption; Protoporphyrins; Pulmonary Artery; Rats, Wistar; Ventricular Dysfunction, Right; Ventricular Function, Right | 2015 |
Echocardiography and invasive hemodynamics during stress testing for diagnosis of heart failure with preserved ejection fraction: an experimental study.
Topics: Animals; Area Under Curve; Cardiac Catheterization; Disease Models, Animal; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Exercise Tolerance; Feasibility Studies; Head-Down Tilt; Heart Failure; Hemodynamics; Male; Obesity; Oxygen Consumption; Phenylephrine; Predictive Value of Tests; Rats, Inbred WKY; Rats, Zucker; Reproducibility of Results; ROC Curve; Stroke Volume; Time Factors; Ventricular Function, Left; Ventricular Pressure | 2015 |
Reversible Cardiomyopathy After Epirubicin Administration.
Topics: Aged; Antibiotics, Antineoplastic; Atrial Natriuretic Factor; Breast Neoplasms; Cardiomyopathies; Cardiotonic Agents; Diuretics; Dobutamine; Echocardiography; Electrocardiography; Epirubicin; Female; Heart Failure; Heart Ventricles; Humans; Magnetic Resonance Imaging, Cine; Respiration, Artificial; Severity of Illness Index; Treatment Outcome | 2015 |
Urocortin 2 protects heart and kidney structure and function in an ovine model of acute decompensated heart failure: Comparison with dobutamine.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Biomarkers; Collagen; Disease Models, Animal; Dobutamine; Female; Gene Expression; Heart; Heart Failure; Kidney; Kidney Diseases; Real-Time Polymerase Chain Reaction; Sheep; Transforming Growth Factor beta1; Urocortins | 2015 |
Management of catecholamine-induced stunned myocardium--a case report.
Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Fluid Therapy; Heart Failure; Humans; Intraoperative Complications; Middle Aged; Milrinone; Myocardial Stunning; Neurosurgical Procedures; Norepinephrine; Subarachnoid Hemorrhage; Vasodilator Agents | 2015 |
Na+-induced Ca2+ influx through reverse mode of Na+-Ca2+ exchanger in mouse ventricular cardiomyocyte.
Topics: Action Potentials; Animals; Calcium; Dobutamine; Dose-Response Relationship, Drug; Electrophysiology; Heart; Heart Failure; Heart Ventricles; Male; Mice; Myocytes, Cardiac; Patch-Clamp Techniques; Receptors, Adrenergic, beta; Sodium-Calcium Exchanger; Thiourea | 2015 |
Hemodynamic and neurochemical determinates of renal function in chronic heart failure.
Topics: Aged; Aged, 80 and over; Arterial Pressure; Atrial Function, Right; Atrial Pressure; Cardiac Catheterization; Case-Control Studies; Chronic Disease; Dobutamine; Female; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Kidney; Male; Middle Aged; Models, Cardiovascular; Nitroprusside; Renal Plasma Flow; Sympathetic Nervous System; Sympathomimetics; Vasodilator Agents; Ventricular Function, Left | 2016 |
Temporal Development of Autonomic Dysfunction in Heart Failure: Effects of Age in an Ovine Rapid-pacing Model.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Age Factors; Animals; Autonomic Nervous System; Biomarkers; Cardiac Pacing, Artificial; Disease Models, Animal; Dobutamine; Echocardiography; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Female; Heart Failure; Heart Rate; Hemodynamics; Norepinephrine; Sheep, Domestic; Time Factors | 2016 |
Infections, Arrhythmias, and Hospitalizations on Home Intravenous Inotropic Therapy.
Topics: Administration, Intravenous; Adult; Aged; Alabama; Atrial Fibrillation; Bacteremia; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Female; Follow-Up Studies; Heart Arrest; Heart Conduction System; Heart Failure; Home Care Services; Hospitals, University; Humans; Male; Middle Aged; Milrinone; Pacemaker, Artificial; Patient Readmission; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome | 2016 |
Citric Acid Cycle Metabolites Predict the Severity of Myocardial Stunning and Mortality in Newborn Pigs.
Topics: Animals; Biomarkers; Cardiotonic Agents; Chromatography, Liquid; Citric Acid Cycle; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Microdialysis; Milrinone; Myocardial Stunning; Random Allocation; Severity of Illness Index; Sodium Chloride; Spectrometry, Mass, Electrospray Ionization; Swine; Tandem Mass Spectrometry; Treatment Outcome | 2016 |
Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adult; Animals; Blood Glucose; Cardiomyopathies; Dobutamine; Female; Heart Failure; Humans; Isoproterenol; Male; Mice, Knockout; MicroRNAs; Mitochondria, Heart; Myocardium; Myocytes, Cardiac; Peripartum Period; Puerperal Disorders; Purine Nucleotides; Random Allocation; Reactive Oxygen Species; Receptor, ErbB-4; STAT3 Transcription Factor; Ventricular Dysfunction, Left | 2017 |
Prediction of functional capacity by low-dose dobutamine stress echocardiography in chronic heart failure.
Topics: Adrenergic beta-Agonists; Aged; Chronic Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Oxygen Consumption; Peptide Fragments; Prospective Studies; Respiratory Function Tests; Ventricular Dysfunction, Left | 2008 |
Inotropic agents improve the peripheral microcirculation of patients with end-stage chronic heart failure.
Topics: Adrenergic beta-Agonists; Brachial Artery; Cardiotonic Agents; Case-Control Studies; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Microcirculation; Middle Aged; Muscle, Skeletal; Myocardial Reperfusion; Oxygen Consumption; Prognosis; Prospective Studies; Pyridazines; Simendan; Spectroscopy, Near-Infrared; Vasodilator Agents | 2008 |
Decompensated heart failure in the emergency department of a cardiology hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Pressure; Brazil; Cardiotonic Agents; Child; Child, Preschool; Dobutamine; Dopamine; Emergency Service, Hospital; Epidemiologic Methods; Female; Heart Failure; Hospitalization; Humans; Infant; Infant, Newborn; Length of Stay; Male; Middle Aged; Young Adult | 2008 |
Cardiac ErbB-1/ErbB-2 mutant expression in young adult mice leads to cardiac dysfunction.
Topics: Adenylyl Cyclases; Animals; Cardiomyopathy, Dilated; Cardiotonic Agents; Colforsin; Dobutamine; ErbB Receptors; Female; Heart Failure; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Transgenic; Mutation; Myocardial Contraction; Myocytes, Cardiac; Phenotype; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Time Factors; Ventricular Dysfunction, Left | 2008 |
Effect of glucose-insulin-potassium in severe acute heart failure after brain death.
Topics: Adult; Brain Death; Confidence Intervals; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Echocardiography, Transesophageal; Female; Follow-Up Studies; Glucose; Heart Failure; Heart Rate; Heart Transplantation; Humans; Infusions, Intravenous; Insulin; Male; Middle Aged; Organ Preservation; Potassium; Probability; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Tissue Donors; Treatment Outcome; Ventricular Remodeling | 2008 |
A comparison of central and mixed venous oxygen saturation in circulatory failure.
Topics: Aged; Cardiac Output; Cardiotonic Agents; Catheterization, Swan-Ganz; Dobutamine; Female; Heart Failure; Heart Function Tests; Humans; Intra-Aortic Balloon Pumping; Male; Middle Aged; Norepinephrine; Oxygen; Respiration, Artificial; ROC Curve; Sample Size; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2010 |
Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Heart Ventricles; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Severity of Illness Index; Simendan; Stroke Volume | 2008 |
Intermittent inotrope infusion for end stage heart failure in Duchenne muscular dystrophy.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Infusions, Intravenous; Male; Muscular Dystrophy, Duchenne; Time Factors | 2008 |
A short duration of high-fat diet induces insulin resistance and predisposes to adverse left ventricular remodeling after pressure overload.
Topics: Acetylcholine; Animals; Apoptosis; Blood Glucose; Capillaries; Coronary Circulation; Dietary Fats; Disease Models, Animal; Dobutamine; Fibrosis; Heart Failure; Hemodynamics; Hypertension; Insulin; Insulin Resistance; Lipid Metabolism; Male; Mice; Mice, Inbred C57BL; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Risk Factors; Time Factors; Ultrasonography; Vasodilation; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Levosimendan: from basic science to clinical practice.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Heart Failure; Hemodynamics; Humans; Hydrazones; Kidney; Myocardial Contraction; Natriuretic Peptide, Brain; Prognosis; Pyridazines; Quality of Life; Simendan; Vasodilator Agents; Ventricular Dysfunction, Left; Ventricular Function, Right | 2009 |
Intermittent inotropic infusions combined with prophylactic oral amiodarone for patients with decompensated end-stage heart failure.
Topics: Administration, Oral; Amiodarone; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Prospective Studies; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2009 |
Identification of responders to cardiac resynchronization therapy by contractile reserve during stress echocardiography.
Topics: Aged; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Contraction; Prospective Studies; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2009 |
Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Pyridazines; Randomized Controlled Trials as Topic; Retrospective Studies; Simendan | 2009 |
Effect of ivabradine in dobutamine induced sinus tachycardia in a case of acute heart failure.
Topics: Acute Disease; Benzazepines; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Rate; Humans; Ivabradine; Male; Middle Aged; Tachycardia, Sinus; Treatment Outcome | 2009 |
Low-dose vasopressin infusion results in increased mortality and cardiac dysfunction following ischemia-reperfusion injury in mice.
Topics: Animals; Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Heart Failure; Infusions, Intravenous; Male; Mice; Mice, Inbred C57BL; Myocardial Reperfusion Injury; Shock; Stroke Volume; Survival Analysis; Vasoconstrictor Agents; Ventricular Dysfunction, Left | 2009 |
Prognostic value of a comprehensive cardiac magnetic resonance assessment soon after a first ST-segment elevation myocardial infarction.
Topics: Adrenergic beta-Agonists; Adult; Aged; Angioplasty, Balloon, Coronary; Coronary Vessels; Dobutamine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Microvessels; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Recurrence; Risk Assessment; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Outcome | 2009 |
Variation on a theme: CMR as the "one-stop shop" for risk stratification after infarction?
Topics: Adrenergic beta-Agonists; Angioplasty, Balloon, Coronary; Coronary Vessels; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Microvessels; Myocardial Contraction; Myocardial Infarction; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Recurrence; Risk Assessment; Risk Factors; Thrombolytic Therapy; Time Factors; Treatment Outcome | 2009 |
Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure.
Topics: Analysis of Variance; Animals; Dobutamine; Dogs; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Failure; Hemodynamics; Hypertrophy, Left Ventricular; Longitudinal Studies; Male; Models, Animal; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Signal Transduction | 2009 |
Adverse effect of increased left ventricular wall thickness on five year outcomes of patients with negative dobutamine stress.
Topics: Adrenergic beta-Agonists; Aged; Aged, 80 and over; Angina, Unstable; Cardiovascular Diseases; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Observer Variation; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Dysfunction, Left | 2009 |
Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Overdose; Heart Failure; Hemodynamics; Hydrazones; Propranolol; Pyridazines; Random Allocation; Simendan; Survival Analysis; Swine | 2009 |
Prognosis on chronic dobutamine or milrinone infusions for stage D heart failure.
Topics: Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2009 |
Should we use outpatient dobutamine or milrinone?
Topics: Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Injections, Intravenous; Milrinone; Outpatients; Treatment Outcome | 2009 |
Prognostic factors of acute heart failure in patients with pulmonary arterial hypertension.
Topics: Acute Disease; Adolescent; Adult; Aged; Blood Pressure; C-Reactive Protein; Cardiotonic Agents; Creatinine; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Hypertension, Pulmonary; Intensive Care Units; Male; Middle Aged; Natriuretic Peptide, Brain; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Risk Factors; Sodium; Survival Analysis; Vasoconstrictor Agents; Young Adult | 2010 |
Pressure-volume relationship during dobutamine stress echocardiography predicts exercise tolerance in patients with congestive heart failure.
Topics: Aged; Blood Pressure; Dobutamine; Echocardiography; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Male; Natriuretic Peptide, Brain; Stroke Volume; Vasodilator Agents | 2010 |
Prognostic value of dobutamine stress echocardiography in diabetic patients.
Topics: Aged; Cardiotonic Agents; Chi-Square Distribution; Comorbidity; Coronary Disease; Diabetic Angiopathies; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Rest; Risk Factors; Statistics, Nonparametric; Survival Analysis | 2010 |
Is levosimendan better than dobutamine in acute heart failure in patients on beta-blockade treatment? What is the evidence?
Topics: Acute Disease; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Evidence-Based Medicine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan | 2010 |
[Angiotensin II receptor blocker add-on therapy for low cardiac output in decompensated heart failure].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cardiac Output, Low; Dobutamine; Drug Therapy, Combination; Epidemiologic Methods; Female; Heart Failure; Humans; Kidney; Male; Middle Aged; Stroke Volume | 2010 |
Rotating inotrope therapy in a pediatric population with decompensated heart failure.
Topics: Adolescent; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Echocardiography; Female; Heart Failure; Humans; Hydrazones; Infant; Infant, Newborn; Intensive Care Units, Pediatric; Male; Milrinone; Pyridazines; Retrospective Studies; Simendan; Treatment Outcome | 2011 |
The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output; Dietary Fats; Disease Models, Animal; Dobutamine; Energy Metabolism; Fatty Acids; Gene Expression Profiling; Gene Expression Regulation; Heart Failure; Male; Myocardial Contraction; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Rats; Rats, Wistar; Recovery of Function; Signal Transduction; Stress, Physiological; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2010 |
Acute heart failure with low cardiac output: can we develop a short-term inotropic agent that does not increase adverse events?
Topics: Acute Disease; Animals; Cardiac Output; Cardiotonic Agents; Clinical Trials as Topic; Digoxin; Dobutamine; Etiocholanolone; Genetic Therapy; Heart Failure; Humans; Hydrazones; Pyridazines; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Simendan; Sodium-Potassium-Exchanging ATPase; Urea | 2010 |
Intolerance to ß-blockade in a mouse model of δ-sarcoglycan-deficient muscular dystrophy cardiomyopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Disease Models, Animal; Dobutamine; Heart Failure; Hemodynamics; Metoprolol; Mice; Mice, Inbred C57BL; Mice, Inbred mdx; Mice, Inbred Strains; Muscular Dystrophies, Limb-Girdle; Muscular Dystrophy, Duchenne; Papillary Muscles | 2010 |
Correspondence concerning the article: is levosimendan better than dobutamine in acute heart failure in patients on beta blockade treatment? What is the evidence?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan | 2010 |
How to treat acute decompensated heart failure in the 'beta-blocker era'?
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Pyridazines; Simendan; Vasodilator Agents | 2010 |
Dobutamine-norepinephrine, but not vasopressin, restores the ventriculoarterial matching in experimental cardiogenic shock.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Male; Norepinephrine; Orchiectomy; Shock, Cardiogenic; Swine; Vasodilator Agents; Vasopressins; Ventricular Function, Left | 2010 |
Automated drug delivery system for the management of hemodynamics and cardiac energetic in acute heart failure.
Topics: Acute Disease; Animals; Automation; Bradycardia; Cardiac Output; Computer Simulation; Dextrans; Dobutamine; Dogs; Drug Delivery Systems; Embolization, Therapeutic; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Nitroprusside; Systole; Time Factors | 2010 |
Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
Topics: Aged; Atrial Function, Left; Biomarkers; Chronic Disease; Dobutamine; Echocardiography; Echocardiography, Stress; Female; Forecasting; Heart Failure; Humans; Hydrazones; Male; Middle Aged; Natriuretic Peptide, Brain; Neurotransmitter Agents; Pyridazines; Simendan; Treatment Outcome | 2012 |
Impaired left ventricular stroke volume reserve during clinical dobutamine stress predicts future episodes of pulmonary edema.
Topics: Aged; Atropine; Dobutamine; Female; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pulmonary Edema; Risk Factors; Stroke Volume | 2011 |
Long-term prognostic value of dobutamine stress CMR.
Topics: Aged; Chi-Square Distribution; Coronary Artery Disease; Disease-Free Survival; Dobutamine; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left | 2011 |
Dobutamine stress CMR: can we predict outcome?
Topics: Coronary Artery Disease; Disease-Free Survival; Dobutamine; Heart Failure; Humans; Magnetic Resonance Imaging; Myocardial Contraction; Myocardial Infarction; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Ventricular Function, Left | 2011 |
Altered microRNA expression associated with reduced catecholamine sensitivity in patients with chronic heart failure.
Topics: Cardiac Catheterization; Cardiomyopathy, Dilated; Catecholamines; Chronic Disease; Dobutamine; Female; Gene Expression Regulation; Heart Failure; Humans; Male; Microarray Analysis; MicroRNAs; Middle Aged; Myocardial Contraction; Myocardium; Norepinephrine; Receptors, Adrenergic; Ventricular Function | 2011 |
[Treatment of heart failure patients with inotropic drugs: beyond traditional agents].
Topics: Adrenergic beta-1 Receptor Agonists; Cardiotonic Agents; Dobutamine; Guidelines as Topic; Heart Failure; Hydrazones; Meta-Analysis as Topic; Phosphodiesterase Inhibitors; Pyridazines; Retrospective Studies; Risk Assessment; Simendan | 2010 |
Cardiomyopathy in α-kinase 3 (ALPK3)-deficient mice.
Topics: Animals; Cardiomyopathies; Diastole; Dobutamine; Female; Heart; Heart Failure; Heart Rate; Heart Ventricles; Humans; Male; Mice; Mice, Knockout; Muscle Proteins; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Phosphotransferases; Sequence Deletion; Stroke Volume; Systole | 2012 |
Usefulness of low-dose dobutamine echocardiography to predict response and outcome in patients undergoing cardiac resynchronization therapy.
Topics: Adrenergic beta-1 Receptor Agonists; Aged; Cardiac Pacing, Artificial; Defibrillators, Implantable; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Hospitalization; Humans; Male; Myocardial Ischemia; Pacemaker, Artificial; Prospective Studies; Stroke Volume; Systole; Ventricular Dysfunction, Left | 2011 |
MR perfusion-weighted imaging may help in differentiating between nonenhancing gliomas and nonneoplastic lesions in the cervicomedullary junction.
Topics: Animals; Aorta; Brain Neoplasms; Cardiac Output; Dobutamine; Glioma; Heart Failure; Heart Ventricles; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Perfusion; Swine | 2011 |
Cost-effectiveness of levosimendan in patients with acute heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Patient Readmission; Pyridazines; Retrospective Studies; Simendan; Survival Rate | 2011 |
Hospital in the home.
Topics: Australia; Cardiotonic Agents; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Milrinone; Palliative Care | 2011 |
Beta-blockers and dobutamine in heart failure: a safe combination?
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Withholding Treatment | 2011 |
Influence of preload and afterload on stroke volume response to low-dose dobutamine stress in patients with non-ischemic heart failure: a cardiac MR study.
Topics: Aged; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Ischemia; Stroke Volume | 2013 |
[Levosimendan treatment of severe acute congestive heart failure refractory to dobutamine/milrinone in children].
Topics: Acute Disease; Adolescent; Cardiotonic Agents; Child, Preschool; Dobutamine; Heart Failure; Humans; Hydrazones; Male; Milrinone; Pyridazines; Simendan | 2011 |
Creatine kinase-mediated improvement of function in failing mouse hearts provides causal evidence the failing heart is energy starved.
Topics: Adenosine Triphosphate; Animals; Creatine Kinase, MM Form; Disease Models, Animal; Dobutamine; Energy Metabolism; Gene Expression; Heart Failure; In Vitro Techniques; Mice; Mice, Inbred C57BL; Mice, Transgenic; Myocardial Contraction; Perfusion; Recombinant Proteins | 2012 |
Heart failure syndrome due to dobutamine stress echocardiography: Tako-Tsubo induced-cardiomiopathy.
Topics: Adrenergic beta-1 Receptor Agonists; Dobutamine; Echocardiography, Stress; Electrocardiography; Female; Heart Failure; Humans; Middle Aged; Myocardial Ischemia; Takotsubo Cardiomyopathy | 2012 |
Heart failure secondary to dilated cardiomyopathy: a role for emergency physician bedside ultrasonography.
Topics: Abdominal Pain; Acute Disease; Cardiomyopathy, Dilated; Child, Preschool; Diagnostic Errors; Dobutamine; Dopamine; Dyspnea; Echocardiography; Edema; Electrocardiography; Emergency Service, Hospital; Female; Gastroenteritis; Gastrointestinal Hemorrhage; Heart Failure; Heart Transplantation; Humans; Point-of-Care Systems; Vomiting | 2012 |
Intermittent infusions of carperitide or inotoropes in out-patients with advanced heart failure.
Topics: Aged; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Dobutamine; Dopamine; Female; Follow-Up Studies; Heart Failure; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Outpatients; Pyridones; Severity of Illness Index; Survival Rate; Systole; Treatment Outcome | 2012 |
[Occurrence of severe cardiac alterations in Amanita proxima poisoning: two original observations].
Topics: Adrenergic beta-Agonists; Adult; Amanita; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Hemodiafiltration; Hemodynamics; Humans; Long QT Syndrome; Male; Middle Aged; Mushroom Poisoning; Nausea; Resuscitation; Shock, Cardiogenic; Ultrasonography; Ventricular Dysfunction, Left | 2012 |
Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading.
Topics: Animals; Arteries; Body Weight; Dobutamine; Echocardiography; Heart; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Hypertrophy, Left Ventricular; Male; Pressure; Rats; Rats, Sprague-Dawley; Stroke; Stroke Volume; Systole; Ventricular Function, Left | 2012 |
Liver function abnormalities, clinical profile, and outcome in acute decompensated heart failure.
Topics: Acute Disease; Aged; Alkaline Phosphatase; Cardiotonic Agents; Cholestasis; Dobutamine; Female; Heart Failure; Humans; Hydrazones; Liver Diseases; Liver Function Tests; Male; Prognosis; Prospective Studies; Pyridazines; Randomized Controlled Trials as Topic; Simendan; Transaminases | 2013 |
Characterization of the cardiac response to a low and high dose of dobutamine in the mouse model of dilated cardiomyopathy by MRI in vivo.
Topics: Adrenergic beta-1 Receptor Agonists; Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Heart Rate; Magnetic Resonance Imaging; Mice; Myocardium; Receptors, Adrenergic, beta; Software; Ventricular Function, Left | 2013 |
Economic evaluation of levosimendan versus dobutamine for the treatment of acute heart failure in Italy.
Topics: Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Heart Failure; Hospitalization; Humans; Hydrazones; Pyridazines; Retrospective Studies; Rome; Simendan; Treatment Outcome | 2012 |
Oxygen costs of left ventricular contractility for dobutamine and Ca(2+) in normal rat hearts and the cost for dobutamine in Ca(2+) overload-induced failing hearts.
Topics: Animals; Calcium Chloride; Cardiotonic Agents; Dobutamine; Heart Failure; Male; Myocardial Contraction; Myocardial Stunning; Myocardium; Oxygen Consumption; Rats; Rats, Wistar; Ventricular Function, Left | 2002 |
Short-term treatment with ranolazine improves mechanical efficiency in dogs with chronic heart failure.
Topics: Acetanilides; Animals; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Drug Administration Schedule; Fatty Acids, Nonesterified; Glucose; Heart; Heart Failure; Heart Rate; Lactic Acid; Myocardium; Oxygen Consumption; Piperazines; Ranolazine; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
[How is catecholamine therapy carried out in heart failure?].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Catecholamines; Chronic Disease; Dobutamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Treatment Outcome | 2002 |
Differential pre- and postsynaptic effects of desipramine on cardiac sympathetic nerve terminals in RHF.
Topics: Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Animals; Blood Pressure; Cardiotonic Agents; Desipramine; Dobutamine; Dogs; Heart Failure; Immunohistochemistry; Myocardial Contraction; Myocardium; Neuropeptide Y; Norepinephrine; Organ Size; Presynaptic Terminals; Receptors, Adrenergic, beta; Sympathetic Nervous System; Tyrosine 3-Monooxygenase; Ventricular Dysfunction, Right | 2002 |
Combined inotropic and bradycardic effects of a sodium channel enhancer in conscious dogs with heart failure: a mechanism for improved myocardial efficiency compared with dobutamine.
Topics: Animals; Azetidines; Cardiotonic Agents; Chronic Disease; Coronary Circulation; Cyclic AMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Electrocardiography; Heart Failure; Heart Rate; Male; Myocardial Contraction; Myocardium; Oxygen Consumption; Sodium Channel Agonists; Ventricular Function, Left | 2002 |
Incidence and risk calculation of inotropic support in patients undergoing cardiac surgery with cardiopulmonary bypass using an automated anaesthesia record-keeping system.
Topics: Aged; Anesthesia; Cardiopulmonary Bypass; Cardiotonic Agents; Dobutamine; Enoximone; Epinephrine; Female; Heart Failure; Humans; Male; Medical Records Systems, Computerized; Middle Aged; Myocardial Infarction; Preoperative Care; Retrospective Studies; Risk Factors; Time Factors | 2002 |
Successful resuscitation of serious bupivacaine intoxication in a patient with pre-existing heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anesthetics, Local; Bupivacaine; Clonidine; Dobutamine; Female; Heart Failure; Humans; Injections, Intravenous; Middle Aged; Resuscitation | 2003 |
Disparate force-frequency effects of pimobendan and dobutamine in conscious dogs with tachycardia-induced cardiomyopathy.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Heart Rate; Myocardial Contraction; Pyridazines; Stimulation, Chemical; Stroke Volume; Tachycardia; Ventricular Pressure | 2002 |
Prognosis of patients with chronic coronary artery disease and severe left ventricular dysfunction. The importance of myocardial viability.
Topics: Adrenergic beta-Agonists; Adult; Aged; Aged, 80 and over; Cardiac Surgical Procedures; Cell Survival; Chronic Disease; Coronary Artery Disease; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardium; Postoperative Complications; Prognosis; Severity of Illness Index; Stroke Volume; Survival Analysis; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
A bridge for the 21st century in heart transplantation?
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Heart Transplantation; Humans; Milrinone; Prospective Studies; Randomized Controlled Trials as Topic | 2003 |
Prognostic value of dobutamine stress echocardiography in patients with diabetes.
Topics: Adrenergic beta-Agonists; Coronary Disease; Diabetic Angiopathies; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Hypercholesterolemia; Image Processing, Computer-Assisted; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Prognosis; Survival Analysis; Time Factors; Treatment Outcome | 2003 |
Morbidity and mortality of UNOS status 1B cardiac transplant candidates at home.
Topics: Adult; Aged; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Electric Countershock; Female; Heart Failure; Heart Transplantation; Home Care Services; Humans; Male; Middle Aged; Milrinone; Outcome Assessment, Health Care; Retrospective Studies; Severity of Illness Index; Waiting Lists | 2003 |
Dobutamine for patients with end-stage heart failure in a hospice program?
Topics: Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Hospice Care; Humans; Male; Palliative Care; Treatment Outcome; United States | 2003 |
Sustained use of nesiritide to aid in bridging to heart transplant.
Topics: Adult; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Preoperative Care; Time Factors; Treatment Outcome; Waiting Lists | 2003 |
The cul-de-sac at the end of the road.
Topics: Ambulatory Care; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Palliative Care | 2003 |
Hemodynamic effects of a new inotropic compound, PST-2744, in dogs with chronic ischemic heart failure.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Etiocholanolone; Heart Failure; Hemodynamics; Ventricular Dysfunction, Left | 2003 |
Hypercontractile heart failure caused by catecholamine therapy in premature neonates.
Topics: Adrenergic Agonists; Adrenergic beta-Agonists; Dobutamine; Drug Therapy, Combination; Epinephrine; Female; Heart Failure; Heart Rate; Humans; Hypertrophy, Left Ventricular; Hypotension; Infant, Newborn; Infant, Premature; Infant, Very Low Birth Weight; Male; Myocardial Contraction; Norepinephrine; Ultrasonography | 2003 |
Nesiritide in acute heart failure.
Topics: Acute Disease; Cardiac Output, Low; Clinical Trials as Topic; Comorbidity; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Treatment Outcome | 2003 |
Redox modulation of the inotropic response to dobutamine is impaired in patients with heart failure.
Topics: Ascorbic Acid; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; History, Early Modern 1451-1600; Humans; Male; Middle Aged; Myocardial Contraction; Oxidation-Reduction; Reference Values; Ventricular Dysfunction, Left | 2004 |
Myocardial contractile reserve by dobutamine stress echocardiography predicts improvement in ejection fraction with beta-blockade in patients with heart failure: the Beta-Blocker Evaluation of Survival Trial (BEST).
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Dobutamine; Echocardiography, Stress; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Propanolamines; Prospective Studies; Radionuclide Imaging; Stroke Volume; Ventricular Function, Left | 2003 |
Preliminary clinical experience with the repetitive administration of levosimendan in patients with end-stage heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; Blood Pressure; Calcium Channels, L-Type; Cardiac Output, Low; Cardiotonic Agents; Diastole; Dobutamine; Dopamine; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Greece; Heart Failure; Heart Ventricles; Hematocrit; Hemoglobins; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Potassium; Pyridazines; Severity of Illness Index; Simendan; Stimulation, Chemical; Survival Analysis; Systole; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Valsartan restores sarcoplasmic reticulum function with no appreciable effect on resting cardiac function in pacing-induced heart failure.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Calcium Signaling; Calcium-Transporting ATPases; Cardiac Pacing, Artificial; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Dogs; Drug Evaluation, Preclinical; Heart Failure; Myocardial Contraction; Norepinephrine; Phosphorylation; Protein Processing, Post-Translational; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Tachycardia, Ventricular; Tacrolimus Binding Proteins; Tetrazoles; Valine; Valsartan; Ventricular Remodeling | 2004 |
The effects of cardiac resynchronization therapy on left ventricular function, myocardial energetics, and metabolic reserve in patients with dilated cardiomyopathy and heart failure.
Topics: Carbon Radioisotopes; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Coronary Circulation; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardium; Oxygen Consumption; Regional Blood Flow; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Home continuous positive inotropic infusion as a bridge to cardiac transplantation in patients with end-stage heart failure.
Topics: Adult; Cardiotonic Agents; Defibrillators, Implantable; Dobutamine; Dopamine; Empirical Research; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Longitudinal Studies; Male; Middle Aged; Milrinone; Survival Rate; Waiting Lists | 2004 |
To infuse or not?
Topics: Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous | 2004 |
Dobutamine-induced myoclonia in severe renal failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Myoclonus | 2004 |
Catecholamines restore myocardial contractility in dilated cardiomyopathy at the expense of increased coronary blood flow and myocardial oxygen consumption (MvO2 cost of catecholamines in heart failure).
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Blood Flow Velocity; Blood Pressure; Cardiomyopathy, Dilated; Catecholamines; Coronary Circulation; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Heart Ventricles; Male; Models, Cardiovascular; Myocardial Contraction; Norepinephrine; Oxygen Consumption; Severity of Illness Index; Stroke Volume; Vasodilation | 2004 |
Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure.
Topics: Actin Cytoskeleton; Animals; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agents; Disease Progression; Dobutamine; Drug Resistance; Enzyme Induction; Heart Failure; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Myosin Light Chains; Osteopontin; Phosphorylation; Protein Kinase C; Protein Kinase C-epsilon; Protein Processing, Post-Translational; Recombinant Fusion Proteins; RNA, Messenger; Sialoglycoproteins | 2004 |
Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart.
Topics: Adrenergic beta-Agonists; Cardiomyopathy, Hypertrophic; Dobutamine; Drug Hypersensitivity; Echocardiography; Female; Heart Failure; Humans; Middle Aged; Mitral Valve Insufficiency; Myocarditis; Myocardium; Stroke Volume; Ventricular Dysfunction, Left | 2004 |
Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Stress; Electrocardiography; Ethnicity; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Male; Mathematical Computing; Middle Aged; Prospective Studies; Reference Values | 2004 |
Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
Topics: Adrenergic beta-Agonists; Animals; Autocrine Communication; Caveolin 3; Caveolins; Dobutamine; Enzyme Induction; Heart Failure; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Myocardium; Nerve Tissue Proteins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Ryanodine Receptor Calcium Release Channel; Sarcolemma; Ventricular Dysfunction, Left | 2004 |
Simplified peak power reserve in patients with an implantable cardioverter-defibrillator and advanced heart failure.
Topics: Case-Control Studies; Defibrillators, Implantable; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Prospective Studies; Severity of Illness Index; Ventricular Dysfunction, Left | 2005 |
Heart failure after Caesarean section for twin delivery.
Topics: Adult; Anesthesia, Obstetrical; Anesthesia, Spinal; Cardiotonic Agents; Catheterization, Swan-Ganz; Cesarean Section; Diagnosis, Differential; Digoxin; Diuretics; Dobutamine; Electrocardiography; Female; Furosemide; Heart Failure; Humans; Hydralazine; Intubation, Intratracheal; Nitroprusside; Pulmonary Edema; Twins; Vasodilator Agents | 2004 |
Efficacy and safety of intermittent, long-term, concomitant dobutamine and levosimendan infusions in severe heart failure refractory to dobutamine alone.
Topics: Adult; Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Infusions, Intravenous; Male; Middle Aged; Multivariate Analysis; Pyridazines; Radionuclide Ventriculography; Risk; Simendan; Survival Rate | 2005 |
Natriuretic peptides and E-selectin as predictors of acute deterioration in patients with inotrope-dependent heart failure.
Topics: Adolescent; Adult; Aged; Biomarkers; C-Reactive Protein; Dobutamine; Dopamine; Drug Administration Schedule; Drug Therapy, Combination; E-Selectin; Enoximone; Epidemiologic Methods; Epinephrine; Female; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Natriuretic Peptides; Nerve Tissue Proteins; Norepinephrine; Peptide Fragments; Prognosis; Shock, Cardiogenic | 2005 |
Impaired vasoreactivity in end-stage heart failure patients on intravenous inotropic support.
Topics: Blood Flow Velocity; Brachial Artery; Cardiac Catheterization; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Follow-Up Studies; Forearm; Heart Failure; Humans; Injections, Intravenous; Isometric Contraction; Male; Middle Aged; Milrinone; Severity of Illness Index; Treatment Outcome; Ultrasonography, Doppler; Vasoconstriction; Ventricular Function, Right | 2005 |
Protein kinase C epsilon induces systolic cardiac failure marked by exhausted inotropic reserve and intact Frank-Starling mechanism.
Topics: Actin Cytoskeleton; Adenosine Triphosphatases; Animals; Animals, Genetically Modified; Cardiotonic Agents; Dobutamine; Electrophoresis, Polyacrylamide Gel; Heart Failure; Mice; Myocardial Contraction; Myocardium; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Sarcomeres; Systole; Ultrasonography | 2005 |
The fall in creatine levels and creatine kinase isozyme changes in the failing heart are reversible: complex post-transcriptional regulation of the components of the CK system.
Topics: Animals; Blotting, Western; Cardiac Pacing, Artificial; Cardiotonic Agents; Creatine; Creatine Kinase; Creatine Kinase, BB Form; Creatine Kinase, MM Form; Dobutamine; Dogs; Dose-Response Relationship, Drug; Glyceraldehyde-3-Phosphate Dehydrogenases; Heart Failure; Isoenzymes; Random Allocation; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors | 2005 |
In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE).
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Dobutamine; Female; Heart Failure; Hospital Mortality; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Retrospective Studies | 2005 |
Acute decompensated heart failure: the shrinking role of inotropic therapy.
Topics: Acute Disease; Cardiovascular Agents; Dobutamine; Heart Failure; Humans; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Treatment Outcome | 2005 |
[Cost analysis of the treatment of acute decompensated heart failure. Levosimendan versus dobutamine].
Topics: Acute Disease; Adrenergic beta-Agonists; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Health Care Costs; Heart Failure; Hospital Costs; Humans; Hydrazones; Length of Stay; Pyridazines; Simendan | 2005 |
Adenoviral gene transfer of Akt enhances myocardial contractility and intracellular calcium handling.
Topics: Adenoviridae; Adrenergic beta-Agonists; Animals; Calcium; Calcium-Transporting ATPases; Dobutamine; Echocardiography; Genetic Therapy; Genetic Vectors; Heart Failure; Male; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Oxygen Consumption; Perfusion; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Transduction, Genetic | 2006 |
Effect of myocardial ischemia during dobutamine stress echocardiography on cardiac mortality in patients with heart failure secondary to ischemic cardiomyopathy.
Topics: Blood Pressure; Cardiotonic Agents; Death, Sudden, Cardiac; Dobutamine; Echocardiography, Stress; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Heart Rate; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Netherlands; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Survival Rate | 2005 |
Risk of death with nesiritide.
Topics: Adrenergic beta-Antagonists; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain | 2005 |
Risk of death with nesiritide.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Natriuretic Agents; Natriuretic Peptide, Brain; Nitroglycerin; Research Design | 2005 |
The Pilot Randomized Study of Nesiritide Versus Dobutamine in Heart Failure (PRESERVD-HF).
Topics: Adrenergic beta-Agonists; Aged; Biomarkers; Dobutamine; Female; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Agents; Natriuretic Peptide, Brain; Pilot Projects; Predictive Value of Tests; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Troponin I; Troponin T | 2005 |
Prediction of beneficial effect of beta blocker treatment in severe ischaemic cardiomyopathy: assessment of global left ventricular ejection fraction using dobutamine stress cardiovascular magnetic resonance.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Dobutamine; Feasibility Studies; Heart Failure; Humans; Magnetic Resonance Angiography; Male; Middle Aged; Myocardial Ischemia; Propanolamines; Stroke Volume; Treatment Outcome; Ventricular Dysfunction, Left | 2005 |
Automated drug delivery system to control systemic arterial pressure, cardiac output, and left heart filling pressure in acute decompensated heart failure.
Topics: Animals; Antihypertensive Agents; Atrial Function, Left; Automation; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Drug Delivery Systems; Drug Therapy, Combination; Furosemide; Heart Failure; Infusions, Intravenous; Models, Cardiovascular; Nitroprusside | 2006 |
[Therapy of acute decompensated heart failure with levosimendan].
Topics: Adult; Aged; Calcium Channel Agonists; Cardiotonic Agents; Conscious Sedation; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Hydrazones; Male; Middle Aged; Norepinephrine; Pyridazines; Shock, Cardiogenic; Simendan | 2006 |
Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
Topics: Acute Disease; Aged; Cardiotonic Agents; Cohort Studies; Dobutamine; Female; Health Care Costs; Heart Failure; Hospital Mortality; Humans; Length of Stay; Male; Middle Aged; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Odds Ratio; Patient Readmission; Regression Analysis; Retrospective Studies; Treatment Outcome | 2006 |
Effects of levosimendan versus dobutamine on pressure load-induced right ventricular failure.
Topics: Animals; Cardiotonic Agents; Dobutamine; Dogs; Heart Failure; Hydrazones; Hypertension, Pulmonary; Prospective Studies; Pulmonary Artery; Pulmonary Circulation; Pyridazines; Random Allocation; Simendan; Ventricular Dysfunction, Right | 2006 |
Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
Topics: Aged; Cardiotonic Agents; Creatinine; Diuretics; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kaplan-Meier Estimate; Kidney; Male; Milrinone; Natriuretic Agents; Natriuretic Peptide, Brain; Survival Rate; Urine | 2006 |
Cardiac dilatation and pump dysfunction without intrinsic myocardial systolic failure following chronic beta-adrenoreceptor activation.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Animals; Apoptosis; Cardiomyopathy, Dilated; Dobutamine; Down-Regulation; Heart Failure; Male; Myocardial Contraction; Myocardium; Norepinephrine; Organ Size; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Systole; Ventricular Dysfunction, Left | 2007 |
Chronic inotropic therapy in end-stage heart failure.
Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Administration Schedule; Drug Costs; Female; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Medicare; Middle Aged; Milrinone; Severity of Illness Index; Time Factors | 2006 |
Cardiac hypertrophy and reduced contractility in hearts deficient in the titin kinase region.
Topics: Animals; Calcium; Cardiomegaly; Connectin; Dobutamine; Heart Failure; Mice; Mice, Knockout; Muscle Proteins; Myocardial Contraction; Protein Kinase C; Protein Kinases; Signal Transduction; Tamoxifen; Tripartite Motif Proteins; Ubiquitin-Protein Ligases | 2007 |
Levosimendan restores both systolic and diastolic cardiac performance in lipopolysaccharide-treated rabbits: comparison with dobutamine and milrinone.
Topics: Animals; Cardiotonic Agents; Diastole; Disease Models, Animal; Dobutamine; Heart Failure; Hydrazones; Lipopolysaccharides; Milrinone; Pyridazines; Rabbits; Sepsis; Simendan; Systole; Ventricular Function, Left | 2007 |
Home inotropic therapy in children.
Topics: Adolescent; Cardiotonic Agents; Child; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Prognosis; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Rate; Time Factors; Treatment Outcome; Waiting Lists | 2007 |
Importance of contractile reserve for CRT.
Topics: Aged; Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Ischemia; Male; Middle Aged; Myocardial Contraction; Pacemaker, Artificial; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2007 |
A struggle to SURVIVE: to abandon or not to abandon levosimendan?
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Natriuretic Peptide, Brain; Pyridazines; Simendan; Survival Rate; Treatment Outcome | 2007 |
Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Ascorbic Acid; Cardiac Catheterization; Cardiac Output; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Reactive Oxygen Species; Thermodilution; Ventricular Function, Left | 2007 |
Levosimendan improves renal function in acute decompensated heart failure: cause and clinical application. Editorial to: "Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine by Yilmaz et al."
Topics: Acute Disease; Cardiotonic Agents; Dobutamine; Glomerular Filtration Rate; Heart Failure; Humans; Hydrazones; Kidney; Pyridazines; Simendan | 2007 |
Myocardial contractile reserve predicts improvement in left ventricular function after cardiac resynchronization therapy.
Topics: Cardiac Pacing, Artificial; Dobutamine; Echocardiography; Heart Failure; Humans; Myocardial Contraction; Regression Analysis; Sensitivity and Specificity; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2007 |
[Infusion of inotropic agents at home in patients with severe heart failure: an important role for the nurse practitioner].
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Health Care Costs; Heart Failure; Home Infusion Therapy; Humans; Nursing; Quality of Life | 2007 |
[Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Female; Health Care Costs; Heart Failure; Heart Transplantation; Hemodynamics; Home Infusion Therapy; Humans; Male; Middle Aged; Nursing; Quality of Life; Retrospective Studies; Treatment Outcome; Waiting Lists | 2007 |
Endomyocardial upregulation of beta1 adrenoreceptor gene expression and myocardial contractile reserve following cardiac resynchronization therapy.
Topics: Aged; Cardiac Output, Low; Cardiac Pacing, Artificial; Dobutamine; Endocardium; Exercise Tolerance; Female; Gene Expression; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Muscle Contraction; Myocardial Contraction; Myocardium; Receptors, Adrenergic; Stroke Volume; Ventricular Function, Left | 2008 |
Combined deficiency of dystrophin and beta1 integrin in the cardiac myocyte causes myocardial dysfunction, fibrosis and calcification.
Topics: Adrenergic beta-Agonists; Animals; Calcinosis; Calcium-Binding Proteins; Cardiomyopathies; Cell Adhesion Molecules; Core Binding Factor Alpha 1 Subunit; Decorin; Disease Models, Animal; Dobutamine; Dystrophin; Extracellular Matrix Proteins; Female; Fibrosis; Heart Failure; Integrin beta1; Isoproterenol; Male; Matrix Gla Protein; Mice; Mice, Inbred mdx; Mice, Knockout; Myocytes, Cardiac; Necrosis; Phenotype; Pregnancy; Proteoglycans; RNA, Messenger; Severity of Illness Index; Time Factors; Up-Regulation; Ventricular Function | 2008 |
Comparison of the initial hospitalization costs between the patients treated with dobutamine and the patients treated with amrinone for acute decompensated heart failure in a Japanese institute.
Topics: Aged; Amrinone; Cardiotonic Agents; Chi-Square Distribution; Cost-Benefit Analysis; Dobutamine; Drug Costs; Economics, Pharmaceutical; Female; Heart Failure; Hospital Costs; Humans; Japan; Length of Stay; Male; Statistics, Nonparametric | 2008 |
The effect of pharmacological stress on intraventricular dyssynchrony in left ventricular systolic dysfunction.
Topics: Aged; Cardiac Pacing, Artificial; Dobutamine; Dose-Response Relationship, Drug; Echocardiography, Doppler, Color; Echocardiography, Stress; Electrocardiography; Female; Heart Failure; Heart Ventricles; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Stroke Volume; Systole; Ventricular Dysfunction, Left; Ventricular Function, Left | 2008 |
NT-proBNP response to dobutamine stress echocardiography predicts left ventricular contractile reserve in dilated cardiomyopathy.
Topics: Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Natriuretic Peptide, Brain; Peptide Fragments | 2008 |
Hemodynamic effects of dobutamine in patients with an exacerbation of chronic systolic heart failure treated with low doses of carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carbazoles; Cardiotonic Agents; Carvedilol; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Middle Aged; Propanolamines; Stroke Volume | 2008 |
The effects of dobutamine on renal sympathetic activity in human heart failure.
Topics: Adrenergic beta-Agonists; Dobutamine; Dose-Response Relationship, Drug; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Kidney; Male; Middle Aged; Renal Plasma Flow; Sympathetic Nervous System | 2008 |
Impaired relaxation is the main manifestation in transgenic mice expressing a restrictive cardiomyopathy mutation, R193H, in cardiac TnI.
Topics: Age Factors; Animals; Cardiac Output; Cardiomyopathy, Restrictive; Cardiotonic Agents; Cell Size; Diastole; Disease Progression; Dobutamine; Echocardiography, Doppler; Genotype; Heart Failure; Heart Rate; Mice; Mice, Transgenic; Mutation; Myocardial Contraction; Phenotype; Troponin I | 2008 |
Natriuretic peptide-guided levosimendan therapy for heart failure: a promising new approach.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors | 2008 |
The prolonged lowering effect of levosimendan on brain natriuretic peptide levels in patients with decompansated heart failure: clinical implications.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Hydrazones; Infusions, Intravenous; Natriuretic Peptide, Brain; Predictive Value of Tests; Prognosis; Pyridazines; Simendan; Time Factors | 2008 |
Combined haemodynamic effects of low doses of dopamine and dobutamine in patients with acute infarction and cardiac failure.
Topics: Acute Disease; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Drug Therapy, Combination; Electroencephalography; Heart Failure; Heart Rate; Hemodynamics; Humans; Kidney; Myocardial Infarction; Pulmonary Circulation; Vascular Resistance | 1984 |
Possible value of H2-receptor agonists for treatment of catecholamine-insensitive congestive heart failure.
Topics: Adenylyl Cyclases; Adult; Aged; Catecholamines; Dihydroalprenolol; Dobutamine; Female; Heart Failure; Heart Valve Diseases; Hemodynamics; Humans; Imidazoles; Impromidine; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Receptors, Histamine; Receptors, Histamine H2 | 1984 |
[Therapy of heart failure with beta adrenoceptor agonists].
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Heart Failure; Humans; Practolol; Prenalterol | 1983 |
New and old inotropic drugs: controversies and challenges, Oslo, Norway, May 21-22, 1982: reflections on inotropic drugs: a personal commentary.
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Dopamine; Heart Failure; Humans; Kinetics; Myocardial Contraction | 1984 |
[Alternatives to digitalis therapy?].
Topics: Albuterol; Captopril; Dobutamine; Dopamine; Heart Failure; Humans; Hydralazine; Nitrates; Prazosin; Teprotide | 1981 |
Sympathomimetic amines: potential clinical applications in ischemic heart disease.
Topics: Animals; Coronary Disease; Deoxyepinephrine; Dobutamine; Dogs; Dopamine; Heart Failure; Humans; Levodopa; Myocardial Contraction; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Receptors, Dopamine; Sympathomimetics | 1982 |
Effect of combined nitroglycerin and dobutamine infusion in left ventricular dysfunction.
Topics: Catecholamines; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1983 |
Dobutamine effects on blood gases and hemodynamics in acute myocardial infarction with heart failure.
Topics: Aged; Carbon Dioxide; Cardiac Output; Catecholamines; Dobutamine; Female; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Oxygen; Pulmonary Circulation; Pulmonary Wedge Pressure | 1984 |
Cardiogenic pulmonary edema.
Topics: Aminophylline; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Morphine; Nitroglycerin; Nitroprusside; Pulmonary Edema; Verapamil | 1984 |
[Diagnostic possibilities and therapy in the acute phase of myocardial infarct].
Topics: Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Nitroglycerin; Nitroprusside; Norepinephrine; Prognosis; Vasodilator Agents | 1984 |
[Catecholamines in internal medicine emergencies].
Topics: Acute Disease; Catecholamines; Coronary Disease; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Myocardial Infarction; Oxygen Consumption; Shock, Cardiogenic; Shock, Septic | 1984 |
Hemodynamic effects of dobutamine in patients below and over 65 years, with left heart failure secondary to an acute myocardial infarction.
Topics: Age Factors; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Middle Aged; Myocardial Infarction; Stroke Volume; Vascular Resistance | 1984 |
Positive inotropic effect of 3, 4-dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-qu inolinone (OPC-8212) in the dog with experimentally-induced right-sided heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Injections, Intravenous; Male; Myocardial Contraction; Pyrazines; Quinolines | 1984 |
[Combined medication of nitroprusside and dopamine or dobutamine in acute heart failure].
Topics: Acute Disease; Adult; Aged; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Humans; Male; Middle Aged; Nitroprusside | 1984 |
Drugs five years later. Dobutamine.
Topics: Animals; Cardiac Output; Catecholamines; Coronary Disease; Dobutamine; Dogs; Dopamine; Heart Failure; Heart Rate; Heart Ventricles; Humans; Myocardial Contraction; Myocardial Infarction; Stroke Volume | 1983 |
[Dopamine and dobutamine as circulatory drugs].
Topics: Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1983 |
[Heart failure and acute myocardial infarct. Current treatment].
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Imidazoles; Labetalol; Myocardial Infarction; Phentolamine; Vasodilator Agents | 1983 |
Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Stroke Volume; Time Factors; Vascular Resistance | 1984 |
[Dobutamine in childhood].
Topics: Adolescent; Age Factors; Blood Pressure; Catecholamines; Child; Child, Preschool; Dobutamine; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn | 1984 |
Impaired skeletal muscle nutritive flow during exercise in patients with congestive heart failure: role of cardiac pump dysfunction as determined by the effect of dobutamine.
Topics: Blood Flow Velocity; Cardiac Output; Catecholamines; Dobutamine; Exercise Test; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Leg; Muscles; Oxygen Consumption | 1984 |
Hemodynamic effects of a new inotropic agent, piroximone (MDL 19205), in patients with chronic heart failure.
Topics: Adult; Blood Pressure; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Myocardial Contraction; Pulmonary Artery; Pulmonary Wedge Pressure; Stimulation, Chemical; Vascular Resistance | 1984 |
Combined hemodynamic effects of dobutamine and IV nitroglycerin in congestive heart failure.
Topics: Adult; Aged; Cardiac Output; Catecholamines; Dobutamine; Drug Synergism; Heart Failure; Hemodynamics; Humans; Middle Aged; Nitroglycerin; Pulmonary Wedge Pressure | 1980 |
Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure.
Topics: Catecholamines; Catheterization; Dobutamine; Drug Tolerance; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Outpatient Clinics, Hospital; Quality of Life; Stroke Volume; Time Factors | 1983 |
Dobutamine and hydralazine: comparative influences of positive inotropy and vasodilation on coronary blood flow and myocardial energetics in nonischemic congestive heart failure.
Topics: Adult; Catecholamines; Coronary Circulation; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Stimulation, Chemical; Vasodilation | 1983 |
The clinical use of inotropes in cardiac failure: dopamine, dobutamine, prenalterol and pirbuterol.
Topics: Catecholamines; Dobutamine; Dopamine; Ethanolamines; Heart Failure; Hemodynamics; Humans; Practolol; Prenalterol | 1983 |
Radiocardiographic assessment of dobutamine and isosorbide dinitrate therapy in patients with mitral stenosis and pulmonary congestion.
Topics: Adult; Aged; Blood Pressure; Blood Volume; Cardiac Output; Catecholamines; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Mitral Valve Stenosis; Pulmonary Edema | 1983 |
[Positive inotropic effects of doxaminol in congestive heart failure].
Topics: Aged; Chemical Phenomena; Chemistry; Dibenzoxepins; Dobutamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Sympathomimetics; Thermodilution | 1983 |
Failure of dobutamine to increase exercise capacity despite hemodynamic improvement in severe chronic heart failure.
Topics: Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume | 1983 |
The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy.
Topics: Adenosine Triphosphate; Adult; Aged; Blood Urea Nitrogen; Catecholamines; Coronary Circulation; Creatine; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardium; Sodium | 1983 |
[Noninvasive monitoring of stroke volume during intravenous infusion of dobutamine].
Topics: Adult; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Infusions, Parenteral; Male; Middle Aged; Monitoring, Physiologic; Plethysmography, Impedance; Stroke Volume | 1983 |
Dobutamine: a new inotropic agent.
Topics: Adult; Catecholamines; Digoxin; Dobutamine; Female; Heart Failure; Humans; Myocardial Infarction | 1980 |
Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.
Topics: Aged; Captopril; Cardiac Output; Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardium; Oxygen Consumption; Proline | 1981 |
Cardiotonic agents in the management of chronic cardiac failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Ethanolamines; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Kidney Function Tests; Male; Middle Aged; Oxygen Consumption | 1982 |
Hemodynamic and cardiac metabolic effects of inotropic stimulation with dobutamine in patients with coronary artery disease.
Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption | 1982 |
Hemodynamic effects of dobutamine in children with cardiovascular failure.
Topics: Adolescent; Blood Pressure; Cardiac Output; Catecholamines; Child; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infant; Infant, Newborn; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1982 |
[Hemodynamic effects of dobutamine in patients with severe low-output heart failure (author's transl)].
Topics: Adult; Aged; Cardiac Output, Low; Cardiomyopathy, Hypertrophic; Catecholamines; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged | 1980 |
The comparison of the effects of AR-L 115 BS and dobutamine in patients with severe cardiac failure.
Topics: Blood Pressure; Cardiotonic Agents; Catecholamines; Dobutamine; Female; Heart Failure; Heart Rate; Humans; Imidazoles; Male | 1981 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart Rupture; Hemodynamics; Humans; Hypertension; Hypotension; Myocardial Infarction; Propranolol; Shock, Cardiogenic; Vasodilator Agents | 1981 |
Myocardial metabolic and hemodynamic effects of dobutamine in heart failure complicating coronary artery disease.
Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Humans; Lactates; Male; Middle Aged; Myocardium; Radionuclide Imaging | 1981 |
Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure.
Topics: Adolescent; Adult; Aged; Aminopyridines; Amrinone; Cardiac Output; Catecholamines; Chronic Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Pulmonary Wedge Pressure; Time Factors | 1981 |
[Catecholamines in the treatment of therapy-refractory heart insufficiency].
Topics: Catecholamines; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans | 1981 |
Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
Topics: Administration, Oral; Adult; Cardiotonic Agents; Dobutamine; Drug Evaluation; Drug Therapy, Combination; Ethanolamines; Heart Failure; Hemodynamics; Humans; Time Factors; Vasodilator Agents | 1981 |
Dobutamine in chronic ischemic heart failure: alterations in left ventricular function and coronary hemodynamics.
Topics: Aged; Catecholamines; Coronary Circulation; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Lactates; Male; Middle Aged; Myocardial Contraction; Myocardium; Oxygen Consumption; Pulmonary Wedge Pressure; Stroke Volume | 1981 |
Ventricular failure.
Topics: Dobutamine; Heart Failure; Heart Ventricles; Humans; Intra-Aortic Balloon Pumping | 1981 |
[Sympathomimetics in intensive medicine].
Topics: Anaphylaxis; Critical Care; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Metaproterenol; Norepinephrine; Resuscitation; Sympathomimetics | 1981 |
[Dobutamine in low cardiac output syndrome. Haemodynamic study (author's transl)].
Topics: Adult; Cardiac Output, Low; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Isoproterenol; Male; Postoperative Complications | 1981 |
New approaches to therapy of acute heart failure.
Topics: Antihypertensive Agents; Dobutamine; Heart Failure; Humans; Hydralazine; Nitrates; Nitroprusside; Oxygen Inhalation Therapy; Prazosin | 1980 |
Drug regimens for congestive heart failure.
Topics: Cardiac Glycosides; Cardiotonic Agents; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Vasodilator Agents | 1980 |
Tolerance to dobutamine after a 72 hour continuous infusion.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Tolerance; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Systole; Time Factors | 1980 |
A comparison of digoxin and dobutamine in patients with acute infarction and cardiac failure.
Topics: Aged; Blood Pressure; Catecholamines; Digoxin; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Vascular Resistance | 1980 |
Improvement of human myocardial mitochondria after dobutamine: a quantitative ultrastructural study.
Topics: Catecholamines; Coronary Circulation; Dobutamine; Heart Failure; Humans; Mitochondria, Heart | 1980 |
New catecholamines in clinical cardiovascular medicine.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Catecholamines; Dobutamine; Heart Diseases; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardial Infarction; Myocardium; Oxygen Consumption | 1980 |
Comparison of hemodynamic actions of pirbuterol and dobutamine on cardiac function in severe congestive heart failure.
Topics: Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Ethanolamines; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume; Vascular Resistance | 1981 |
Dobutamine as palliative drug in home-care advanced cancer patients.
Topics: Dobutamine; Female; Heart Failure; Home Care Services; Humans; Middle Aged; Neoplasms; Palliative Care | 1994 |
Effects of pulsed beta-stimulant therapy on beta-adrenoceptors and chronotropic responsiveness in chronic heart failure.
Topics: Dobutamine; Heart Failure; Heart Rate; Humans; Receptors, Adrenergic, beta | 1995 |
Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.
Topics: Amrinone; Animals; Blood Pressure; Bucladesine; Calcium; Cardiomyopathies; Cardiotonic Agents; Cricetinae; Digoxin; Disease Models, Animal; Dobutamine; Energy Metabolism; Heart Failure; Isoproterenol; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardial Contraction; Oxygen Consumption; Phosphates; Phosphorylation | 1995 |
The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; Dogs; Dose-Response Relationship, Drug; Female; Heart; Heart Failure; Heart Rate; Infusions, Intravenous; Injections, Intra-Arterial; Male; Methoxamine; Myocardium; Nitroglycerin; Propranolol; Structure-Activity Relationship; Vascular Resistance; Ventricular Function, Left | 1994 |
Digoxin in chronic heart failure.
Topics: Digoxin; Dobutamine; Exercise Tolerance; Heart Failure; Humans | 1995 |
Long-term dobutamine in heart failure.
Topics: Dobutamine; Drug Administration Schedule; Heart Failure; Home Care Services; Humans; Male; Middle Aged | 1994 |
[Dobutamine pulse therapy in patients with severe heart failure. Is it a beneficial measure?].
Topics: Dobutamine; Heart Failure; Humans; Infusions, Intravenous | 1994 |
Exercise training in a patient with congestive heart failure on continuous dobutamine.
Topics: Dobutamine; Exercise Test; Exercise Therapy; Exercise Tolerance; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Oxygen Consumption; Physical Endurance | 1994 |
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
Topics: Aged; Cardiac Output, Low; Cohort Studies; Coronary Disease; Critical Care; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Stroke Volume; Vasodilation | 1994 |
Left ventricular remodelling and disparate changes in contractility and relaxation during the development of and recovery from experimental heart failure.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiac Pacing, Artificial; Dobutamine; Dogs; Electrocardiography; Heart; Heart Failure; Heart Rate; Male; Myocardial Contraction; Stroke Volume; Ventricular Function, Left | 1994 |
Divergent effects of intravenous dobutamine and nitroprusside on left atrial contribution to ventricular filling in dogs with chronic heart failure.
Topics: Animals; Chronic Disease; Coronary Angiography; Diastole; Dobutamine; Dogs; Echocardiography, Doppler; Heart Atria; Heart Failure; Hemodynamics; Infusions, Intravenous; Nitroprusside; Ventricular Function, Left | 1994 |
Improved hemodynamic function and mechanical efficiency in congestive heart failure with sodium dichloroacetate.
Topics: Dichloroacetic Acid; Dobutamine; Heart; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Myocardium; Oxygen Consumption; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; Pyruvate Dehydrogenase Complex | 1994 |
Managing dobutamine infusions.
Topics: Dobutamine; Drug Monitoring; Heart Failure; Humans; Infusions, Intravenous; Nursing Assessment; Patient Care Planning | 1993 |
Pulmonary function tests in patients with congestive heart failure: effects of medical therapy.
Topics: Adult; Aged; Captopril; Cardiovascular Agents; Digoxin; Dobutamine; Drug Therapy, Combination; Echocardiography, Doppler; Forced Expiratory Volume; Furosemide; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Nitroprusside; Vasodilator Agents; Vital Capacity | 1993 |
Down-regulation of beta-adrenergic receptors on mononuclear leukocytes induced by dobutamine treatment in patients with congestive heart failure.
Topics: Adult; Aged; Dobutamine; Down-Regulation; Epinephrine; Female; Heart Failure; Humans; Infusions, Intravenous; Leukocytes, Mononuclear; Male; Middle Aged; Norepinephrine; Receptors, Adrenergic, beta; Ventricular Function, Left | 1993 |
Cardiac study by dobutamine stress echocardiography in thalassemic patients.
Topics: Adolescent; Adult; beta-Thalassemia; Chelation Therapy; Child; Combined Modality Therapy; Deferoxamine; Diastole; Dobutamine; Echocardiography; Female; Heart Failure; Hemosiderosis; Humans; Iron; Male; Transfusion Reaction | 1993 |
Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Dobutamine; Exercise; Female; Heart Failure; Hemodynamics; Humans; Isoquinolines; Lymphocytes; Male; Middle Aged; Quinapril; Receptors, Adrenergic, beta; Tetrahydroisoquinolines; Up-Regulation | 1993 |
Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
Topics: Animals; Blood Pressure; Cardiac Output; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Enalaprilat; Heart Failure; Heart Rate; Hemodynamics; Nitroprusside; Stroke Volume; Vascular Resistance; Ventricular Function, Left | 1993 |
Cardiac index vs oxygen-derived parameters for rational use of dobutamine in patients with congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Cardiac Output; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Heart Rate; Humans; Lactates; Male; Middle Aged; Oxygen; Oxygen Consumption | 1993 |
Long-term dobutamine therapy.
Topics: Dobutamine; Heart Failure; Humans; Time Factors | 1993 |
Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure.
Topics: Adult; Aged; Cardiac Catheterization; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1993 |
Cardiovascular effects of dopamine and dobutamine in conscious pigs with chronic heart failure.
Topics: Animals; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Male; Prospective Studies; Swine; Ventricular Function, Left | 1993 |
The renal effects of dopamine and dobutamine in stable chronic heart failure.
Topics: Dobutamine; Dopamine; Heart Failure; Humans; Kidney | 1993 |
Degree of external force to the left ventricle determines hemodynamic response to nitroprusside in failing hearts: comparison with the response to dobutamine.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Microspheres; Nitroprusside; Pressure; Random Allocation; Vasodilator Agents; Ventricular Function, Left | 1995 |
Experimental rat model representing both acute and chronic heart failure related to autoimmune myocarditis.
Topics: Acute Disease; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Autoimmune Diseases; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Dobutamine; Electrocardiography; Heart; Heart Failure; Male; Myocarditis; Myocardium; Myosins; Organ Size; Rats; Rats, Inbred Lew; Staining and Labeling; Ventricular Function, Left | 1995 |
[Anesthesiologic management in cardiomyoplasty].
Topics: Adult; Aged; Anesthesia, General; Anti-Arrhythmia Agents; Cardiomyoplasty; Cardiotonic Agents; Dobutamine; Electrocardiography; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Monitoring, Intraoperative; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 1995 |
[Treatment of heart failure in children].
Topics: Adult; Age Factors; Cardiotonic Agents; Child; Diuretics; Dobutamine; Dopamine; Heart Defects, Congenital; Heart Failure; Hemodynamics; Humans; Infant; Infant, Newborn; Phosphodiesterase Inhibitors; Vasodilator Agents | 1995 |
Regional alterations of left ventricular contraction and inotropic reserve in conscious dogs with heart failure.
Topics: Analysis of Variance; Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Myocardial Contraction; Stimulation, Chemical; Ventricular Dysfunction, Left | 1995 |
Reversal of end-stage heart failure is predicted by long-term therapeutic response rather than initial hemodynamic and neurohormonal profile.
Topics: Adult; Cardiovascular Agents; Dobutamine; Dose-Response Relationship, Drug; Enalapril; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Norepinephrine; Survival Rate; Treatment Outcome; Waiting Lists | 1996 |
Effect of prostaglandin E1 infusion on kidney function in patients with severe heart failure.
Topics: Alprostadil; Creatinine; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Heart Failure; Humans; Infusions, Intravenous; Kidney; Kidney Function Tests; Male; Middle Aged; Retrospective Studies; Vasodilator Agents | 1996 |
Reproducibility of heart rate variability indices during exercise stress testing and inotrope infusion in chronic heart failure patients.
Topics: Aged; Chronic Disease; Dobutamine; Electrocardiography; Exercise Test; Heart Failure; Heart Rate; Humans; Middle Aged; Reproducibility of Results; Signal Processing, Computer-Assisted; Sympathomimetics | 1996 |
Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure.
Topics: Ambulatory Care; Amrinone; Cardiotonic Agents; Cost-Benefit Analysis; Dobutamine; Drug Administration Schedule; Emergency Service, Hospital; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Length of Stay; Male; Middle Aged; Milrinone; Patient Admission; Patient Education as Topic; Pyridones; Time Factors | 1996 |
Inotropic interventions in the assessment of myocardial failure associated with taurine deficiency in domestic cats.
Topics: Animals; Blood Pressure; Cats; Dobutamine; Echocardiography; Female; Food, Fortified; Heart; Heart Failure; In Vitro Techniques; Male; Myocardial Contraction; Taurine; Ventricular Function, Left | 1996 |
Muscarinic receptor modulation of basal and beta-adrenergic stimulated function of the failing human left ventricle.
Topics: Acetylcholine; Adrenergic beta-Agonists; Atropine; Catheterization; Dobutamine; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Receptors, Muscarinic | 1996 |
Right ventricular performance and contractile reserve in patients with severe heart failure. Assessment by pressure-area relations and association with outcome.
Topics: Adult; Cardiac Output; Cardiotonic Agents; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Pulmonary Artery; Pulmonary Wedge Pressure; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Function, Right | 1996 |
[Refractory heart failure: it requires the use of polychemotherapy. What is the rationale?].
Topics: Adrenergic Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cardiomyopathy, Dilated; Cyclooxygenase Inhibitors; Deoxyepinephrine; Digitalis Glycosides; Diuretics; Dobutamine; Dopamine; Dopamine Agonists; Drug Therapy, Combination; Heart Failure; Humans; Nitrates; Phosphodiesterase Inhibitors; Vasodilator Agents | 1995 |
[Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure].
Topics: Aged; Atrial Natriuretic Factor; Dobutamine; Electrocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Ventricular Function, Left | 1996 |
[Epidural anesthesia for herniorrhaphy in a patient with severe dilated cardiomyopathy (DCM) under pimobendan control].
Topics: Anesthesia, Epidural; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Dopamine; Fentanyl; Heart Failure; Hernia, Inguinal; Humans; Hypotension; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Pyridazines | 1997 |
Prostaglandin E1--bridge to cardiac transplantation. Technique, dosage, results.
Topics: Alprostadil; Cardiotonic Agents; Catheters, Indwelling; Chronic Disease; Disease Progression; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Safety; Treatment Outcome; Vasodilator Agents | 1997 |
The effect of positive inotropes on the failing human myocardium.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Calcium; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Milrinone; Myocardial Contraction; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones | 1997 |
Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine Tc-99m sestamibi tomoscintigraphy.
Topics: Aged; Aortic Aneurysm, Abdominal; Carotid Stenosis; Coronary Artery Bypass; Dobutamine; Echocardiography; Endarterectomy, Carotid; Exercise Test; Female; Heart Failure; Humans; Intraoperative Complications; Ischemia; Leg; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Prospective Studies; Risk Factors; Sympathomimetics; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Vascular Diseases | 1997 |
[Current views on Milrinon--a PDE-III-inhibitor].
Topics: Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Heart Ventricles; Humans; Milrinone; Oxygen Consumption; Pyridones | 1994 |
Is dobutamine stress echocardiography useful for noninvasive differentiation of ischemic from idiopathic dilated cardiomyopathy?
Topics: Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Feasibility Studies; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Sensitivity and Specificity; Ventricular Function, Left | 1997 |
Home inotropic therapy in advanced heart failure: cost analysis and clinical outcomes.
Topics: Cardiotonic Agents; Cause of Death; Costs and Cost Analysis; Direct Service Costs; Dobutamine; Female; Heart Failure; Home Care Services; Humans; Length of Stay; Male; Middle Aged; Milrinone; Pyridones; Retrospective Studies; Stroke Volume; Survival Rate; Treatment Outcome | 1997 |
Continuous home ambulatory intravenous inotropic drug therapy in severe heart failure: safety and cost efficacy.
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Dopamine; Drug Delivery Systems; Female; Heart Failure; Hemodynamics; Home Nursing; Humans; Infusions, Intravenous; Male; Middle Aged; Time Factors; Treatment Outcome | 1997 |
[Improvement of short-term prognosis in patients with refractory heart failure].
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Assisted Circulation; Cardiotonic Agents; Coronary Care Units; Data Interpretation, Statistical; Dobutamine; Dopamine; Epinephrine; Female; Follow-Up Studies; Heart Failure; Heart Transplantation; Hemodynamics; Hemofiltration; Humans; Male; Middle Aged; Norepinephrine; Prognosis; Survival Rate; Sympathomimetics; Time Factors; Ventilators, Mechanical | 1997 |
Comparative hemodynamic effects of OPC-18790 and dobutamine in patients with advanced heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Quinolones; Ventricular Function, Left | 1994 |
Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
Topics: Atrial Function, Left; Cardiotonic Agents; Chronic Disease; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Mitral Valve; Nitroprusside; Pulmonary Wedge Pressure; Vasodilator Agents; Ventricular Function, Left | 1997 |
Hyperkalemia: a dangerous diagnosis for patients with congestive heart failure.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Electrocardiography; Heart Failure; Humans; Hyperkalemia | 1997 |
Acute changes of left atrial distensibility in congestive heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiac Catheterization; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Atria; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Propanolamines; Vasodilator Agents | 1998 |
Celiprolol, a beta-adrenoceptor antagonist with vasodilator effect, improves hemodynamic response to catecholamine, spontaneous locomotor activity, and survival in cardiomyopathic hamsters with advanced heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Analysis of Variance; Animals; Body Weight; Cardiomyopathies; Celiprolol; Cricetinae; Dobutamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Hemodynamics; Liver; Lung; Mesocricetus; Motor Activity; Myocardium; Organ Size; Random Allocation; Receptors, Adrenergic, beta; Renin; Survival Rate; Ventricular Function, Left | 1998 |
Lack of beneficial effects of growth hormone treatment in conscious dogs during development of heart failure.
Topics: Adrenergic beta-Agonists; Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiac Pacing, Artificial; Dobutamine; Dogs; Growth Hormone; Heart Failure; Insulin-Like Growth Factor I; Isoproterenol; Kidney; Microscopy, Electron; Myocardial Contraction; Myocardium; Vascular Resistance; Ventricular Function, Left | 1998 |
[Perioperative management of two patients with severe dilated cardiomyopathy].
Topics: Aged; Aged, 80 and over; Anesthesia, General; Cardiomyopathy, Dilated; Cardiotonic Agents; Diuretics; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Humans; Intraoperative Complications; Male; Middle Aged; Monitoring, Intraoperative; Perioperative Care; Postoperative Complications | 1998 |
Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 1: Hemodynamic effects in normal dogs and dogs with acute heart failure.
Topics: Acute Disease; Adrenergic beta-Agonists; Anesthesia; Angiotensin II; Animals; Blood Pressure; Calcium Channel Blockers; Dobutamine; Dogs; Female; Heart Conduction System; Heart Failure; Heart Rate; Hemodynamics; Male; Nicardipine; Nitroglycerin; Vasodilator Agents | 1998 |
[Peritoneal dialysis and chronic dobutamine, two experiences contrasted. Possible role and indications in refractory cardiac decompensation].
Topics: Aged; Cardiotonic Agents; Dobutamine; Drug Evaluation; Feasibility Studies; Female; Heart Failure; Hemofiltration; Humans; Male; Middle Aged; Peritoneal Dialysis; Peritoneal Dialysis, Continuous Ambulatory; Salvage Therapy; Survival Rate; Treatment Outcome; Water-Electrolyte Balance | 1998 |
Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
Topics: Aged; Aged, 80 and over; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Monitoring, Physiologic; Observer Variation; Oxygen; Pyridones; Retrospective Studies; Thermodilution; Tricuspid Valve Insufficiency | 1998 |
Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure.
Topics: Cardiotonic Agents; Chronic Disease; Coronary Artery Bypass; Coronary Disease; Dobutamine; Echocardiography; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Patient Selection; Predictive Value of Tests; Regression Analysis; Tomography, Emission-Computed | 1998 |
Value of the venous-arterial PCO2 gradient to reflect the oxygen supply to demand in humans: effects of dobutamine.
Topics: Adult; Aged; Aged, 80 and over; Arteries; Carbon Dioxide; Cardiac Output; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Humans; Intensive Care Units; Male; Middle Aged; Oxygen Consumption; Prospective Studies; Veins | 1998 |
Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure.
Topics: Adenylyl Cyclases; Animals; Atrial Function, Left; beta-Adrenergic Receptor Kinases; Blood Pressure; Cyclic AMP-Dependent Protein Kinases; Dobutamine; Echocardiography; Female; G-Protein-Coupled Receptor Kinase 5; GTP-Binding Proteins; Guanylyl Imidodiphosphate; Heart; Heart Failure; Hemodynamics; Isoproterenol; Myocardium; Norepinephrine; Protein Serine-Threonine Kinases; Receptor Protein-Tyrosine Kinases; Receptors, Adrenergic, beta; Signal Transduction; Swine | 1998 |
Atrioventricular plane displacement during low dose dobutamine infusion predicts recovery of left ventricular dyssynergies.
Topics: Atrioventricular Node; Cardiotonic Agents; Dobutamine; Echocardiography; Heart Failure; Humans; Prognosis | 1998 |
Dobutamine-induced changes in pulmonary artery pressure in patients with congestive heart failure and their relation to abnormalities of lung diffusing capacity.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Pulmonary Diffusing Capacity; Pulmonary Wedge Pressure; Respiratory Function Tests; Ventricular Dysfunction, Left | 1998 |
[The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation].
Topics: Aged; Amrinone; Cardiotonic Agents; Diuresis; Dobutamine; Dopamine; Drug Evaluation; Drug Therapy, Combination; Edema, Cardiac; Female; Heart Failure; Humans; Kidney Failure, Chronic; Male; Middle Aged; Myocardial Contraction; Prospective Studies | 1998 |
[Extracorporeal membrane oxygenation in myocardial failure after pediatric heart surgery].
Topics: Bioprosthesis; Cardiac Output, Low; Cardiotonic Agents; Child, Preschool; Combined Modality Therapy; Dobutamine; Dopamine; Down Syndrome; Electric Countershock; Epinephrine; Extracorporeal Membrane Oxygenation; Female; Heart Failure; Heart Septal Defects; Hemodynamics; Humans; Infant; Male; Postoperative Complications; Reoperation; Surgical Wound Dehiscence; Tetralogy of Fallot; Ventricular Fibrillation | 1998 |
Reversal of severe pulmonary hypertension with beta blockade in a patient with end stage left ventricular failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Cardiac Output; Dobutamine; Drug Administration Schedule; Drug Therapy, Combination; Heart Failure; Heart Transplantation; Humans; Hypertension, Pulmonary; Male; Metoprolol; Middle Aged; Patient Selection; Vascular Resistance | 1998 |
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Torsade de pointes ventricular tachycardia during low dose intermittent dobutamine treatment in a patient with dilated cardiomyopathy and congestive heart failure.
Topics: Adrenergic beta-Agonists; Cardiomyopathy, Dilated; Dobutamine; Electrocardiography, Ambulatory; Female; Heart Failure; Humans; Infusions, Intravenous; Middle Aged; Potassium; Torsades de Pointes | 1999 |
Arrhythmic effects of intermittent dobutamine therapy in chronic heart disease failure. The Working Group of Cardiology of the Academic Committee of Veszprém, Hungary.
Topics: Adrenergic beta-Agonists; Adult; Aged; Arrhythmias, Cardiac; Chronic Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged | 1998 |
Effects of dobutamine on ischemic vasodilation of the forearm in patients with severe congestive heart failure.
Topics: Adrenergic beta-Agonists; Aged; Dobutamine; Forearm; Heart Failure; Humans; Hyperemia; Ischemia; Middle Aged; Peripheral Vascular Diseases; Regional Blood Flow; Vascular Resistance; Vasodilation; Ventricular Dysfunction, Left | 1999 |
Partial left ventriculectomy in a two-year-old girl with dilated cardiomyopathy.
Topics: Antihypertensive Agents; Captopril; Cardiomyopathy, Dilated; Cardiotonic Agents; Child, Preschool; Digoxin; Diuretics; Dobutamine; Female; Follow-Up Studies; Furosemide; Heart Failure; Heart Transplantation; Heart Ventricles; Hemodynamics; Humans; Mitral Valve; Mitral Valve Insufficiency; Papillary Muscles | 1999 |
Dobutamine: a drug utilization evaluation.
Topics: Boston; Dobutamine; Drug Utilization; Heart Failure; Hospital Bed Capacity, 500 and over; Humans; Hypotension | 1988 |
Dynamic cardiomyoplasty in patients with end-stage heart failure: anaesthetic considerations.
Topics: Adult; Aged; Anesthesia, General; Cardiomyopathy, Dilated; Cardiomyoplasty; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Humans; Intraoperative Care; Male; Middle Aged; Monitoring, Intraoperative | 1999 |
Myocardial viability on echocardiography predicts long-term survival after revascularization in patients with ischemic congestive heart failure.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Circadian Rhythm; Coronary Angiography; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; ROC Curve; Survival Rate; Ventricular Dysfunction, Left | 1999 |
Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Coronary Disease; Dobutamine; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; ROC Curve; Stroke Volume; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 1999 |
Intermittent inotropes for advanced heart failure: inquiring minds want to know.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Hemodynamics; Humans; Milrinone; Treatment Outcome | 1999 |
Usefulness of low-dose dobutamine stress echocardiography for evaluating reversibility of brain death-induced myocardial dysfunction.
Topics: Adolescent; Adult; Aged; Brain Death; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Exercise Test; Female; Graft Survival; Heart Arrest; Heart Failure; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Contraction; Troponin T | 1999 |
Tailored therapy using dobutamine and nitroglycerin in advanced heart failure.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Infusions, Parenteral; Isosorbide Dinitrate; Male; Middle Aged; Nitroglycerin; Retrospective Studies; Treatment Outcome; Vasodilator Agents | 1999 |
Can dobutamine stress echocardiography predict cardiac events in nonrevascularized diabetic patients following acute myocardial infarction?
Topics: Aged; Angina, Unstable; Cardiac Catheterization; Cardiotonic Agents; Coronary Angiography; Diabetes Complications; Disease-Free Survival; Dobutamine; Echocardiography; Exercise Test; Female; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Infarction; Prognosis; Prospective Studies; Recurrence; Survival Rate | 1999 |
Heart failure management.
Topics: Ambulatory Care; Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Male; United States | 1999 |
Tumor necrosis factor-alpha serum activity during treatment of acute decompensation of cachectic and non-cachectic patients with advanced congestive heart failure.
Topics: Acute Disease; Adult; Aged; Biomarkers; Body Mass Index; Cachexia; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Furosemide; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Contraction; Prognosis; Tumor Necrosis Factor-alpha | 1999 |
Hypotension with dobutamine: beta-adrenergic antagonist selectivity at low doses of carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Drug Interactions; Fatal Outcome; Heart Failure; Heart Rate; Humans; Hypotension; Male; Propanolamines | 1999 |
Hibernating myocardium: morphological correlates of inotropic stimulation and glucose uptake.
Topics: Adult; Aged; Biopsy; Cardiotonic Agents; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Dobutamine; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome | 2000 |
Inotropes in the beta-blocker era.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Phosphodiesterase Inhibitors; Signal Transduction | 2000 |
Hemodynamic effects of a novel sodium channel activator in dogs with chronic heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Chronic Disease; Digoxin; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Sodium Channels; Sympathomimetics; Ventricular Function | 2000 |
Transpulmonary passage of Albunex as a marker of intracardiac hemodynamics and outcome in chronic congestive heart failure.
Topics: Adult; Aged; Albumins; Capillary Permeability; Cardiotonic Agents; Chronic Disease; Contrast Media; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Prognosis; Survival Rate; Treatment Outcome | 2000 |
Pre-operative coagulopathy management of a neonate with complex congenital heart disease: a case study.
Topics: Acidosis, Respiratory; Anti-Bacterial Agents; Antithrombin III; Antithrombin III Deficiency; Blood Coagulation Tests; Colloids; Combined Modality Therapy; Disseminated Intravascular Coagulation; Dobutamine; Dopamine; Drug Therapy, Combination; Endocarditis, Bacterial; Fatal Outcome; Fungemia; Heart Defects, Congenital; Heart Diseases; Heart Failure; Humans; Infant, Newborn; Male; Nitric Oxide; Plasma; Platelet Transfusion; Postoperative Complications; Preoperative Care; Sodium Bicarbonate; Streptococcal Infections; Thrombosis | 2000 |
Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome.
Topics: Adrenergic beta-Agonists; Aged; Cardiomyopathy, Dilated; Disease Progression; Dobutamine; Exercise Test; Exercise Tolerance; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Oxygen Consumption; Prognosis; Reproducibility of Results | 2000 |
Assessment of cardiac risk before nonvascular surgery: dobutamine stress echocardiography in 530 patients.
Topics: Adult; Aged; Aged, 80 and over; Cardiotonic Agents; Cause of Death; Coronary Disease; Dobutamine; Echocardiography; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Postoperative Complications; Risk Assessment | 2000 |
Carbamazepine-associated severe left ventricular dysfunction.
Topics: Adult; Antimanic Agents; Carbamazepine; Cardiotonic Agents; Dobutamine; Drug Overdose; Echocardiography; Female; Heart Failure; Humans; Suicide, Attempted; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |
Neuroadrenergic activation and response to dobutamine in congestive heart failure secondary to idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Aged, 80 and over; Cardiomyopathy, Dilated; Cardiotonic Agents; Chromatography, High Pressure Liquid; Dobutamine; Echocardiography; Female; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stroke Volume | 2000 |
Prognostic value of 12-lead electrocardiogram during dobutamine stress echocardiography.
Topics: Angina Pectoris; Death, Sudden, Cardiac; Dobutamine; Echocardiography; Electrocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Prognosis; Retrospective Studies; Risk Factors | 2000 |
Differential alteration of cardiotonic effects of EMD 57033 and beta-adrenoceptor agonists in volume-overload rabbit ventricular myocytes.
Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Drug Evaluation, Preclinical; Electrocardiography; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Myofibrils; Phosphodiesterase Inhibitors; Quinolines; Rabbits; Thiadiazines | 2000 |
Transient dobutamine-mediated pulsus alternans.
Topics: Aged; Arrhythmias, Cardiac; Cardiotonic Agents; Dobutamine; Electrocardiography; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Male; Myocardial Contraction | 2001 |
Dobutamine as bridge to angiotensin-converting enzyme inhibitor-nitrate therapy in endstage heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Cardiotonic Agents; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Isosorbide Dinitrate; Lisinopril; Prospective Studies; Stroke Volume; Treatment Outcome; Ultrasonography; Vasodilator Agents | 2001 |
Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Radionuclide Ventriculography; Stroke Volume; Survival Rate; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Differential effects of natriuretic peptides and NO on LV function in heart failure and normal dogs.
Topics: Adrenergic beta-Agonists; Animals; Cyclic GMP; Diastole; Dobutamine; Dogs; Drug Synergism; Heart; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Natriuretic Peptide, Brain; Nitric Oxide; Reference Values; Second Messenger Systems; Systole; Ventricular Function, Left | 2001 |
Can pre-treatment with beta-agonists reduce stress test time and the use of atropine in dobutamine stress testing?
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Atropine; Coronary Disease; Diabetes Mellitus; Dobutamine; Dose-Response Relationship, Drug; Electrocardiography; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Hypertension; Male; Middle Aged; Premedication; Risk Factors; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed, Single-Photon | 2001 |
Mitochondrial ATPase and high-energy phosphates in failing hearts.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Body Weight; Cardiac Pacing, Artificial; Coronary Circulation; Disease Models, Animal; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Infusions, Intravenous; Magnetic Resonance Spectroscopy; Mitochondria, Heart; Myocardial Infarction; Organ Size; Phosphocreatine; Protein Subunits; Proton-Translocating ATPases; Swine; Ventricular Remodeling | 2001 |
How many patients with ischemic cardiomyopathy exhibit viable myocardium?
Topics: Aged; Comorbidity; Disease Progression; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart Failure; Heart Function Tests; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Prevalence; Prognosis; Prospective Studies; Risk Factors; Severity of Illness Index; Stroke Volume; Ventricular Dysfunction, Left | 2001 |
Chronic infusion of dobutamine and nitroprusside in patients with end-stage heart failure awaiting heart transplantation: safety and clinical outcome.
Topics: Cardiac Output, Low; Chi-Square Distribution; Dobutamine; Heart Failure; Heart Transplantation; Humans; Middle Aged; Nitroprusside; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2001 |
Long-term results of coronary artery bypass grafting procedure in the presence of left ventricular dysfunction and hibernating myocardium.
Topics: Adult; Aged; Coronary Artery Bypass; Dobutamine; Echocardiography; Female; Follow-Up Studies; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Prognosis; Prospective Studies; Recurrence; Risk Factors; Survival Rate; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Nitric oxide and cardiac contractility in human heart failure: time for reappraisal.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cyclic AMP; Cyclic GMP; Dobutamine; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Heart Failure; Humans; Isoenzymes; Myocardial Contraction; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Substance P; Ventricular Function, Left | 2001 |
Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
Topics: Cost-Benefit Analysis; Dobutamine; Dopamine; Drug Costs; Female; Heart Failure; Hemodynamics; Humans; Length of Stay; Male; Middle Aged; Milrinone; Nitroglycerin; Nitroprusside; Retrospective Studies; Treatment Outcome; United States | 2001 |
Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Dobutamine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Propanolamines; Prospective Studies; Pulmonary Wedge Pressure; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2001 |
The effects of dobutamine on cardiac sympathetic activity in patients with congestive heart failure.
Topics: Adrenergic beta-Agonists; Aged; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Treatment Outcome; Ventricular Function, Left | 2002 |
Positive inotropic drug infusions for patients with heart failure: current controversies and best practice.
Topics: Cardiotonic Agents; Chronic Disease; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Home Infusion Therapy; Humans; Infusions, Intravenous; Male; Milrinone; Monitoring, Physiologic; Patient Selection; Prognosis; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2002 |
Value of Doppler index combining systolic and diastolic myocardial performance in predicting cardiopulmonary exercise capacity in patients with congestive heart failure: effects of dobutamine.
Topics: Adrenergic beta-Agonists; Dobutamine; Echocardiography, Doppler; Exercise Test; Female; Heart; Heart Failure; Humans; Lung; Male; Middle Aged; Myocardial Contraction; Predictive Value of Tests; Severity of Illness Index | 2002 |
Reverse remodeling and enhanced adrenergic reserve from passive external support in experimental dilated heart failure.
Topics: Animals; Cardiomyopathy, Dilated; Coronary Thrombosis; Dobutamine; Dogs; Heart Failure; Image Processing, Computer-Assisted; Models, Animal; Myocardial Contraction; Polyesters; Prostheses and Implants; Ventricular Dysfunction, Left; Ventricular Pressure; Ventricular Remodeling | 2002 |
[Catecholamines for treatment of severe heart failure (author's transl)].
Topics: Catecholamines; Coronary Circulation; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isoproterenol; Microcirculation; Myocardial Infarction; Norepinephrine; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stimulation, Chemical; Strophanthins | 1979 |
The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Stroke Volume | 1979 |
Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure.
Topics: Chronic Disease; Dobutamine; Dopamine; Heart; Heart Failure; Hemodynamics; Humans; Hydralazine; Monitoring, Physiologic; Nitrates; Nitroprusside; Phentolamine; Prazosin; Teprotide; Vasodilator Agents | 1979 |
Dobutamine in left heart failure after acute myocardial infarction.
Topics: Acute Disease; Blood Pressure; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction | 1979 |
[Hemodynamic effects of dobutamine in the low-output cardiac syndrome].
Topics: Adult; Aged; Catecholamines; Coronary Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1979 |
Comparative systemic and regional hemodynamic effects of dopamine and dobutamine in patients with cardiomyopathic heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Dopamine; Dyspnea; Heart Failure; Hemodynamics; Humans; Kidney; Lung; Middle Aged; Regional Blood Flow | 1978 |
Selection of vasodilator, inotropic or combined therapy for the management of heart failure.
Topics: Blood Pressure; Cardiac Output; Coronary Disease; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Myocardial Contraction; Myocardium; Oxygen Consumption; Sympathomimetics; Time Factors; Vascular Resistance; Vasodilator Agents | 1978 |
Efficacy of new inotropic drugs in clinical coronary heart failure.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Phonocardiography; Phosphodiesterase Inhibitors; Piperidines; Pressure; Quinazolines; Vascular Resistance | 1978 |
New and traditional therapy of congestive heart failure. A European view.
Topics: Delayed-Action Preparations; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isosorbide Dinitrate; Nitroprusside; Phentolamine | 1978 |
Vasodilator and inotropic therapy of heart failure [panel discussion].
Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; Heart Failure; Humans; Hydralazine; Myocardial Contraction; Myocardial Infarction; Nitroprusside; Phentolamine; Prazosin; Propranolol; Vasoconstrictor Agents; Vasodilator Agents | 1978 |
Dobutamine pharmacokinetics in severe heart failure.
Topics: Adult; Aged; Catecholamines; Dobutamine; Female; Heart Failure; Humans; Infusions, Parenteral; Kinetics; Male; Middle Aged | 1978 |
[The effect of sodium nitroprusside and dobutamine on the ventricular myocardium in patients with severe left cardiac insufficiency].
Topics: Catecholamines; Dobutamine; Female; Ferricyanides; Heart; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside | 1978 |
Dobutamine (Dobutrex).
Topics: Cardiovascular System; Catecholamines; Dobutamine; Heart Failure; Humans | 1979 |
Haemodynamic effects of dobutamine in patients with coronary artery disease.
Topics: Aged; Blood Pressure; Cardiac Output; Catecholamines; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance | 1977 |
Cardiovascular effects of dobutamine in severe congestive heart failure.
Topics: Adult; Aged; Catecholamines; Dobutamine; Drug Evaluation; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction | 1977 |
The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
Topics: Adolescent; Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Diuresis; Dobutamine; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Myocardial Contraction; Pulmonary Circulation; Sodium; Stimulation, Chemical; Vascular Resistance | 1977 |
Comparative haemodynamic effects of dobutamine and isoproterenol in man.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Evaluation; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Isoproterenol; Male; Middle Aged; Vascular Resistance | 1977 |
Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
Topics: Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Drug Evaluation; Ferricyanides; Heart Failure; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Nitroprusside; Pulmonary Circulation; Vascular Resistance | 1977 |
[Haemodynamic effect of dobutamine in cardiac failure (author's transl)].
Topics: Adult; Blood Pressure; Cardiac Output; Catecholamines; Dobutamine; Heart Failure; Heart Rate; Humans; Middle Aged; Myocardial Contraction; Vascular Resistance | 1976 |
[Hemodynamic effect of dobutamine in patients with cardiac insufficiency].
Topics: Adult; Catecholamines; Coronary Disease; Dobutamine; Heart Failure; Hemodynamics; Humans; Middle Aged; Myocardial Contraction | 1976 |
Effect of therapeutic dopamine administration on myocardial catecholamine and neuropeptide Y concentrations in the failing ventricles of patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Cardiomyopathy, Dilated; Catecholamines; Dobutamine; Dopamine; Electrocardiography; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Neuropeptide Y; Receptors, Adrenergic, beta | 1992 |
Alterations in left ventricular mechanics, energetics, and contractile reserve in experimental heart failure.
Topics: Animals; Body Weight; Cardiac Output; Cardiac Pacing, Artificial; Dobutamine; Dogs; Dose-Response Relationship, Drug; Energy Metabolism; Heart Failure; Models, Cardiovascular; Myocardial Contraction; Organ Size; Receptors, Adrenergic, beta; Ventricular Function, Left | 1992 |
Dobutamine therapy for outpatients.
Topics: Community Health Nursing; Dobutamine; Heart Failure; Humans; Outpatients | 1992 |
Increased uncoupling of beta-, beta 1- and beta 2-adrenoceptor to myocardial contraction in failing human myocardium.
Topics: Adult; Aged; Binding, Competitive; Dobutamine; Down-Regulation; Female; Heart Failure; Humans; Iodocyanopindolol; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Pindolol; Quinazolines; Receptors, Adrenergic, beta; Terbutaline | 1992 |
[A study on the human beta-receptor regulation by dobutamine and propranolol].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Propranolol; Receptors, Adrenergic, beta; Up-Regulation | 1992 |
Myocardial beta-adrenergic desensitization and neuronal norepinephrine uptake function in idiopathic dilated cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Iodobenzenes; Male; Middle Aged; Myocardial Contraction; Neurons; Norepinephrine; Radionuclide Imaging; Receptors, Adrenergic, beta | 1992 |
Relationship among neuropeptide Y, catecholamines and haemodynamics in congestive heart failure.
Topics: Adult; Cardiac Output; Cardiomyopathy, Dilated; Chronic Disease; Coronary Vessels; Dobutamine; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Neuropeptide Y; Norepinephrine; Sympathetic Nervous System | 1992 |
Late doxorubicin cardiotoxicity.
Topics: Coronary Angiography; Dobutamine; Doxorubicin; Female; Heart Failure; Humans; Middle Aged; Time Factors; Ventricular Function, Left | 1992 |
Effect of dobutamine on pulmonary gas exchange in patients with severe heart failure.
Topics: Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Gas Exchange | 1992 |
Continuous measurement of the pressure-volume relationship in experimental heart failure produced by rapid ventricular pacing in conscious dogs.
Topics: Animals; Blood Pressure; Blood Volume; Cardiac Catheterization; Cardiac Pacing, Artificial; Cardiac Volume; Diastole; Dobutamine; Dogs; Heart Failure; Heart Rate; Manometry; Models, Cardiovascular; Myocardial Contraction; Stroke Volume; Ventricular Function, Left | 1992 |
Dobutamine-induced fever.
Topics: Aged; Dobutamine; Female; Fever; Heart Failure; Humans; Vancomycin | 1992 |
Ventricular-load optimization in patients with heart failure.
Topics: Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Contraction; Nitroprusside; Phenylephrine; Ventricular Function, Left | 1992 |
Ventricular contractility evaluated by mechanical perturbation of the myocardium--experimental and clinical approach adopting small amplitude vibration input.
Topics: Animals; Dobutamine; Dogs; Heart Failure; Humans; Myocardial Contraction; Propranolol; Ventricular Function, Left; Vibration | 1992 |
Effects of cardiovascular drugs on oxygen consumption/oxygen delivery relationship in patients with congestive heart failure.
Topics: Acute Disease; Aged; Aged, 80 and over; Cardiovascular Agents; Catheterization, Swan-Ganz; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Oxygen Consumption; Phosphodiesterase Inhibitors; Pulmonary Edema | 1992 |
Perioperative management of a case of severe peripartum cardiomyopathy.
Topics: Adult; Captopril; Cardiomegaly; Cesarean Section; Critical Care; Digoxin; Dobutamine; Dopamine; Female; Furosemide; Heart Failure; Heparin; Humans; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular | 1992 |
[Additive effects of milrinone and dobutamine in severe heart failure].
Topics: Aged; Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Pyridones | 1992 |
Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.
Topics: Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Receptors, Adrenergic, beta; Ventricular Function, Left | 1991 |
Acute effects of beta-adrenergic stimulation with dobutamine on the plasma levels of atrial natriuretic peptide and cyclic guanosine monophosphate in patients with chronic heart failure.
Topics: Aged; Atrial Natriuretic Factor; Cardiomyopathy, Dilated; Chronic Disease; Cyclic GMP; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
Beta-adrenergic receptor-G protein-adenylate cyclase complex in experimental canine congestive heart failure produced by rapid ventricular pacing.
Topics: Adenylate Cyclase Toxin; Adenylyl Cyclases; Animals; Catecholamines; Dihydropyridines; Dobutamine; Dogs; Electric Stimulation; GTP-Binding Proteins; Heart Failure; Heart Rate; Hemodynamics; Pertussis Toxin; Receptors, Adrenergic, beta; Virulence Factors, Bordetella | 1991 |
Combined intravenous pharmacotherapy in the treatment of patients with decompensated congestive heart failure.
Topics: Adrenergic beta-Agonists; Cardiotonic Agents; Dobutamine; Dopamine; Drug Therapy, Combination; Goals; Heart Failure; Heart Transplantation; Humans; Injections, Intravenous; Phosphodiesterase Inhibitors; Vasodilator Agents | 1991 |
Chronic beta-adrenoceptor blockade prevents the development of beta-adrenergic subsensitivity in experimental right-sided congestive heart failure in dogs.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Aorta; Blood Pressure; Dobutamine; Dogs; Heart Failure; Heart Rate; Isoproterenol; Myocardial Contraction; Myocardium; Nadolol; Norepinephrine; Receptors, Adrenergic, beta | 1991 |
Acute neurohormonal and hemodynamic response to a new peak III phosphodiesterase inhibitor (ICI 153,110) in patients with chronic heart failure.
Topics: Dihydropyridines; Dobutamine; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Norepinephrine; Phosphodiesterase Inhibitors; Pyridazines; Renin | 1990 |
Two weeks of intermittent dobutamine therapy restores cardiac performance and inotropic responsiveness in conscious rats with heart failure.
Topics: Animals; Coronary Vessels; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Male; Myocardial Contraction; Myocardial Infarction; Rats; Rats, Inbred Strains | 1991 |
Effects of dobutamine and salbutamol on haemodynamics and atrial natriuretic factor in patients with severe congestive heart failure.
Topics: Adult; Aged; Albuterol; Atrial Natriuretic Factor; Blood Pressure; Cardiac Output; Dobutamine; Female; Furosemide; Heart Failure; Heart Rate; Hematocrit; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardium; Pulmonary Wedge Pressure | 1991 |
Comparison between the positive inotropic effects of enoximone, a cardiac phosphodiesterase III inhibitor, and dobutamine in patients with moderate to severe congestive heart failure. A study using the end-systolic pressure-volume relationship method.
Topics: Cardiac Volume; Cardiotonic Agents; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Myocardial Contraction; Phosphodiesterase Inhibitors; Radionuclide Angiography; Stroke Volume | 1991 |
Could glucose-insulin-potassium be considered only a step of a complete nutritional program for complicated cardiac patients?
Topics: Cardiopulmonary Bypass; Chronic Disease; Dobutamine; Glucose; Heart Failure; Humans; Insulin; Parenteral Nutrition; Potassium | 1991 |
[Hemodynamic changes in patients with myocardial infarct complicated by acute left ventricular failure during combined nitroglycerin and dobutamine therapy].
Topics: Aged; Blood Pressure; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitroglycerin | 1991 |
Mechanics of contraction and relaxation of the ventricle in experimental heart failure produced by rapid ventricular pacing in the conscious dog.
Topics: Animals; Cardiac Pacing, Artificial; Dobutamine; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Ventricular Function, Left | 1991 |
Dobutamine stress testing in chronic heart failure--dose-response effects assessed by echo-Doppler.
Topics: Aged; Chronic Disease; Dobutamine; Drug Administration Schedule; Echocardiography, Doppler; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1991 |
Physical and pharmacological conditioning in chronic heart failure: a proposal for pulsed inotrope therapy.
Topics: Chronic Disease; Dobutamine; Drug Administration Schedule; Exercise Therapy; Heart Failure; Humans | 1991 |
Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure.
Topics: Adult; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Hydralazine; Male | 1991 |
Effects of short-term administration of dobutamine on left ventricular performance, exercise capacity, norepinephrine levels, and lymphocyte adrenergic receptor density in congestive heart failure.
Topics: Dobutamine; Heart Failure; Hemodynamics; Humans; Lymphocytes; Male; Middle Aged; Norepinephrine; Physical Exertion; Receptors, Adrenergic, beta; Ventricular Function, Left | 1990 |
Neurotransmitter depletion compromises the ability of indirect-acting amines to provide inotropic support in the failing human heart.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Ethanolamines; Female; Heart Failure; Humans; In Vitro Techniques; Isoproterenol; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Stimulation, Chemical | 1990 |
Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output.
Topics: Adrenergic beta-Agonists; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Male; Middle Aged; Time Factors; Urine | 1990 |
[Dopamine and dopaminergic drugs as therapeutic agents in heart failure].
Topics: Deoxyepinephrine; Dobutamine; Dopamine; Dopamine Agents; Heart Failure; Hemodynamics; Humans; Vasodilator Agents | 1990 |
Effects of chronic dobutamine on cardiac mechanics and biochemistry after myocardial infarction in rats.
Topics: Animals; Contractile Proteins; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; In Vitro Techniques; Myocardial Infarction; Myocardium; Organ Size; Oxygen Consumption; Rats; Rats, Inbred Strains; Time Factors | 1991 |
[Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison].
Topics: Adult; Aged; Cardiomyopathy, Dilated; Cardiotonic Agents; Coronary Disease; Dobutamine; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male; Middle Aged; Milrinone; Pyridones | 1991 |
Ventricular-load optimization by inotropic stimulation in patients with heart failure.
Topics: Adult; Aged; Dobutamine; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Oxygen Consumption; Stroke Volume; Ventricular Function, Left | 1991 |
Systolic time intervals as indicators for cardiac function in rat models for heart failure.
Topics: Age Factors; Animals; Blood Flow Velocity; Captopril; Cardiac Output; Cardiotonic Agents; Dobutamine; Heart Failure; Heart Ventricles; Humans; Hypertension; Milrinone; Myocardial Infarction; Pyridones; Rats; Rats, Inbred SHR; Systole | 1990 |
[Medical strategy in patients awaiting emergency heart transplantation].
Topics: Adult; Assisted Circulation; Cardiac Output, Low; Cardiotonic Agents; Contraindications; Critical Care; Diuretics; Dobutamine; Dopamine; Emergencies; Enoximone; Female; Heart Failure; Heart Transplantation; Hemodynamics; Humans; Imidazoles; Infusions, Intravenous; Injections, Intravenous; Male; Middle Aged; Shock, Cardiogenic | 1990 |
Intra-cellular electrolyte changes and levels of endogenous digoxin-like substance within the plasma in patients with congestive heart failure.
Topics: Adult; Aged; Blood Proteins; Cardenolides; Digoxin; Dobutamine; Electrolytes; Erythrocyte Membrane; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Saponins; Sodium-Potassium-Exchanging ATPase | 1990 |
A new direction for dobutamine.
Topics: Aged; Dobutamine; Heart Failure; Home Care Services; Humans; Infusions, Intravenous; Male; Patient Discharge | 1990 |
Outpatient dobutamine for end-stage congestive heart failure.
Topics: Adult; Aged; Ambulatory Care; Catheterization, Peripheral; Dobutamine; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Middle Aged | 1990 |
[Short-term dobutamine therapy in severe cardiac insufficiency].
Topics: Adult; Aged; Dobutamine; Drug Administration Schedule; Female; Heart Failure; Hemodynamics; Humans; Lidocaine; Male; Middle Aged | 1990 |
Inotropic response to dobutamine in elderly patients with decompensated congestive heart failure.
Topics: Aged; Aged, 80 and over; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1990 |
Effect of inotropic and vasodilator therapy on left ventricular diastolic filling in dogs with severe left ventricular dysfunction.
Topics: Animals; Diastole; Disease Models, Animal; Dobutamine; Dogs; Echocardiography; Ferricyanides; Heart Failure; Hemodynamics; Myocardial Contraction; Nitroprusside | 1990 |
Effect of dobutamine on skeletal muscle metabolism in patients with congestive heart failure.
Topics: Dobutamine; Femoral Vein; Heart Failure; Hemodynamics; Humans; Hydrogen-Ion Concentration; Leg; Magnetic Resonance Spectroscopy; Middle Aged; Muscles; Oxygen Consumption; Phosphorus; Regional Blood Flow | 1990 |
Oxygen uptake/supply dependency. Effects of short-term dobutamine infusion.
Topics: Acidosis, Lactic; Aged; Bacterial Infections; Dobutamine; Female; Heart Failure; Humans; Lactates; Lactic Acid; Male; Middle Aged; Oxygen Consumption; Oxyhemoglobins; Respiration, Artificial; Respiratory Distress Syndrome | 1990 |
Intermittent dobutamine infusion in severe chronic heart failure in elderly patients.
Topics: Aged; Chronic Disease; Clinical Protocols; Dobutamine; Drug Administration Schedule; Heart Failure; Hemodynamics; Humans; Infusions, Intravenous; Male | 1990 |
Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
Topics: Aged; Captopril; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurosecretory Systems; Nitroglycerin; Time Factors; Vasodilator Agents | 1987 |
Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Hemodynamics; Male; Milrinone; Pyridones; Regional Blood Flow; Vasodilator Agents | 1987 |
Chronic therapy of severe heart failure with enoximone.
Topics: Aged; Cardiotonic Agents; Chronic Disease; Dobutamine; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged | 1989 |
A one-sided affair? Myocardial infarction with pulmonary edema and forward failure.
Topics: Aged; Dobutamine; Female; Furosemide; Heart Failure; Humans; Myocardial Infarction; Nitroglycerin; Posture; Pulmonary Edema; Radiography | 1989 |
Dynamic mitral regurgitation. An important determinant of the hemodynamic response to load alterations and inotropic therapy in severe heart failure.
Topics: Aged; Cardiac Catheterization; Cardiac Output; Dobutamine; Echocardiography, Doppler; Exercise; Female; Heart Failure; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Nitroglycerin; Stroke Volume | 1989 |
Potentiation of the effects of enoximone by a dobutamine infusion.
Topics: Aged; Aged, 80 and over; Cardiac Output; Dobutamine; Drug Synergism; Drug Therapy, Combination; Enoximone; Female; Heart Failure; Humans; Imidazoles; Phosphodiesterase Inhibitors | 1989 |
[Severe cardiac decompensation: value in the early hours of a combination of amrinone and dobutamine].
Topics: Aged; Aged, 80 and over; Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1989 |
The effect of dobutamine on myocardial performance and high-energy phosphate metabolism at different stages of heart failure in cardiomyopathic hamsters: a 31P MRS study.
Topics: Adenosine Triphosphate; Animals; Cricetinae; Dobutamine; Heart; Heart Failure; Hydrogen-Ion Concentration; Magnetic Resonance Spectroscopy; Mesocricetus; Myocardium; Oxygen Consumption; Phosphates; Phosphocreatine | 1989 |
Assessing cardiac pumping capability by exercise testing and inotropic stimulation.
Topics: Adult; Aged; Cardiac Output; Cardiomyopathy, Dilated; Dobutamine; Exercise Test; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Stimulation, Chemical | 1989 |
[Acute postoperative psychosyndromes. A prospective study and multivariate analysis of risk factors].
Topics: Adult; Aged; Aged, 80 and over; Brain Damage, Chronic; Delirium; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Neurocognitive Disorders; Oxygen; Postoperative Complications; Prospective Studies; Respiration, Artificial; Risk Factors; Tomography, X-Ray Computed | 1989 |
Dynamics of functional mitral regurgitation during dobutamine therapy in patients with severe congestive heart failure: a Doppler echocardiographic study.
Topics: Aged; Dobutamine; Echocardiography, Doppler; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Mitral Valve Insufficiency; Stroke Volume | 1989 |
Alterations in cardiac beta-adrenoceptor responsiveness and adenylate cyclase system by congestive heart failure in dogs.
Topics: 5'-Nucleotidase; Adenylyl Cyclases; Animals; Chlorides; Colforsin; Dihydroalprenolol; Dobutamine; Dogs; Guanylyl Imidodiphosphate; Heart Failure; Hemodynamics; In Vitro Techniques; Isoproterenol; Kinetics; Manganese; Manganese Compounds; Myocardium; Norepinephrine; Nucleotidases; Receptors, Adrenergic, beta | 1987 |
Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
Topics: Catecholamines; Dobutamine; Dose-Response Relationship, Drug; Heart Failure; Hemodynamics; Humans; Middle Aged; Milrinone; Myocardial Contraction; Pyridones; Receptors, Adrenergic, beta | 1988 |
[The sympathetic nervous activity and beta-adrenergic receptor function in congestive heart failure].
Topics: Bucladesine; Dobutamine; Heart Failure; Humans; Lymphocytes; Norepinephrine; Receptors, Adrenergic, beta; Sympathetic Nervous System | 1987 |
Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
Topics: Aged; Blood Pressure; Bucladesine; Captopril; Cardiac Output; Dobutamine; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Vascular Resistance | 1988 |
The role of adrenergic and dopamine receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cardiotonic Agents; Deoxyepinephrine; Dobutamine; Dopamine; Heart Failure; Hemodynamics; Humans; Levodopa; Receptors, Adrenergic; Receptors, Dopamine | 1985 |
[Positive inotropic agents. Generalities and classification].
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Calcium; Cardiotonic Agents; Digitalis Glycosides; Dobutamine; Ethanolamines; Heart Failure; Heart Ventricles; Humans; Myocardial Contraction; Phosphodiesterase Inhibitors; Practolol; Prenalterol | 1985 |
Comparison of the renal and pulmonary hemodynamic effects of fenoldopam, dobutamine, dopamine and norepinephrine in the anesthetized dog.
Topics: Animals; Benzazepines; Cardiotonic Agents; Dobutamine; Dogs; Dopamine; Female; Fenoldopam; Heart Failure; Humans; Male; Norepinephrine; Pulmonary Circulation; Renal Circulation; Vascular Resistance | 1988 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
Do positive inotropic agents adversely affect the survival of patients with chronic congestive heart failure? III. Antagonist's viewpoint.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Chronic Disease; Death, Sudden; Dobutamine; Heart Failure; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1988 |
[Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs].
Topics: Adrenergic alpha-Antagonists; Animals; Disease Models, Animal; Dobutamine; Dogs; Heart Failure; Hemodynamics; Isoproterenol; Prazosin; Quinazolines | 1988 |
Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
Topics: Coronary Circulation; Coronary Vessels; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Infusions, Intra-Arterial; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Effect of dobutamine on plasma potassium in congestive heart failure secondary to idiopathic or ischemic cardiomyopathy.
Topics: Arrhythmias, Cardiac; Cardiomyopathy, Dilated; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Potassium | 1989 |
Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathies; Cardiomyopathy, Dilated; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged | 1986 |
Comparative hemodynamic and hormonal response of enoximone and dobutamine in severe congestive heart failure.
Topics: Aged; Arginine Vasopressin; Cardiotonic Agents; Depression, Chemical; Dobutamine; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Norepinephrine; Renin; Stimulation, Chemical | 1986 |
Enoximone (MDL 17,043) for stable, chronic heart failure secondary to ischemic or idiopathic cardiomyopathy.
Topics: Administration, Oral; Cardiac Output; Cardiotonic Agents; Dobutamine; Drug Evaluation; Enoximone; Heart Failure; Heart Rate; Humans; Imidazoles; Injections, Intravenous; Physical Exertion | 1986 |
Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
Topics: Amrinone; Cardiotonic Agents; Digoxin; Dobutamine; Enoximone; Ethanolamines; Heart; Heart Failure; Heart Function Tests; Hemodynamics; Humans; Imidazoles | 1986 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
New positive inotropic drugs for the treatment of congestive heart failure.
Topics: Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Dipeptides; Dobutamine; Enalapril; Heart Failure; Humans; Milrinone; Myocardial Contraction; Pyridones; Stimulation, Chemical; Vascular Resistance; Vasodilator Agents | 1985 |
Assessment of the beta-adrenergic receptor pathway in the intact failing human heart: progressive receptor down-regulation and subsensitivity to agonist response.
Topics: Adult; Biopsy; Calcium Gluconate; Cardiac Catheterization; Dobutamine; Endocardium; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Myocardium; Radioligand Assay; Receptors, Adrenergic, beta | 1986 |
Synergistic effect of captopril and dobutamine on left ventricular pressure-volume and pressure-shortening relations in severe cardiac failure.
Topics: Aged; Blood Pressure; Captopril; Cardiac Output; Cardiac Volume; Dobutamine; Drug Therapy, Combination; Heart Failure; Humans; Middle Aged; Myocardial Contraction; Stroke Volume | 1988 |
[Therapy of acute heart failure].
Topics: Acute Disease; Combined Modality Therapy; Digitalis Glycosides; Dobutamine; Dopamine; Drug Therapy, Combination; Epinephrine; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Nitroglycerin; Norepinephrine; Oxygen; Vascular Resistance | 1986 |
Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
Topics: Aged; Blood Pressure; Catecholamines; Dobutamine; Enoximone; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Pulmonary Artery; Stroke Volume; Vascular Resistance | 1985 |
CI-930, a new cardiotonic and vasodilating agent: hemodynamic comparison to dobutamine and long-term clinical effects.
Topics: Cardiotonic Agents; Dobutamine; Dose-Response Relationship, Drug; Female; Heart Failure; Hemodynamics; Humans; Middle Aged; Phosphodiesterase Inhibitors; Pyridazines; Time Factors | 1988 |
Dobutamine rescue for intractable CHF.
Topics: Chronic Disease; Dobutamine; Heart Failure; Humans; Infusions, Intravenous; Monitoring, Physiologic | 1988 |
Combined therapy with dobutamine and amrinone in severe heart failure. Improved hemodynamics and increased activation of the renin-angiotensin system with combined intravenous therapy.
Topics: Adult; Amrinone; Arginine Vasopressin; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System | 1987 |
[Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
Topics: Animals; Captopril; Dobutamine; Heart Failure; Hemodynamics; Male; Milrinone; Muscles; Myocardial Infarction; Pyridones; Rats; Rats, Inbred Strains; Regional Blood Flow; Renal Circulation; Skin; Splanchnic Circulation | 1987 |
Regional blood flow and hemodynamics in the rabbit with adriamycin cardiomyopathy: effects of isosorbide dinitrate, dobutamine and captopril.
Topics: Animals; Captopril; Cardiomyopathies; Dobutamine; Doxorubicin; Heart Failure; Hemodynamics; Isosorbide Dinitrate; Rabbits; Regional Blood Flow | 1987 |
Inotropic therapy for cardiac failure associated with acute myocardial infarction.
Topics: Amrinone; Cardiotonic Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Heart Failure; Humans; Myocardial Infarction; Vasodilator Agents | 1988 |
Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
Topics: Blood Pressure; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Heart; Heart Failure; Heart Ventricles; Hemodynamics; Humans; Myocardial Contraction; Neurosecretory Systems; Norepinephrine; Vascular Resistance; Vasodilation | 1988 |
[Determination of active components of amrinone by analysis of pressure-volume results; use of the conductance (volume) catheter technic and rapid load change by balloon occlusion of the inferior vena cava].
Topics: Amrinone; Cardiac Catheterization; Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Myocardial Contraction; Myocardium; Nitroprusside; Oxygen Consumption | 1987 |
[Combination of different inotropic agents in the treatment of chronic refractory cardiac insufficiency].
Topics: Amrinone; Dobutamine; Drug Therapy, Combination; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged | 1987 |
Effects of dobutamine on left ventricular performance in newborns as determined by systolic time intervals.
Topics: Cardiotonic Agents; Dobutamine; Heart Failure; Humans; Infant, Newborn; Myocardial Contraction | 1987 |
Short- and long-term dobutamine treatment in chronic ischemic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Radionuclide Angiography; Stroke Volume; Time Factors | 1987 |
Hemodynamic and regional blood flow response to piroximone (MDL 19,205) in dogs with congestive heart failure: a comparison with dobutamine.
Topics: Animals; Coronary Circulation; Dobutamine; Dogs; Heart Failure; Heart Rate; Hemodynamics; Imidazoles; Regional Blood Flow | 1987 |
[Effects of dobutamine on hemodynamics, myocardial metabolism and mechanical efficiency in patients with old myocardial infarctions].
Topics: Adult; Aged; Coronary Circulation; Dobutamine; Female; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Vascular Resistance | 1987 |
Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: clinical experience in 21 patients.
Topics: Adult; Aged; Ambulatory Care; Cardiac Output; Chronic Disease; Dobutamine; Dopamine; Equipment Failure; Female; Heart Failure; Humans; Infusion Pumps; Infusions, Intravenous; Male; Middle Aged; Stroke Volume | 1987 |
Prolonged beneficial effects of dobutamine in refractory heart failure--case histories.
Topics: Dobutamine; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Time Factors | 1987 |
[Treatment of cardiac insufficiency in adults].
Topics: Adult; Anticoagulants; Digitalis Glycosides; Diuretics; Dobutamine; Heart Failure; Humans; Isoproterenol; Vasodilator Agents | 1986 |
Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
Topics: Blood Pressure; Coronary Vessels; Dobutamine; Female; Heart Failure; Hemodynamics; Humans; Injections; Male; Middle Aged; Myocardial Contraction; Norepinephrine; Sympathomimetics | 1987 |
The hemodynamic effects of ventricular pacing with and without atrioventricular synchrony in patients with normal and diminished left ventricular function.
Topics: Adult; Aged; Aged, 80 and over; Atrioventricular Node; Cardiac Pacing, Artificial; Dobutamine; Female; Heart Conduction System; Heart Failure; Heart Rate; Heart Ventricles; Hemodynamics; Humans; Male; Middle Aged; Myocardial Contraction; Syncope | 1987 |
Combined hemodynamic and scintigraphic assessment of piroximone (MDL 19,205) and comparison with dobutamine and nitroprusside.
Topics: Adult; Aged; Dobutamine; Drug Administration Schedule; Ferricyanides; Heart Failure; Hemodynamics; Humans; Imidazoles; Male; Middle Aged; Nitroprusside; Radionuclide Imaging | 1987 |
Acute hemodynamic effects of dopamine, dobutamine, and isoproterenol in congested infants or young children with large ventricular septal defect.
Topics: Dobutamine; Dopamine; Heart Failure; Heart Septal Defects, Ventricular; Hemodynamics; Humans; Infant; Isoproterenol; Pulmonary Circulation | 1987 |
[Tolerance development during a 1-week course of dobutamine treatment].
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Dobutamine; Drug Tolerance; Echocardiography; Female; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Stimulation, Chemical; Water-Electrolyte Balance | 1986 |
Additive effects of dobutamine and amrinone on myocardial contractility and ventricular performance in patients with severe heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Blood Pressure; Dobutamine; Drug Synergism; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Contraction; Stroke Volume | 1986 |
[Effects of intravenous amrinone (Win 40680) on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine].
Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1986 |
Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure.
Topics: Aged; Ambulatory Care; Cardiac Output; Dobutamine; Follow-Up Studies; Heart Failure; Humans; Infusion Pumps; Male; Middle Aged; Time Factors | 1986 |
Effects of intravenous amrinone on heart failure complicated by acute myocardial infarction: comparative study with dopamine and dobutamine.
Topics: Aged; Amrinone; Dobutamine; Dopamine; Female; Heart Failure; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction | 1986 |
Drug therapy for congestive heart failure.
Topics: Amrinone; Dobutamine; Heart Failure; Humans | 1986 |
The value of mixed venous oxygen saturation as a therapeutic indicator in the treatment of advanced congestive heart failure.
Topics: Cardiac Output; Dobutamine; Female; Heart Failure; Humans; Male; Middle Aged; Monitoring, Physiologic; Oxygen; Prognosis; Veins | 1987 |
Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Diuretics; Dobutamine; Dopamine; Drug Administration Schedule; Edema; Heart Diseases; Heart Failure; Heart Rate; Hemodynamics; Horse Diseases; Horses; Injections, Intravenous; Lidocaine; Procainamide; Propranolol; Quinidine | 1985 |
[Significance of nitrates in acute therapy of heart failure with and without lung edema].
Topics: Cardiac Output, Low; Cardiomyopathy, Dilated; Dobutamine; Drug Therapy, Combination; Heart Failure; Hemodynamics; Humans; Isosorbide Dinitrate; Nitrates; Nitroglycerin; Pulmonary Edema; Regional Blood Flow; Shock, Cardiogenic | 1985 |
Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure.
Topics: Cardiac Output; Dobutamine; Exercise Test; Heart Failure; Humans; Male; Middle Aged; Physical Exertion; Prazosin; Pulmonary Gas Exchange; Pulmonary Wedge Pressure | 1986 |
Chronic congestive heart failure. Where have we been? Where are we heading?
Topics: Aminopyridines; Amrinone; Biopsy; Calcium Channel Blockers; Cardiology; Chronic Disease; Digitalis; Dobutamine; Dopamine; Forecasting; Heart Failure; Hemodynamics; Humans; Infusions, Parenteral; Myocardial Contraction; Myocardium; Plants, Medicinal; Plants, Toxic; Prognosis; Quality of Life; Vasodilator Agents | 1986 |
Arrhythmias associated with intermittent outpatient dobutamine infusion.
Topics: Ambulatory Care; Arrhythmias, Cardiac; Dobutamine; Heart Failure; Humans; Infusions, Parenteral | 1986 |
Comparative effects of combined dopamine and nitroprusside versus dobutamine and nitroprusside infusions for computer-controlled management of low-output cardiac failure after open heart surgery.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Computers; Dobutamine; Dopamine; Drug Therapy, Combination; Female; Ferricyanides; Heart Failure; Hemodynamics; Humans; Male; Nitroprusside; Pulmonary Circulation; Vascular Resistance | 1986 |
Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Topics: Aged; Coronary Circulation; Dobutamine; Female; Heart; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Milrinone; Myocardium; Pyridones | 1986 |
Outpatient dobutamine infusion using a totally implantable infusion pump for refractory congestive heart failure.
Topics: Aged; Ambulatory Care; Catecholamines; Dobutamine; Equipment Design; Heart Failure; Humans; Infusions, Parenteral; Male; Prostheses and Implants | 1985 |
Comparative vasoactive therapy for heart failure.
Topics: Adult; Aged; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Cardiotonic Agents; Catecholamines; Dobutamine; Dopamine; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Pulmonary Wedge Pressure; Tachycardia; Vascular Resistance | 1985 |
Pathophysiology of cardiac failure.
Topics: Aminopyridines; Amrinone; Blood Pressure; Cardiac Output; Cardiotonic Agents; Dobutamine; Dopamine; Furosemide; Heart; Heart Failure; Humans; Myocardial Contraction; Nitroprusside; Norepinephrine; Oxygen Consumption; Vascular Resistance; Vasoconstriction | 1985 |
[Regional left ventricular function in dilated cardiomyopathy: observation of regional left ventricular wall motion before and during dobutamine administration].
Topics: Adult; Cardiomyopathy, Dilated; Dobutamine; Echocardiography; Female; Heart Failure; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve; Myocardial Contraction; Papillary Muscles; Prognosis | 1985 |